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Type 1 diabetes is an autoimmune condition that results in the inability of the pancreas to produce 
insulin. The mainstay of treatment for this disease is administration of exogenous insulin. Adherence 
to this therapy is vital in avoiding both life-threatening short-term complications and life-limiting 
long-term complications. Despite its importance, it is an area that many children and young people 
struggle with. While there are a huge number of studies that attempt to identify individual factors 
affecting adherence, to date there have been no studies that attempt to draw these factors together 
into a single systematic review. 
 
Aims 
The aim of this project is to undertake a systematic review of insulin adherence in children and 
young people with T1DM, to understand what impact the factors studied have, and determine the 
areas that have/have not been researched with a view to guiding future research. 
 
Methods 
A systematic review was undertaken following a search of five medical databases aided by extensive 
training on optimising searches. The PICO framework was used to create inclusion/exclusion criteria 
that was used decide which studies to include in the review based on agreement of two reviewers. 
The key inclusion criteria stated that study participants must be humans, under the age of 18, with a 
diagnosis of T1DM and receiving insulin therapy. All study types that contained primary data were 
included. 
 
Included studies had relevant information entered into a data extraction tool, which could then be 
used to perform quality assessments and thematic analysis. 
 
Results 
One thousand three hundred and six studies were identified, of which 76 were included in the final 
analysis. Two hundred and thirty-six factors were assessed for association with adherence, using 38 
different methods. Eleven factors were assessed by four or more studies. Age was the most 
commonly assessed factor (33 studies), followed by HbA1c/glycaemic control (20 studies), duration 
of diabetes (19 studies) and gender (15 studies). There were 210 factors (89%) that were only 
considered in a single study. 
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Overall, 9 969 children and young people have been included in studies assessing adherence to 
insulin (mean: 133, range: 28 to 1 028). Formal meta-analysis was not able to be performed due to 
the large number of different methods of measuring adherence, methods of data presentation and 
differences in populations studied. Amongst the factors that have been assessed by multiple studies, 
there were some that displayed good agreement between studies on the direction of the effect on 
insulin adherence. Increasing age, depression (in the child/young person) and smoking frequency 
showed good agreement between studies for decreased adherence. Higher self-efficacy, family 
support, exercise frequency, increased responsibility taken by the child, higher socio-economic 
status and better parent-child relationship showed good agreement between studies for improved 
insulin adherence. 
 
Factors were divided into overarching themes: demographics, past medical history, diabetes 
management, psycho-social or family dynamics. Factors assigned to the demographics theme were 
the most frequently assessed by multiple studies. The most commonly assigned theme was the 




This prospective cohort study was designed with the aim of assessing the correlation between 
disease severity at diagnosis with a variety of psycho-social outcomes with a view to exploring their 
relationship with later adherence to insulin therapy. Recruitment for the study was interrupted by 
the COVID-19 pandemic after two patients had entered the study. The findings of this initial 
recruitment phase and the systematic review will be used to improve the study going forwards. 
 
Conclusion 
Insulin adherence has been assessed in multiple studies, but the variety of methods and 
heterogeneous populations make comparisons difficult. Harmonising methodologies for assessing 
adherence to insulin would enable improved assessment of factors affecting adherence to this 
critical medication and lead to the identification of potential barriers to target to improve adherence 
in T1DM in the future. Future studies could aim to assess modifiable factors that are currently 
under-researched, while also aiming to assess adherence in a way that considers the complex nature 
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Type 1 diabetes mellitus (T1DM) is a disease characterised by a complete lack of insulin production 
from the beta cells of the Islets of Langerhans within the pancreas (1). Though some remission of 
T1DM is common after following initiation of therapy, this “honeymoon phase” only lasts an average 
7 months before insulin production ceases permanently (2).  
 
In the majority of cases, this is caused by autoimmune destruction (type 1A) of the beta cells. In less 
than 10% of patients, the pathogenesis is idiopathic, with destruction/failure of the beta cells 
without any evidence of autoimmunity (type 1B) (3). The first clinical symptoms usually appear after 
approximately 80% of the total beta cell mass has been destroyed. This is often precipitated by a 
time of increased insulin demand, such as during stress or infection (4).  
 
The exact underlying trigger of T1DM is a complicated interaction of genetic and environmental 
factors that is still not fully understood. 
 
The main genetic component is attributed to certain haplotypes of the human leukocyte antigen 
(HLA) complex; specifically, HLA-DR3 and/or HLA-DR4 subtypes (5). Over 90% of T1DM patients 
possess one of these particular subtypes, versus around 40% of people without the disease (6). 
These HLA molecules are responsible for allowing helper T lymphocytes (CD4+) recognise antigens, 
thereby triggering an immune response (1). 
 
Other contributing genes include the insulin gene promoter (insulin variable number of tandem 
repeats - VNTR) and the cytotoxic T lymphocyte antigen-4 (CTLA-4) (5).  
 
There are three classes of insulin VNTRs, with the number on tandem repeats increasing from class 
1, to 2, to 3 (7). Class I is associated with an increased risk of developing T1DM, whereas class III has 
a protective effect (7).  
 
CTLA-4 is expressed by T cells and acts as an inhibitory receptor with certain alleles conferring to 
substantially increased risk of T1DM and other autoimmune conditions such as rheumatoid arthritis 
(7). Of particular interest is the contribution of CTLA-4 to the development of autoimmune thyroid 
17 
 
disease (7), which is the most common autoimmune disorder associated with T1DM, with a quarter 
of children with T1DM having thyroid autoantibodies at diagnosis (8).  
 
The presence of specific genes alone is not sufficient to guarantee the development of T1DM, 
making the relationship between T1DM and family history a complicated one; 85% of T1DM patients 
have no family history (9). In fact, the population seeing the greatest increase in their incidence rate 
is the genetically low risk population, suggesting that the contribution of environmental factors to 






Figure 1.1 Pathophysiology of T1DM. Legend; CD4+ T cell: Helper T cell, CD8+ T cell: Cytotoxic T cell, β-cell: beta-cell, MHC: 
Major Histocompatability Complex, BCR: B-cell receptor, TCR: T-cell receptor, DC: dendritic cell. Adapted from (10). A β-cell 
autoantigen is presented to the CD4+ and CD8+ T cells and the B cell via interface between T cell receptors and major 
histocompatibility complexes. This causes the CD8+ T cell to have direct cytotoxic effects upon the β-cells within the Islets of 
Langerhans, which are propagated by the effect of the CD4+ T cell and the islet cell autoantibodies produced by the B cell. 
The islet cell autoantibodies also have a direct damaging effect upon the β-cells. 
  
Islet cell autoantibodies 
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The risk of an individual with a positive family history developing T1DM varies depending on which 
other family member is affected. The maternal impact appears to be the least strong, with 2-4% of 
individuals with a mother with T1DM going on to develop the disease, compared with 6-9% of 
individuals with a father with T1DM (11). Concordance (the incidence of both siblings being affected) 
between non-monozygotic twin siblings is around 10% (11).  
 
Monozygotic twin studies show a concordance rate of around 50% (12). Even in the studies that 
suggest higher concordance, this number is always significantly short of 100% (11). 
 
One of the more extensively studied environmental factors is viral infection. The main viruses 
implicated in the development of T1DM are enteroviruses, such as coxsackievirus B. In a Finnish 
study (13), the appearance of islet autoantibodies correlated with the seasonal variance of 
enterovirus infection.  
 
The mechanism by which these viral infections can trigger an autoimmune response is not clear, and 
there are multiple proposed mechanisms depending on the virus implicated (14). 
 
In the case of coxsackievirus B, it produces an inflammatory response in the islets of Langerhans, 
which would lead to introduction of autoantigens as part of the inflammatory process. The virus also 
possesses proteins that molecularly strongly resemble an amino acid found within the pancreatic 
beta cells, causing an autoimmune response via molecular mimicry (14) (15). Other proposed 
mechanisms include direct destruction of beta cells by a virus or causing an imbalance between 
cytotoxic and regulatory T cells (Tregs), in favour of cytotoxic T cells (15) (Figure 1.2). 
 
It is worth noting that no viral vaccine – even in individuals with high-risk alleles – has been shown to 
increase the risk of developing T1DM (14). In fact, there is some evidence in favour of the inverse 
relationship, with the early immune response granted by vaccination potentially reducing viral 
infection of the Islets of Langerhans within the pancreas, thereby protecting against inflammation 





Figure 1.2 Proposed mechanisms leading to Type 1 Diabetes following enterovirus infection. Legend; Anti-VP4 IgG: anti-
Viral Protein 4 Immunoglobulin G, FcyRII: low-affinity IgG binding receptor, CAR: Chimeric Antigen Receptor, CD14: Cluster 
of Differentiation, IFN-α: Interferon Alpha, IFN-β: Interferon Beta, MHC: Major Histocompatability Complex, OAS1: 
Oligoadenylate Synthase 1, IFIH1: Interferon Induced with Helicase C Domain 1.  Adapted from Hober et al. (16) Following 
enterovirus infection and the innate response of the immune system, the adaptive immune response begins with 
presentation of viral antigens and β-cell antigens from cells that have been infected with the virus. The viral antigen 
presentation is part of the desired immune response and ultimately contributes to the resolution of the infection, but the β-
cell antigen presentation results in an autoimmune response via activation of T cells production of β-cell autoantibodies 
against the β-cells. This autoimmune response does not happen in all individuals who have an enterovirus infection. The 
exact reasons for this are incompletely understood, but certain genetic variations – particularly in some subtypes of HLA – 







Type 1 diabetes mellitus (T1DM) accounts for 5-10% of all cases of diabetes worldwide, with the 
remainder being made up of type 2 diabetes mellitus (T2DM), maturity-onset diabetes of the young 
(MODY) or cystic fibrosis-related diabetes (CFRD) (9). In children however, around 95% of diabetes is 
type 1 (Table 1.1) (9). 
 
Type 2 diabetes mellitus (T2DM) in children is a relatively new occurrence, with the first cases being 
officially diagnosed the UK in 2000 (though earlier cases had been reported in the US in some Native 
American populations) (17). These first UK cases were all in overweight girls of Asian origin, who 
have a roughly 9-fold increased risk of developing T2DM when compared with their Caucasian 
counterparts (in whom the first diagnosis occurred two years later) (9). Even in this higher-risk 
group, T2DM is still comparatively rare in children (17). 
 
T1DM is the most common metabolic disease in young people (18). Thirty thousand children in the 
UK are currently living with T1DM and incidence is increasing by about 4% every year. This gives the 
UK one of the highest rates of T1DM worldwide – only 4 countries have a higher incidence (Table 
1.2) (19). Incidence is also increasing worldwide, at a rate of around 3% per year. Only one country – 
Sweden – has reported a steady incidence rate (5). If the worldwide trend were to continue at this 
rate for the next decade, the number of T1DM cases would nearly double (5). 
 
There is a huge range of incidence worldwide, with the highest incidence of 57.6 per 100 000 
children (in Finland) being nearly 600 times that of the lowest incidence of 0.1 per 100 000 (in Papua 
New Guinea and Venezuela) (19). Interestingly, there is even a huge variance in incidence between 
nearby countries. For example, the distance between Estonia and Finland is around 75 miles, but 






Type of Diabetes Percentage of Total Diabetes Cases in Children 
(under the age of 19) 
T1DM 95.1% 
T2DM 1.9% 
MODY, CFRD and Undefined Diagnosis 2.73% 
Other Types 0.27% 
Table 1.1 Types and prevalence of different type of diabetes in children. Adapted from: Diabetes UK (9).  Legend; T1DM: 




Country Incidence per 100 000 
Children Between the Ages of 
0 and 14 
Finland 57.6 
Sweden 43.1 










New Zealand 18 
Poland 17.3 
Czech Republic 17.2 
Estonia 17.1 














Papua New Guinea 
Venezuela 
0.1 





One proposed reason for the increasing incidence of T1DM is the hygiene hypothesis, which 
suggests that exposure to a range of pathogens in early childhood decreases the incidence of 
immune-mediated diseases such as asthma and T1DM (20). This effect has been demonstrated in 
mice; individuals raised in sanitary conditions develop T1DM at a higher rate than those raised in less 
sanitary conditions (20). 
 
Unlike other autoimmune conditions, which tend to affect women more often, T1DM appears to 
affect both males and females equally (5). Incidence tends to increase with age up until puberty, 





Figure 1.3 Age-related incidence rate of T1DM. Adapted from (10). 
  






In the UK, NICE (National Institute of Health and Care Excellence) has published guidance on how 
T1DM should be managed in children (21). 
 
The mainstay of T1DM treatment is insulin replacement, given via varying methods of subcutaneous 
injection (22). 
 
The mechanism of action of insulin varies slightly in each of the tissues where it acts, but all have the 
net effect of reducing blood glucose levels (23). In skeletal muscle, insulin promotes storage of 
glucose as glycogen, as well as promoting use of glucose by the cells (23). In the liver, as with in 
skeletal muscle, insulin increases the storage of glucose as glycogen and additionally increases fat 
formation from glucose (lipogenesis) and decreases the formation of glucose from non-carbohydrate 
sources (gluconeogenesis) (23). It achieves this through mediation of gene expression (23). Lastly, in 
white adipose tissue (WAT), insulin decreases the breakdown of fat into glucose (lipolysis), while 
promoting its storage as fat via lipogenesis (23). 
 
On a molecular level, all of these mechanisms are started when insulin binds to an insulin receptor 
on the cell surface membrane, triggering a cascade that ultimately results in the movement of 
glucose transport proteins (GLUT-4) to the cell surface (23). The concentration of glucose outside of 
the cell is greater than the concentration of glucose inside of the cell, and so glucose can enter the 
cell through the GLUT-4 proteins via facilitated diffusion (24). 
 
 
The two main regimens of insulin therapy that are used in children are 
• Multiple Daily Injection (MDI) 
• Continuous Subcutaneous Insulin Infusion (CSII), commonly known as insulin pump therapy 
and 
MDI consists of short or rapid-acting insulin before meals and snacks and long-acting insulin at least 
once per day (21).  
 
There are 5 main types of insulin, separated according to their duration of action and time of onset 




In CSII, insulin is delivered via an indwelling cannula that is connected to a programmable pump (21). 
These devices usually contain rapid or short-acting insulin that is delivered automatically at a 
programmable variable basal rate, with boluses for meals/snacks controlled manually by the patient 
(21). This method is often considered if the first-line MDI treatment is unsuitable for the patient’s 
lifestyle or if their glycaemic control on MDI has been consistently poor (21). 
 
There are currently 9 insulin pumps on the market in the UK, each with their own pros and cons. 
Most pumps are “tethered”, meaning that the pump is connected to a thin section of plastic tubing 
that delivers the insulin to the patient, though some are “patch” pumps, which attach directly to the 
skin and as such, do not require any tubing (26). Pumps can also be “integrated”, meaning that they 
can communicate directly with a CGM (26). Patients using pumps that lack this capability will either 
use SMBG or will have a separate CGM device (26). Table 1.4 summarises the 9 pumps currently 




Type of Insulin Examples (brand name) Approximate 
time to 
onset 
Approximate time to 
peak of action 
Approximate 
duration of effect 
Role in treatment 
Rapid-acting • Insulin lispro 
(Admelog, Humalog) 
• Insulin aspart (Fiasp, 
NovoLog) 
15 minutes 1 hour 2-4 hours Taken before meals 
Short-acting • Regular insulin 
(Humulin R, Novolin 
R, Velosulin R) 
30 minutes 2-3 hours 3-6 hours Taken before meals 
Intermediate-
acting 
• Insulin isophane/NPH 
(Humulin N, Novolin 
N, ReliOn) 
2-4 hours 4-12 hours 12-18 hours Usually taken twice per day 
to cover elevations in 
glucose when rapid/short-
acting insulin wears off. May 
be combined with 
rapid/short-acting insulin in 
a mixed insulin regimen. 
Long-acting • Insulin detemir 
(Levemir) 
• Insulin glargine 
(Lantus) 
3-4 hours No defined peak Up to 24 hours Usually taken once or twice 
per day to cover elevations 
in glucose when rapid/-
acting insulin wears off 
Ultra-long-acting • Insulin degludec 
(Tresiba) 
• Insulin glargine u-300 
(Toujeo) 
6 hours No defined peak Up to 36 hours May be useful in patients for 
whom regular injections 
prove challenging 
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Bolus settings • Up to 
50U 
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• Up to 30U • Up to 30U • Up to 80U 






• Up to 80U 






• Up to 25U 






Table 1.4 Insulin pumps currently available in the UK and their features. Legend; U: units, U/h: units per hour, Y: yes, N: no. Adapted from (37).
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All insulin regimens require some sort of monitoring of blood glucose levels, which in the first 
instance is usually done with Self-Monitoring of Blood Glucose (SMBG), where the patient will take 
their own capillary blood glucose a recommended 5 times per day (21). Alternatively, patients may 
have Continuous Glucose Monitoring (CGM), where a sensor continually monitors the glucose levels 
in the interstitial fluid via a cannula just under the skin (38). These can be “standalone”, where the 
patient can view their glucose levels via a separate device or “integrated”, where the CGM is 
connected to a pump, which can display glucose levels in addition to delivering insulin (38). 
 
Management of children with diabetes is typically done via a multi-disciplinary team (MDT) 
approach (21). Teams should comprise of diabetologists, dieticians, nurse educators/diabetes nurse 
specialists and clinical psychologists (21). It is recommended that children with diabetes be seen in 




As a part of the 4 clinic appointments each year, patients should also attend an annual review where 
they receive screening for autoimmune thyroid disease (21) at all ages, and screening for diabetic 
nephropathy and cardiovascular risk factors (including blood pressure, lipid levels, BMI and smoking 
status) from the age of 12 (21). Additionally, screening for diabetic retinopathy and peripheral 
vascular disease and neuropathy (via assessment of the feet) should also be done annually from the 
age of 12 (21). Most of these assessments will be done at the time of the annual review 
appointment (21) though the retinopathy screening is usually done by an optician (39). 
 
HbA1c (glycated haemoglobin) is the primary outcome measure for diabetes with a target of 
48mmol/mol or lower (40), and while this has improved significantly in over the past decade, from 
an average HbA1c of 72mmol/mol in the 2005-06 audit period, the average in 2018-19 was still 
61.5mmol/mol (40). Figure 1.4 shows some of the improvements in diabetes care in the past decade 
have impacted HbA1c management (41). 
 
Other outcome measures (as defined by the Royal College of Paediatrics and Child Health – RCPCH 
(42)) exist relating to microvascular disease (such as kidney and eye disease), large vessel disease 
and autoimmune disease. These are summarised in Table 1.5. 
 
Most patients expect to transition from paediatric services to adult care between the ages of 17 and 
19 years old, though in reality, the mean age of transition is 19.5-20.1 years of age (43). The 
transition process can be a challenging time for patients and healthcare providers alike with only 
14% of transitioning patients meeting their targets for glycaemic control (44) and HbA1c rising from 
a mean of 58mmol/mol at their last paediatric appointment, to a mean of 77mmol/mol at their first 
adult visit (45). It has been suggested that the reasons for this worsening in glycaemic control can be 
attributed to the upheaval that young people often face in their lives around this age, as attendance 
at university takes them away from their families, as well as financial, educational and social issues 
which can affect young people whether they are at university or not, all of which can all have a 
detrimental effect on treatment adherence (46). Around a third of patients report feeling unsatisfied 





Figure 1.4 Changes to diabetes management in England and Wales since 2005 and associated changes in median HbA1c. 
Legend; HbA1c: glycosylated haemoglobin, mmol/mol: millimoles per mole. Adapted from (41). 
 
Outcome Measurement/assessment 
Glycaemic control HbA1c 
Kidney disease Albuminuria 
Eye disease Dilated eye examination 
Large blood vessel disease Blood pressure 
Cholesterol 
Body mass index (BMI) 
Smoking status 
Table 1.5 Summary of core outcome measures for T1DM in children, adapted from (42). Legend; HbA1c: glycated 




1.3.1. Treatment Adherence 
 
How effective insulin therapy is in achieving good glycaemic control depends hugely on the 
adherence of the patient with said therapy (49), with the definition of adherence being “the extent 
to which a person’s behaviour coincides with medical or health advice” (50). The terms “compliance” 
and “adherence” may be used interchangeably, but modern medical literature tends to prefer the 
term “adherence” as it is seen as a more empowering term for the patient, as opposed to the more 
paternalistic view of “complying” (50) (51).  
 
T1DM is not a condition where the patient takes their medicine once per day and then forgets about 
it; following advice on blood glucose monitoring (BGM), diet, exercise, hypoglycaemia management 
and regular clinic attendance are all required in order to optimise adherence and subsequent 
glycaemic control (52). Given this long list of tasks, it is perhaps not surprising that time constraints 
are a frequently reported barrier to adherence (52). Other reported barriers are numerous and 
wide-ranging and include lack of treatment understanding behavioural issues and fear of 
hypoglycaemia (53). 
 
Frequency of Blood Glucose Monitoring (BGM) may be used as an objective marker of treatment 
adherence. When comparing BGM frequency in patients on MDI versus those using CSII, a 2019 
study (54) found that CSII users had higher frequency of BGM, inferring better adherence, though 
this was only statistically different when including the readings registered by the CSII users’ CGM 
device. 
 
The importance of the link between treatment adherence and better diabetes outcomes cannot be 
overstated; a meta-analysis of 21 studies (that included a total of 2492 adolescents) showed that 
better treatment adherence is strongly positively correlated with better glycaemic control, 
irrespective of any demographic variables (55). The impact of adherence is lasting, and children with 
suboptimal adherence (and subsequent suboptimal glycaemic control) have a higher risk of long-
term complications, even if their glycaemic control improves as adults (52).  
 
It is important to be able to assess treatment adherence, so that improved adherence can be 
promoted, resulting in better diabetes outcomes in both the short and long-term (50). However, 
unlike for glycaemic control, there is no objective biomarker to measure adherence, meaning that 




There have been many studies that examine factors that affect adherence, but to date there have 
been no systematic reviews that attempt to collate this information. 
 
1.4. Complications of T1DM 
 
 
T1DM is therefore complex, and difficult. Furthermore, the disease has a range of short- and long-
term complications that are related to underlying pathophysiology and adherence to treatment, 
which impacts the survival of patients. The life expectancy of a person with T1DM is reduced by an 
average of 20 years, when compared with people without T1DM. For T2DM, the average reduction 
in life expectancy is 10 years (56). 
 
These complications of T1DM can be both short and long term. The long-term complications can be 
further classified into those that affect the small blood vessels in the body (microvascular) and the 
large blood vessels (macrovascular). Short-term complications are not classified in this way as their 
pathogenesis is systemic. 
 
1.4.1. Short-Term – Hypoglycaemia 
 
Hypoglycaemia is generally said to occur when blood glucose is below 4mmol/L (57). 
 
Administration of insulin will decrease the blood sugar. However, in T1DM, either the dose used, or 
the lack of a normal physiological feedback loop, can cause a hypoglycaemic episode. These are 
common, and potentially dangerous complications of insulin therapy (58). The average person with 
T1DM has two episodes of hypoglycaemia (that is serious enough to cause symptoms) per week and 
up to 40% of these patients will have at least one episode of severe hypoglycaemia (episodes that 
require treatment with glucagon) each year (58).  
 
The risk of hypoglycaemia goes up with tight glycaemic control. Risk also tends to be higher in 
individuals who have had T1DM for longer (59). This is because the normal glucagon response to 
hypoglycaemia tends to become less effective over time, with almost all patients being unable to 
mount an adequate response after 5 years of the disease (60). 
 
Signs and symptoms of early hypoglycaemia include dizziness, lethargy and sweating and if 
untreated can even progress to cause collapse and seizures (58). The vast majority of cases never 
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progress this far and are easily corrected, but it is still a huge worry of diabetic patients; studies have 
shown that the fear of hypoglycaemia is comparable to that of retinopathy and nephropathy (61). 
This creates a potential barrier to achieving good glycaemic control, as many patients would rather 
tolerate slightly higher blood glucose levels than risk having a hypoglycaemic episode (61). 
 
The potential for hypoglycaemia can further negatively impact a patient’s mental health and can 
restrict the activities that patients feel they are able to do, from sporting activities to driving (62). 
 
1.4.2. Short-Term – Hyperglycaemia and Diabetic Ketoacidosis 
 
Like hypoglycaemia, there is some variability as to the precise value that constitutes hyperglycaemia, 
but it is generally considered to be blood glucose readings above 7.8mmol/L (63). 
 
Some of the most common symptoms of T1DM (such as polydipsia and polyuria) (62) - are as a result 
of hyperglycaemia (64). The hyperglycaemia results in osmotic diuresis in the kidneys, resulting in 
dehydration and loss of electrolytes. Other earlier signs of hyperglycaemia include fatigue and 
headache (65). 
 
If a person remains in untreated hyperglycaemia, they may enter into diabetic ketoacidosis (DKA) 
(66). Since people with undiagnosed diabetes are not receiving treatment, DKA can be their first 
presentation of the disease (67). 20% of DKA cases are in previously undiagnosed T1DM patients 
(68).  
 
In the vast majority of cases, it occurs in people with T1DM, due to their absolute (as opposed to 
relative, as in T2DM) deficiency of insulin. This absolute deficiency results in an inability of glucose to 
enter the body’s cells, leading to increased glycogenolysis and – more problematically – increased 
gluconeogenesis (production of glucose from non-carbohydrate sources, which takes place 
predominantly in the liver), which produces acidic ketone bodies (69). To try and compensate for 
this decrease in pH, the body attempts to get rid of acidic hydrogen ions by vomiting, which worsens 
the dehydration and electrolyte loss - initially resulting from polyuria - subsequently impairing renal 
function (70). With decreased renal function comes decreased glycosuria, worsening the 
hyperglycaemia, which is further worsened by increased cortisol and growth hormone production, 




The classical picture of polyuria, polydipsia and weight loss is seen less commonly in younger 
children, where it may be misdiagnosed as respiratory disease such as asthma or bronchiolitis (71). 
This can be an especially dangerous misdiagnosis, as the treatments for these conditions frequently 
involve the use of corticosteroids, which worsen hyperglycaemia (71). 
 
Treated DKA across all stages of severity has a mortality rate of 2-5% (66), and if left untreated, is 
invariably fatal (67). In 60-90% of deaths in DKA, the cause of death is cerebral oedema, making it 
the most common cause of death (71). By the time cerebral oedema has occurred, the mortality rate 
is around 25% (71). For patients that survive this advanced stage, 10-25% will go on to develop 
pituitary insufficiency, which can be a significant cause of morbidity requiring lifelong treatment 
(71).  
 
Around 1 in 10 T1DM patients reported at least one case of DKA in the previous year (69).  
 
Along with the aforementioned polyuria, polydipsia and vomiting, abdominal pain and a history of 
weight loss are also common (69). 
 
The most common cause of DKA is non-compliance with insulin therapy, accounting for just under 
half of all cases. Infection is the next most common cause (69).  
 
NICE has published national guidance on how DKA in children should be managed under section 1.4 
of their paediatric diabetes management guideline (21). The general principles of DKA management 
are: 
• Rehydration 
• Providing insulin 
• Correcting electrolyte imbalances (21) (72). 
 
In particular regarding electrolyte imbalances is the provision of potassium, with severe 
hypokalaemia being the most common derangement during treatment. This occurs due to one of 
the other effects of insulin, which causes potassium to enter the cells from the blood (73).  
 
If untreated, hypokalaemia can result in potentially fatal cardiac arrhythmias (71). Electrocardiogram 
(ECG) changes can be seen in the earlier stages of hypokalaemia and as such patients will often have 





Figure 1.5 Pathophysiology of diabetic ketoacidosis, from Round, J (74). 
  
Prostaglandins (PGI2 and PGE2) 
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1.4.3. Long-Term – Retinopathy 
 
Diabetic retinopathy is the most common cause of new-onset blindness in people aged 20-74 (75).  
In one study, 3.6% of the T1DM patients sampled were legally blind, with diabetic retinopathy being 
the cause in 86% of cases (76). Though less affected, retinopathy still affects T2DM patients, with the 
same study finding that 1.6% of type 2 diabetics were blind and that diabetic retinopathy was the 
cause in around a third of cases (with the significantly lower proportion being due to the higher 
incidence of other eye diseases in older people) (76).  
 
Presence and severity of diabetic retinopathy is best predicted by the duration of the diabetes 
diagnosis, with prevalence increasing with each year post-diagnosis (76). Almost all people with type 
1 diabetes will have some form of diabetic retinopathy 20 years post-diabetes diagnosis (76).  
 
It begins as mild non-proliferative retinopathy, progressing through to severe non-proliferative 
retinopathy, before finally becoming proliferative retinopathy (76).  
 
There are multiple mechanisms by which retinopathy causes vision loss, including macular oedema 
and distortion of the retina itself by the growth of the new blood vessels (55). 
 





Time Post-Diagnosis Prevalence 
Any Stage of Retinopathy 
3 years 8% 
5 years 25% 
10 years 60% 
15 years 80% 
Proliferative Retinopathy 
3 years 0% 
15 years 25% 
Table 1.6 Prevalence of diabetic retinopathy over time. Adapted from Fong et al. (76) 
 
Stage of Diabetic Retinopathy Characteristic Findings 
Mild non-proliferative Increased vascular permeability 
Moderate-severe non-proliferative Vascular closure 
Proliferative Growth of new blood vessels 





1.4.4. Long-Term – Peripheral Neuropathy 
 
Neuropathy is the most common complication of diabetes (78) and affects almost 1 in 10 children 
with T1DM (78). Prevalence increases significantly with age; almost 60% of T1DM patients over the 
age of 30 are affected (77). 
 
Diabetic neuropathy can affect all nerves within the body, including both motor and sensory 
peripheral nerves (most common) and the autonomic nerves that supply the cardiovascular and 
gastrointestinal systems (77). Autonomic neuropathy is one of the contributing factors of diabetes-
related sexual impotence in men, with the nerves that supply the urogenital system also becoming 
damaged (79). Damage to the autonomic nerves supplying the heart can result in unexplained 
bradycardia and tachycardia as well as silent myocardial ischaemia, which may then go untreated 
(77). 
 
It usually has an insidious onset of a number of years and can manifest in several different ways, 
including loss of sensation, pain, or weakness (78). 
 
Quality of life can be seriously negatively impacted by diabetic neuropathy, with 43% of patients 
reporting at least one of depression, anxiety, or sleep disturbance (78). The aforementioned sensory 
loss can result in injuries which go undetected, which can then lead to ulcers, affecting 50% of 
diabetic patients at some point (79). The healing of these ulcers is then further negatively impacted 
by the increased incidence of peripheral arterial disease in this population (79) (80). If left untreated, 
limb amputation can become necessary, with diabetic ulcers being the cause of 10% of all 
amputations (across all ages) (78). 
 
It also carries a significant economic burden and is responsible for around a quarter of all costs 
related to diabetes treatment (78). Around 40% of people report it affecting their employment, with 
this group missing an average of 5.5 days of work every month due to pain (77). 
 
The most effective method of prevention, much like other diabetic complications, is good glycaemic 
control (81) and patients should have a diabetic foot check at least annually (77). If neuropathy does 
occur, its management revolves around symptomatic relief with analgesia and mitigating further 




1.4.5. Long-Term – Nephropathy 
 
Diabetic nephropathy is the most common cause of kidney disease worldwide (82). Around half of all 
T1DM patients will be affected at some point in their life and around a quarter of these patients will 
progress to end-stage renal disease (ESRD), which requires potentially debilitating renal replacement 
therapy, such as dialysis or even renal transplant (83). Mortality after initiation of haemodialysis is 
high, with a 5-year survival rate of only 30% (83). Renal transplantation, despite increased short-
term mortality, has much improves long-term mortality by around 70% (83). This is still not without 
its difficulties; hyperglycaemia increases the risk of infection and immunosuppressive drugs impair 
pancreatic beta-cell function and worsen peripheral insulin risk, which further worsens the 
hyperglycaemia (84). 
 
The exact mechanism by which diabetes causes kidney damage is uncertain, (84) but much like other 
diabetic complications, it is significantly linked to glycaemic control (85). There is a demonstrable 
benefit to good glycaemic control, with just a 1% reduction in HbA1c potentially resulting in a 25% 
decrease in risk of diabetic complications such as nephropathy (85). 
 
High blood pressure is also strongly correlated with incidence of nephropathy (85); this generally 
contributes less to the incidence of the disease in T1DM, who are usually younger and as such have 
not been subjected to years of potential hypertension-inducing factors such as smoking and obesity 
(82). 
 
The early signs of the disease typically have no obvious symptoms (84) and as such, it is important 
for all diabetic patients to undergo annual screening (in the form of a urine test for albumin) (82) to 
increase the chance of early detection. 
If nephropathy does occur, blood pressure controlling medications such as Angiotensin Converting 
Enzyme (ACE) inhibitors and Angiotensin-Receptor Blockers (ARBs) may have a protective effect (82). 
Young people, however, are severely undertreated, with only a third of people under the age of 20 
who have diagnostic nephropathy receiving either of these clinical interventions (86).  
 
1.4.6. Long-Term – Cardiovascular 
 
Cardiovascular complications represent a key factor in the reduction in life expectancy in patients 




Coronary heart disease, cerebrovascular disease, peripheral arterial disease, cardiomyopathy, and 
heart failure all fall under the general banner of “cardiovascular disease” and the incidence of all of 
them is higher in patients with T1DM (87). 
 
While atherosclerotic cardiovascular disease in the general population is almost exclusively a 
problem of middle-age and above (87), this is not necessarily the case with T1DM patients; even in 
young adults with T1DM, the incidence of cardiovascular disease is about 1-2% annually (87). 
Incidence does still increase with age with 70% of men and 50% of women with T1DM showing signs 
of atherosclerosis by the age of 45 (87). 
 
In addition to age and gender, glycaemic control also has a huge effect on the relative risk of 
cardiovascular disease, with the worst controlled patients having 10 times the risk of the best 
controlled patients (87) (though the risk in these patients is still double that of the general 
population (87). Though the correlation is strong, the underlying mechanism is not clear and is likely 
to have many contributing factors (87).  
 
Presence of cardiovascular disease in T1DM patients is strongly predicted by the presence of 
diabetic retinopathy, so presence of this at the recommended annual check would likely prompt 
further cardiovascular investigation, initially by ECG (87). Additional investigations include Carotid 
Intima-Media Thickness (CIMT) assessed by ultrasound or Computed Tomography Coronary 
Angiography (CTCA) (87). 
 
Reducing the risk of cardiovascular disease involves optimal blood glucose management, reduction 
of cholesterol with statins, blood pressure control and lifestyle measures such as smoking cessation 
(87). Interestingly, even when management is completely optimised in T1DM patients, they still have 
a markedly increased risk of cardiovascular disease than the general population; this is not true for 
T2DM, where optimal management brings the risk back to near baseline levels (88). 
 




The current annual direct cost (with “direct cost” meaning treatment and management of the 
disease and its complications) of T1DM is estimated at £1 billion (88). It costs close to another £1 
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billion indirectly (through the effects of increased death and illness) (88). The breakdown of these 
costs is shown in Table 1.8. 
 
By 2035 these costs are estimated to double to direct costs of £1.8 billion and indirect costs of £2.4 
billion (89). 
 
The total annual cost of caring for all forms of diabetes and their complications is £14 billion (89). To 
put that in perspective, that is the equivalent of: 
• £1.5 million per hour 
• £25 000 per minute or 





Area of Cost Percentage of Total Cost 
Diabetes Medications 7.8% 
Non-Diabetes Medications (to treat complications) 15.2% 
Inpatient Care 65.8% 
Outpatient Care (excluding medications) 9.7% 
Other (e.g.- social service) 1.7% 
Table 1.8 Healthcare costs associated with Type 1 Diabetes Mellitus. Adapted from Streisand et al. (90)  
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1.5.2. Psychological Impact  
 
Studies have shown that children with T1DM have higher incidences of emotional and behavioural 
problems (91). 
 
The very routine required to manage T1DM can have a significant psychosocial impact upon patients 
and has been described by some researchers as “unrelenting” (92). Injections several times per day, 
counting of carbohydrates and anticipation and management of hypoglycaemia can combine to form 
a highly stressful routine; nearly 40% of people feel that their treatment interferes with their lives 
and over half worry about hypoglycaemia (92). The same study aimed to assess exactly which parts 
of life diabetes affects, and found that no part of life is immune to effect: 
• Physical health (62.2%) 
• Emotional well-being (45.2%) 
• Finances (44%) 
• Leisure activities (38.2%) 
• Work-related activities (35.4%) 
• Relationships with family and friends (20.5%) (93). 
 
As mentioned above, the routine of diabetes management can be a central point in conflict between 
parents and children. (94) However, the relationship is a complex one. Addressing conflict through 
family therapy can improve treatment adherence and glycaemic control (95), but children with 
better glycaemic control report positive family dynamics even without intervention (92). 
 
Up to 13.6% of family members of people with diabetes report a poor or very poor quality of life and 
up to 16.2% have WHO-5 scores indicative of depression (18). These figures are similar in the 
patients themselves (18). 
 
Friends can also have a significant impact on T1DM outcomes. Many young people report that their 
friends are an important source of support (96). Young people with strong support networks tend to 
have greater treatment adherence and glycaemic control (96). 
 
Psychological impact can have direct as well as indirect effects on a patient’s glycaemic control. If a 
patient becomes stressed, the effect of cortisol can lead to increased hyperglycaemia (97). It can 
also make it more difficult for the patient to complete the tasks required to manage their condition, 
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such as insulin injections or carbohydrate counting (18).  Furthermore, another study showed that 
using CBT (Cognitive Behavioural Therapy) to treat stress-related depression in T1DM results in 
improved glycaemic control (98). This relationship is not clear-cut however, as other studies have 
found no direct relationship between stress and glycaemic control (though they do add that an 
indirect relationship is likely). This is an area where more work needs to be done; studies have 
demonstrated conflicting ideas and no study included more than 100 participants. Additionally, 
whilst several studies have looked at the psychological effect of diabetes as a whole, to date, no 
studies have assessed the specific impact of diagnosis.  
 
Despite the evidence showing the importance of psychological factors in management of diabetes – 
whether it be through a direct or indirect effect - and the reflection of this is national management 
guidelines (99), it is recognised that psychological support for diabetic patients is under-resourced, 
with only around 10% of patients accessing psychological services (99). Care providers are identifying 
high numbers of people with diabetes-related psychological issues, but state that they lack the 
resources to provide these people with the support that they need (100). 
 
Even when removing diabetes from the equation, the individual and societal impact of poor mental 
health is significant (101). Worldwide, depression is second only to lower back pain as a cause of 
years lived with disability (and is actually the most common cause in 26 countries) (101). Severe 
depression can lead to suicide, which is the second most common cause of death for people aged 
15-29 (102). 
 
1.6. Aims of Thesis 
 
Despite the critical importance of adherence in long term complication free survival with T1DM, and 
the varied factors that affect it across childhood and adolescence, the range and impact of these 
factors has not been examined previously. Therefore, the initial aim of this project is to undertake a 
systematic review of insulin adherence in children and young people with T1DM, to understand 
what impact the factors studied have, and determine the areas that have/have not been researched. 
 








This review was titled "Factors Affecting Adherence to Insulin in Children and Young People with 
Type 1 Diabetes". 
 
With an ever-growing number of scientific studies, it can be difficult, if not impossible, for clinicians 
to keep up to date with every new study that is published (103). Systematic reviews are an effective 
way of collecting all available information on a particular topic, assessing the risk of bias and quality 
of the studies and thus summarising the scientific consensus, making them an important step 
between primary research and the application of it in clinical practice (103).  
 
The PRISMA checklist (104) is an evidence-based system designed to provide structure to and 
improve the reporting of systematic reviews. It is primarily used for systematic reviews that report 
on RCTs but can also be used for reviews that use studies of other methodology (104) and as such, 




2.2.1. Inclusion and Exclusion Criteria 
 
This systematic review was undertaken in accordance with the PRISMA checklist on systematic 
reviews (105). The completed PRISMA checklist is shown in Appendix 1. 
 
The eligibility criteria for the articles was described using the PICO framework, a full description of 
which can be found below in Table 2.1. The “comparison” aspect of the framework was not deemed 
relevant in the given context.  
 
All study types and those published during any year were considered. Studies published in all 
languages were empirically considered, pending being able to find a translator for said language. 




Studies were required to contain primary data and be published in writing in full. As such, reviews 
and conference abstracts were excluded. Theses were also not considered. 
 
Regarding the participant population, studies were required to include children (participants under 
the age of 18) with type 1 diabetes. Studies that included some adults were not necessarily 
excluded, as long as inferences could be drawn specifically regarding children.  Examples where this 
may be the case include: 
a) Adults were part of the study sample, but results were separated according to age. 
b) Adults were part of the study sample, but the mean participant age was below 18. 
 
In terms of an intervention, it was required that participants be receiving insulin therapy. Given that 
no T1DM patients should ever not be receiving insulin therapy in some form, this part of the criteria 
was not expected to ever be utilised. 
 
The outcome of interest was factors that affect adherence to insulin therapy. “Factors” could be 
quantitative (such as demographical correlations to adherence/non-adherence) or qualitative (such 
as patient-reported reasons for non-adherence/adherence). Studies were required to specifically 
assess insulin therapy in some way - whether it be through objective measures such as downloading 
of insulin pump data, or more subjective measures such as self-report questionnaires – but they 
were not required to separate the components of adherence out in results (i.e.- results being 
expressed as a composite measure of adherence were acceptable). Studies did not measure insulin 
adherence and instead inferred adherence by measuring of another aspect of care (such as BGM 








● Children (below the age of 18) 
● With type 1 diabetes 
● Not humans 
● Adults (people aged 18 and over) 
o Including papers where some children are included along with adults, but 
the results are not separated out into adults/children 
● Do not have type 1 diabetes (including those with any form of diabetes other than 
type 1, e.g.- type 2 or cystic fibrosis-related) 
Intervention ● Insulin treatment ● Not receiving insulin treatment (NB: this aspect of the exclusion criteria should 
theoretically never be met as every T1DM patient will receive insulin) 







● Primary data that relates to: 
o Adherence to treatment 
o Non-adherence to 
treatment 
● Results may show correlations 
(e.g.- “as children get older their 
adherence to insulin treatment 
gets worse”) or reasons for 
adherence/non-adherence (e.g.- 
“non-compliant children stated 
that they were fearful of hypos”) 
● Any outcome not relevant to insulin treatment adherence 
● Outcomes that infer insulin adherence via measuring a different variable (e.g.- “we 
measured how often the patients performed blood glucose testing. Patients who 
measured more often we deemed as being more adherent to treatment.”) 
● Outcomes that relate to treatment adherence, but are not from primary data (e.g.- 
reviews) 
● Outcomes that relate to treatment adherence, but is not published in full (e.g.- 
conference papers that have not been fully published) 
Table 2.1 Inclusion and Exclusion Criteria for determining relevant studies. Legend; T1DM: Type 1 Diabetes, N/A: not applicable, PICO: framework used to construct criteria (Population, 
Intervention, Comparison and Outcomes.
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2.2.2. Identification of Relevant Studies 
 
To improve the chances of finding relevant studies, 5 databases were searched using the Healthcare 
Databases Advanced Search (HDAS) (106). HDAS is a search engine with access to 9 databases. Each 
database was researched to determine their predominant area of research and if it was likely to 
contain relevant studies. Based upon this, 5 of these 9 databases were searched: 
• Excerpta Medica Database (EMBASE) 





EMBASE is produced by Elselvier (107) and includes biomedical and pharmacological studies, 
including 32 million records across 8 500 journals, with the earliest dating to 1947. 
 
HMIC (accessed only through HDAS (106)) is published by the UK Department of Health in 
association with the Nuffield Institute for Health and the King’s Fund Library. It is a combination of 
the databases of the UK Department of Health’s Library and Information Services (DH-Data) and the 
King’s Fund Information and Library Service. It contains 214 000 articles between the two databases, 
dating back to 1979. 
 
Medline is a component of PubMed, through which it is accessed (108). It contains over 26 million 
articles from a range of fields including medicine, nursing and pharmacy. Its records date back to 
1946. 
 
PsychINFO is produced by the American Psychological Association (APA) (109) and contains over 3.5 
million articles, dating back to 1887 from the field of psychology. 
 
PubMed is maintained by the United States National Library of Medicine (108) and has over 30 
million articles dating back to 1966 from the fields of life science and biomedicine. 
 
2.2.3. Design of Search Strategy 
 
The search strategy was designed following training from a medical librarian with extensive 
experience in conducting medical literature searches. It was constructed with the main concepts of 
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the research question in mind and to maximise the number of potentially relevant results by 
including synonyms listed within the database thesauruses (MeSH – medical sub-heading – terms, 
accessed via the “explode” function within HDAS), as well as manually input synonyms added 
following discussions with experts in paediatrics and paediatric diabetology. The search strategy was 
largely similar across all databases, with small adjustments to cover potential omissions from each 
database’s in-built thesaurus and to account for the desired age of the population, where this was 
not part of the in-built search strategy. 
 
The full search strategy can be found in Appendix 10. The core strategy first involved searching for 
articles relating to T1DM. Synonyms such as “insulin dependent diabetes” and “juvenile onset 
diabetes” were separated by the Boolean operator OR. The in-built search engine thesaurus 
specifically used the term “diabetes mellitus”, so additional search terms were manually added to 
exclude “mellitus”, to cover for the possibility of articles using the shortened name for the disease. 
All search terms were included in parentheses to ensure searching for that specific term, as opposed 
to all articles containing the word “type” and “one” et cetera.  
 
The next step was to begin narrowing the search results by including the term insulin (separated 
from the first step of the strategy with the Boolean operator AND) followed by including the term 
“adherence” and its synonym “compliance” (again, separated from the previous steps with the 
Boolean operator AND). The final step of the strategy was to further refine to only include articles 
with children as subjects, which was done with each respective database’s “limits” function. 
 
Terms relating to study types were not included as not all studies will state their design in their title, 
abstract or key words. 
 
2.2.4. Selecting Eligible Studies for Inclusion 
 
All of these articles were then screened for eligibility by two independent reviewers (JC and DG). The 
results were passed through 3 times, first to exclude results based upon their title, then abstract and 
finally by full text.  
 





The two reviewers were required to agree on both the stage of screening that an article was 
excluded and the reason for exclusion. Any disagreement was first discussed between the reviewers. 
If a consensus could still not be reached, the article would be independently adjudicated by a third 
member of the research team (who was a consultant paediatrician and experienced academic - DH). 
 
For the non-English language papers, the role of the second reviewer was fulfilled by the foreign 
language speaker. 
 
For 1270 of the articles, agreement was already achieved. The remaining 36 were agreed upon after 
discussion. Adjudication was not required for any of the papers. 
 
2.2.5. Data Extraction 
 
The first reviewer (JC) constructed a data extraction tool in correspondence with an experienced 
academic and consultant paediatrician (DH) and a consultant paediatric diabetologist (MD). This tool 
was then used to extract the following information: 
• Mean age and duration of diabetes of the participants 
• Method of measuring adherence 
• Factors checked for association with adherence their effect on adherence 
• Significance of the effect and the statistical test used. 
 
The data extraction tool can be seen in full in Appendix 2. 
 
Most study results were expressed as Pearson correlations. Pearson correlations (often abbreviated 
to “r”) measure the strength of a linear association between two variables and can be expressed as 
any value between -1 and +1 (110). The closer to -1 or +1 the value is, the stronger the relationship 
between the two variables, with a negative number indicating a negative relationship and vice versa 
(110). It is worth noting that Pearson correlation coefficients are not the same as a line of best fit; 
the Pearson correlation indicates how far all data points are from the line of best fit (110). 
 
In some studies, the size of the effect was illustrated using the beta (β) value. For every change of 1 
unit in the predictor variable (for example, age) the outcome coefficient (adherence) changes by the 




2.2.6. Quality Assessment of Studies 
 
Quality assessments of all English-language studies were performed by the first reviewer (JC). This 
assessment made it possible to determine if the results were valid and if proper conclusions could be 
drawn.  
 
Quality assessment of foreign language studies were not performed as all tools used to assess 
quality were written in English, meaning that they would not necessarily translate appropriately and 
may lead to misleading comparisons.  
 
A different validated quality assessment tool was used for each study design. 
 
For cross-sectional cohort studies, the Appraisal Tool for Cross-Sectional Studies (AXIS) (112) was 
used. This tool has 20 questions across 5 domains: introduction, methods, results, discussion and 
other, with 1, 10, 5, 2 and 2 questions addressing each domain, respectively. All questions can be 
answered by the reviewer as yes, no or do not know. There is no defined, objective way of scoring 
the end results, so a total of the answers that would reduce the risk of bias has been added for the 
purposes of this review, to provide a quick way of comparing the quality of the included studies. For 
all questions apart from 13 and 19, an answer of “yes” would award 1 point and an answer of “no” 
would award 0 points. For questions 13 and 19, this was reversed. An answer of “do not know” for 
any question would award 0 points for that question. Appendix 3 includes the full tool as well as the 
answers and total score for all included cross-sectional cohort studies. 
 
For case-control and longitudinal cohort studies, the Newcastle-Ottawa Scale (NOS) (113) was used. 
This system assesses studies across three domains: selection of study participants, comparability of 
the cohorts and outcome. A star rating system is used, with a possible maximum of 9 stars. The 
questions for cohort studies and case-control studies differ slightly, but still assess these 3 domains 
and still award a maximum of 9 stars. The full case-control study tool and responses can be found in 
Appendix 4 and Appendix 5, respectively. The full cohort study tool and responses can be found in 
Appendix 6 and Appendix 7, respectively. 
 
For randomised control trials (RCTs), the short version of the Revised Cochrane risk of bias tool for 
randomised trials (RoB 2) (114) was used. This tool assesses studies across 5 domains: 
1. Risk of bias arising from the randomisation process 
2. Risk of bias due to deviations from the intended interventions 
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3. Risk of bias due to missing outcome data 
4. Risk of bias in measurement of the outcome 
5. Risk of bias in selection of the reported result.  
 
The study is judged in each of these domains as “low risk”, “some concerns” or “high risk”. 
 
The study is then given an overall rating with the same grading: 
• Low risk: the study was judged as low risk across all 5 domains 
• Some concerns: the study was judged to have some concerns in at least one domain, but 
was not high risk for any domain 
• High risk: the study was judged to be high risk in at least one domain or to have some 
concerns across multiple domains. 
 
The full tool and assessments for all included RCTs can be found in Appendix 8. 
 
2.2.7. Grading of Evidence 
 
Evidence was graded using the validated GRADE (Grading of Recommendations, Assessment, 
Development and Evaluations) framework (115).  
 
With this framework, the quality of evidence relating to each of the pre-defined outcomes is 
assessed and graded as either very low, low, moderate, or high (115). The meanings of each of these 
terms can be found in Table 2.2. 
 
The methodology of studies provides the starting point for the GRADE rating, with RCTs beginning as 
“high” and observational studies beginning as “low” (115). The rating can then be moved down 
according to assessments made to 5 GRADE domains: 
1. Risk of bias, 
a. See section 2.2.6 regarding quality assessment of studies 
2. Imprecision, 
a.  Usually assessed in relation to the 95% confidence interval 
3. Inconsistency, 




a. Whether the intervention of interest is occurring with the population of interest, or 
if assertions are being made based on a different intervention in a different 
population 
5. Publication bias 
a. Requires making inferences about missing evidence to assess if the result of the 
study/studies influenced the decision to publish it/them (115). 
 
Less frequently, evidence can have its rating increased if there is a large magnitude of effect, a dose-
response gradient or if confounding factors would reduce the magnitude of an effect (115).  
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GRADE Rating Meaning 
Very low True effect is probably markedly different from 
the estimated effect. 
Low True effect might be markedly different from 
the estimated. 
Moderate True effect is probably close to the estimated 
effect. 
High The authors (of the systematic review) have a 
lot of confidence that the true effect is similar 
to the estimated effect. 
Table 2.2 Meanings of GRADE ratings. Legend; GRADE: Grading of Recommendations, Assessment, Development and 




2.2.8. Data Analysis 
 
Thematic analysis was performed on all included studies with each factor checked for association 
with adherence being sorted in to one of 5 themes: 
1. Demographics 
I. E.g.- age, gender and socio-economic status. Duration of diabetes was also placed within 
this theme as it is an innate, unidirectional characteristic and cannot fluctuate. 
2. Past medical history 
I. E.g.- number of hospital admissions. 
3. Diabetes management and results 
I. E.g.- insulin regimen, method of insulin delivery, HbA1c. 
4. Psycho-social 
I. E.g.- depression, lifestyle factors (such as exercise frequency). 
5. Family dynamics. 
I. E.g.- support from family members, family cohesion and conflict. 
 
Factors considered to be related to family dynamics are distinct from psycho-social factors that 
involve family members. For example, family conflict would be considered to be related to family 
dynamics, whereas maternal depression would be a psycho-social factor, as how this actually affects 
the interactions between family members cannot be assumed. 
 
Identification of these 5 themes was done following consultation with a consultant paediatric 







3.1. Study Selection 
 
1799 studies were identified from the 5 databases using the search criteria, including 483 duplicates, 
leaving 1306 studies being screened for eligibility based on title or abstract. Of these studies, 1057 
were deemed as being ineligible, leaving 249 studies to be screened by full text. 173 of these studies 
were ineligible, leaving 76 to be included for analysis. Four of these studies did not have an available 
full text after online searches, contacting the British Library and contacting the study authors, so 
were excluded for this reason. A list of all of the original 1306 studies can be found in Appendix 9, 
along with their reasons for exclusion at all stages. Figure 3.1 shows the flowchart illustrating the 






























Additional records identified 
through other sources 
(n =  0) 
Records after duplicates removed 
(n = 1306) 
Records screened 
(n =  1306) 
Records excluded 
(n = 1057) 
Full-text articles assessed 
for eligibility 
(n = 249) 
Full-text articles excluded, 
with reasons 
(n = 173) 
Studies included in 
qualitative synthesis 
(n = 76) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 0) 
Records identified through 
database searching 
(n = 1799) 
Figure 3.1 Flowchart of study identification process. Legend; n: number of studies. 
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3.2. Quality of Included Studies 
 
Forty-four cross-sectional studies (116–159) were assessed for quality using the Appraisal Tool for 
Cross-Sectional Studies (AXIS) (as described in section 2.2.6). The mean score was 16/20 with a range 
of 13-19. The most common shortcoming of studies was relating to accounting for response bias, 
with just 7/44 (15.9%) of studies making any attempt to categorise non-responders. The full 
assessment of each study can be found in Appendix 3.  
 
Two case-control studies (160,161) were assessed for quality using the case-control version of the 
Newcastle-Ottawa scale. Both of these studies earned the maximum number of 9 stars. The full 
assessment of both studies with individual answers can be found in Appendix 4. 
 
Eighteen longitudinal cohort studies (162–179) were assessed for quality using the cohort study 
version of the Newcastle-Ottawa scale (as described in section 2.2.6). The maximum possible score 
for each study was 9 stars. The mean score (rounded to 1 decimal place) amongst the 18 studies was 
6.8 stars with a range of 5-9 stars. The full assessment of each study with individual answers can be 
found in Appendix 6. 
 
Seven Randomised Control Trials (RCTs) (180–186) were assessed for quality using the revised 
Cochrane Risk of Bias tool for randomised trials (RoB 2), as described in section 2.2.6. 3/7 (42.9%) of 
assessed studies were classed as having a high risk of bias, 2/7 (28.6%) as having “some concerns” 
and 2/7 (28.6%) as having a low risk of bias. The most common cause of a rating of high risk of bias 
was relating to domain 5: selection of reported result, with 5/7 (71.4%) of studies using multiple 
outcome measures. The full assessment of each study with individual answers can be found in 
Appendix 8. 
 
The remaining five studies were foreign language studies and were not assessed. 
 
3.3. Study Characteristics 
 
The 76 included studies took place across 27 countries. The number of studies from each country 
were as follows: 44/76 (57.9%) from the USA, 4/76 (5.3%) from France, 3/76 (3.9%) from Canada and 
from across the UK (with a further 2 taking place specifically in Scotland and 1 in England), 2/76 
(2.6%) from each of Austria, Denmark, Finland, Japan, the Netherlands and Spain respectively, and 
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1/76 (1.3%) from each of Australia, Egypt, Germany, Hong Kong, India, Iran, Israel, Kuwait, Malaysia, 
Norway, Poland, Portugal, Puerto Rico and Saudi Arabia. 
 
For one study, the country where it took place could not be determined. The above numbers total to 
more than the total number of studies, as some studies took place across multiple countries. 
 
Seventy-one of the included studies were published in English. One was published in French, 2 in 
Dutch and 2 in Spanish. 
 
A total of 9 969 children and young people were included in all studies, with a mean of 133 children 
per study and a range of 28 to 1 028. 
 
3.4. Methods of Measuring Adherence 
 
The 76 publications contained 38 different methods of measuring adherence. Note that one of these 
methods is “questionnaire not otherwise specified”, so is likely composed of more methods. Table 
3.1 Different methods of adherence assessment used in the included studies and the number of 
studies that used them. Table 3.1 lists the different methods used throughout the included studies 
and the numbers of studies that used each method. 69/76 (90.8%) of studies used 1 method of 
measuring adherence, 4/76 (5.3%) used 2 methods and 1/76 (1.3%) used 3 methods. 
 
The contents of this table are summarised as a bar chart in Figure 3.2. 
 
Questionnaires were the most common methods of assessing adherence, with 55/76 (72.4%) of the 
studies using some form of questionnaire either as a part of, or the as entirety of their adherence 
measure. 
 
One of the most frequently used of the questionnaires was the Diabetes Self-Care Inventory (SCI) 
(187), with 10 of the studies using either the original questionnaire (183), the revised version (SCI-R) 
(128) (188), or creating their own questionnaire (173) based on the SCI. All versions of the SCI are 
self-reports on the patient’s perspective of their adherence to specific management tasks over the 
previous 1-2 months, asking them to grade each item from “never do it” to “always do this as 
recommended, without fail” (188). The original SCI contained 14 items that assessed adherence to 
blood glucose monitoring, insulin treatment, diet, exercise, and emergency precaution guidelines 
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(187). The SCI-R covered the same areas of adherence, but wording was updated to reflect the 
current practice recommendations and improve the efficiency of completion and clarity (188). Table 
3.2 contains details of the changes that were made to items. Additionally, the response of “not 
applicable or N/A” was removed as an option from all items except those relating to ketones, insulin 
and pills; this is because the questionnaire is designed to be used by both patients with T1DM and 
T2DM and as such, items relating to these themes will not always be relevant (188). 
 
The final result of the changes is a 15-item questionnaire consisting of: 
• 4 regarding diet 
• 3 regarding medication administration 
• 3 regarding preventative measures/routine aspects of care 
• 2 regarding glucose monitoring 
• 2 regarding hypoglycaemia 
• 1 regarding exercise (188).  
 
The final score is calculated averaging the scores and converting to a 0-100-point scale, where higher 
scores indicate better adherence (188). 
 
One of the few objective measures used to measure adherence was Medication Possession Ratio 
(MPR) (166) (167). This is calculated by dividing the number of days’ supply of a medication in a 
given period by the number of days that has elapsed between prescription collections (189). The 
ratio is always a positive number (including 0), with 0 being complete non-adherence (where no 
prescriptions have been collected) and 1 being perfect adherence (189). It is possible to get a 
number greater than one, if the patient has collected their prescription too early. This could infer 
medication overdosing but could also be a result of practical reasons such as lost medication, or 
changes in management (189). 
 
The other objective measures are downloaded insulin pump data and BOLUS scores (138) (121). The 
length of time that can be assessed depends on the model of insulin pump, as does the data that can 
be collected from it. For example, the Medtronic pump (31) can store 2-3 months of data and 
captures carbohydrate inputs and doses of delivered insulin boluses, as well as blood glucose 
information by virtue of being an integrated pump (138). Other pumps such as the Omnipod (32) are 
not integrated with a CGM and as such cannot capture blood glucose data (190). 
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BOLUS scores range between 0-3, with 0 being the worst adherence and 3 being the best adherence 
(191). They are calculated by looking at the previous 14 days of downloaded insulin pump data: a 
point is awarded for any food-related bolus occurring at breakfast (6-10am), lunch (11am-3pm) and 
dinner (4-10pm), with a maximum of one point available at each time period (191). A mean of the 2 
weeks of scores are then taken to give the final BOLUS score (191). Studies have shown that BOLUS 
scores are more closely associated with glycaemic control than frequency of SMBG, which was the 




Method of adherence assessment Number of studies 
Questionnaire (not otherwise specified) 11 
Self-Care Inventory/Revised Self-Care Inventory (SCI/SCI-R; La Greca, 1994, 
2004)) 
7 
Downloaded pump data/BOLUS scores 7 
Non-specified interviews 6 
Barriers to Adherence Questionnaire 4 
Diabetes Self-Management Profile (DSMP; Harris et al., 2000) 4 
Questionnaire by Cerkoney and Hart, 1980 3 
Diabetes Regimen Adherence Questionnaire (DRAQ) 2 
Healthcare provider ratings 2 
Interview by Hanson et al., 1992 2 
Medication Possession Ratio (MPR) 2 
Observation of injection technique 2 
Questionnaire by Jacobson et al., 1987 2 
Summary of Self-Care Activities Questionnaire 2 
Adherence and IDDM Interview (Hanson et al., 1987) 1 
Adherence in Diabetes Questionnaire (ADQ) 1 
Child Eating Disorder Examination (ChEDE) version 12.0  1 
Diabetes Adaptation Scale 1 
Diabetes Family Responsibility Questionnaire (DFRQ) 1 
Diabetes Management Questionnaire 1 
Diabetes Self-Management Interview 1 
General Self-Efficacy Scale 1 
Insulin Adjustment Score 1 
Insulin Required of Adherence Scale 1 
Management Behaviours of Adolescents (Harris et al., 2000 and La Greca, 
1995) 
1 
Paediatric Quality of Life Questionnaire (PedsQL) 1 
Participant diaries 1 
Problem Areas in Diabetes Questionnaire (PAID) 1 
Questionnaire by Littlefield et al. 1992 1 
Questionnaire on injection site rotation 1 
Reported Adherence to Medication Scale (Horne, 1999) 1 
Self-Care Questionnaire (Glasgow et al., 1987) 1 
Diabetes Self-Care Inventory (DSCI; Kanematsu, 1997) 1 
Self-Efficacy for Diabetes Questionnaire (SED) 1 
Self-Report Questionnaire on Adherence (Almeida and Pereira, 2003) 1 
Summary of Self-Care Activities Questionnaire (Schafer et al., 1983) 1 
Table 3.1 Different methods of adherence assessment used in the included studies and the number of studies that used 
them. SCI: Self-Care Inventory, SCI-R: Revised Self-Care Inventory, DSMP: Diabetes Self-Management Profile, DRAQ: 
Diabetes Regimen Adherence Questionnaire, MPR: Medication Possession Ratio, IDDM: Insulin Dependent Diabetes 
Mellitus, ChEDE: Child Health Eating Disorder Examination, DFRQ: Diabetes Family Responsibility Questionnaire, PedsQL: 
Paediatric Quality of Life Questionnaire, PAID: Problem Areas in Diabetes Questionnaire, SED: Self-Efficacy for Diabetes 
Questionnaire, DSCI: Diabetes Self-Care Inventory. 
65 
 
Item(s) in SCI Change Made Item in SCI-R 
“eat meals on time” and “eat 
snacks on time” 
Items combined “eat meals/snacks on time“ 
“exercise strenuously” Item removed N/A 
“testing blood glucose” Wording changed “check blood glucose with 
monitor” 
“recording ketones” Wording changed “check ketones when blood 
glucose level is high” 
N/A Item added “keeping food records” 
N/A Item added “reading food labels” 
N/A Item added “treating low blood glucose” 
Table 3.2 Changes made to the SCI to create the SCI-R. Legend; SCI: Self-Care Inventory, SCI-R: Revised Self-Care Inventory, 





































Number of times a method of measuring adherence was used
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3.5. Range of Factors Assessed and Themes  
 
Across the included studies there were 236 factors checked for association with adherence.  
Factor Checked for Association with Adherence Number of Studies 
Assessing this Factor 
Theme 
Age 33 Demographics 
HbA1c/Glycaemic control 20 Diabetes 
management 
Duration of diabetes 19 Demographics 
Gender 15 Demographics 
Family conflict 8 Family dynamics 
Depression 7 Psycho-social 
Self-Efficacy* 7 Psycho-social 
Support from family 7 Family dynamics 
Cohesion 5 Family dynamics 
Diabetes knowledge 4 Diabetes 
management 
Exercise frequency 4 Psycho-social 
Child's increasing responsibility 3 Family dynamics 




Household income 3 Demographics 
Patient perceptions of family organisation 3 Family dynamics 
Socio-economic status 3 Demographics 
Stress 3 Psycho-social 
Better parent-child relationship 2 Family dynamics 
BGM frequency 2 Diabetes 
management 
BMI SDS 2 Past medical 
history 
Caregiver education level 2 Demographics 
Diabetes adjustment 2 Psycho-social 
Family stress 2 Psycho-social 
Frequency of alcohol consumption 2 Psycho-social 
Perceived impact 2 Psycho-social 
Perceived threat 2 Psycho-social 
Single parent household vs both parents 2 Family dynamics 
Smoking frequency 2 Psycho-social 
Social competence 2 Psycho-social 
"Sweet talk" text message intervention 1 Psycho-social 
Acceptance 1 Psycho-social 
Achievement striving 1 Psycho-social 
Activity level 1 Psycho-social 
ADHD 1 Psycho-social 
Adjustment disorder 1 Psycho-social 
Adolescent diabetes technology index 1 Diabetes 
management 
Adventurousness 1 Psycho-social 
Agoraphobia 1 Psycho-social 
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Agreeableness 1 Psycho-social 
Alcohol/drug abuse 1 Psycho-social 
Altruism 1 Psycho-social 
Amount of sleep 1 Psycho-social 
Anger 1 Psycho-social 
Anxiety 1 Psycho-social 
Any psychiatric disorder 1 Psycho-social 
Artistic interests 1 Psycho-social 
Assertiveness 1 Psycho-social 
Attitude 1 Psycho-social 
Authoritarian family function 1 Family dynamics 
Barriers to adherence 1 Psycho-social 
Behavioural support 1 Family dynamics 
Benefits - costs 1 Psycho-social 
Binging 1 Psycho-social 
Boluses delivered day before clinic visit (designed to 
assess white coat adherence)  
1 Diabetes 
management 
Cautiousness 1 Psycho-social 
Cheerfulness 1 Psycho-social 
Child's executive functioning 1 Psycho-social 
Clinical/subclinical eating disorders 1 Psycho-social 
Communication 1 Psycho-social 
Compliance in the first 9 months' association with 
compliance in the second 9 months 
1 Diabetes 
management 
Conduct disorder 1 Psycho-social 
Conscientiousness 1 Psycho-social 
Consequences 1 Psycho-social 
Control group vs intervention (trained by 
professionals who received a communication 
training plan) group 
1 Psycho-social 
Co-operation 1 Psycho-social 
Coping measures: ego defense level 1 Psycho-social 
Cues 1 Psycho-social 





Diabetes Social Support Questionnaire: frequency 1 Psycho-social 
Diabetes Social Support Questionnaire: 
individualised 
1 Psycho-social 
Discipline 1 Psycho-social 




DSMP subscale: glucose testing 
   
1 Diabetes 
management 




Dutifulness 1 Psycho-social 
Dysthymia 1 Psycho-social 
Eating Attitudes Test 26 1 Psycho-social 
Eating disorders (clinical/subclinical) 1 Psycho-social 
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Eating Disorders Inventory - Body Dissatisfaction 
Scale 
1 Psycho-social 
Education group vs positive affect (PA) text message 
group 
1 Psycho-social 
Education intervention 1 Psycho-social 
Emergency (hypoglycaemia) precautions 1 Diabetes 
management 
Emotional adjustment 1 Psycho-social 
Emotionality 1 Psycho-social 
Energy and willpower 1 Psycho-social 
Excitement seeking 1 Psycho-social 
Experience of results  1 Psycho-social 
Expressiveness 1 Psycho-social 
Externalising behaviour 1 Psycho-social 
Extraversion 1 Psycho-social 
Family relations 1 Family dynamics 
Family support: affective 1 Family dynamics 
Family support: control 1 Family dynamics 
Family support: indirect 1 Family dynamics 
Family support: no support 1 Family dynamics 
Father negative 1 Family dynamics 
Father-absent vs father-present 1 Family dynamics 
Feel that diabetes affects their mental wellbeing 1 Psycho-social 
Feel that diabetes affects their physical wellbeing 1 Psycho-social 
Feel that they have support from nurses 1 Psycho-social 
Feel that they have support from their physician 1 Psycho-social 
Frequency of breakfast 1 Psycho-social 
Frequency of dinner 1 Psycho-social 
Frequency of evening snack 1 Psycho-social 
Frequency of help  1 Psycho-social 
Frequency of lunch 1 Psycho-social 
Frequency of mid-afternoon snack 1 Psycho-social 
Frequency of mid-morning snack 1 Psycho-social 
Friendliness 1 Psycho-social 
Functional enuresis 1 Psycho-social 
General monitoring 1 Psycho-social 
Generalised anxiety disorder 1 Psycho-social 
Gregariousness 1 Psycho-social 
HBM: Benefits 1 Psycho-social 
HBM: costs 1 Psycho-social 
HBM: cues to action 1 Psycho-social 
HBM: Susceptibility 1 Psycho-social 
Health Belief Model (HBM): Severity 1 Psycho-social 
HFS: Behaviour 1 Psycho-social 
HFS: worry/fear 1 Psycho-social 
Identity 1 Psycho-social 
Imagination 1 Psycho-social 





Immigrant vs French Native mother: Percentage that 
adjust insulin dose during illness  
1 Demographics 
Impulsiveness 1 Psycho-social 
Increased disease severity 1 Past medical 
history 
Increased severity of risks 1 Psycho-social 
Increased treatment complexity 1 Diabetes 
management 
Increased vulnerability to risks 1 Psycho-social 
Increasing lack of responsibility from mother or child 1 Family dynamics 
Independence 1 Psycho-social 
Independence and encouragement 1 Psycho-social 




Insulin dosage calculator use regularity 1 Diabetes 
management 
Intellect 1 Psycho-social 




Internalising behaviour 1 Psycho-social 
Intervention group (12 play sessions) vs control 
group 
1 Psycho-social 
Intervention group (monthly diabetes education 
session) vs control group 
1 Diabetes 
management 
Intrusive support 1 Psycho-social 
Liberalism 1 Psycho-social 
Locus of control (internal/external etc.) 1 Psycho-social 
Maternal Involvement 1 Family dynamics 
Mean daily blood glucose 1 Diabetes 
management 
Mean diabetes-specific stress (DSS) severity 1 Psycho-social 
Method of insulin delivery 1 Diabetes 
management 
Modesty 1 Psycho-social 
Morality 1 Psycho-social 
Mother negative 1 Family dynamics 
Mother report of social functioning 1 Psycho-social 
Mother's age 1 Demographics 
Mother's education 1 Demographics 
Mother's increasing responsibility for management 
of daily regimen tasks 
1 Family dynamics 
Mother's increasing responsibility for management 
of general health 
1 Family dynamics 
Mother's increasing responsibility for social 
presentation (talking to family and friends about 
disease etc.) 
1 Family dynamics 
Mother's sense of empowerment 1 Psycho-social 
Motivation level 1 Psycho-social 
Negative communication 1 Psycho-social 
Negotiated Telephone Support 1 Psycho-social 
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Negotiated Telephone Support, yearly clinical 
review, 3-monthly measurement of HbA1c 
1 Diabetes 
management 
Neuroticism 1 Psycho-social 
Non-supportive family 1 Family dynamics 
Non-white adolescent 1 Demographics 
Number of adverse life events 1 Psycho-social 
Number of children in family 1 Family dynamics 
Number of hospital admissions 1 Past medical 
history 
OCD 1 Psycho-social 
Openness to experience 1 Psycho-social 
Oppositional defiant disorder 1 Psycho-social 
Orderliness 1 Psycho-social 
Overall QoL 1 Psycho-social 
Parent perception of child’s independence 1 Family dynamics 
Parent perception of control 1 Psycho-social 
Parent perception of family organisation 1 Family dynamics 
Parental marital status 1 Family dynamics 
Parents' health literacy 1 Psycho-social 
Parents perceptions of expressiveness 1 Psycho-social 
Parents' reading comprehension 1 Psycho-social 
Patient perception of control 1 Psycho-social 
Patient perception of independence 1 Family dynamics 
Patient perceptions of expressiveness 1 Psycho-social 
Perceived competence 1 Psycho-social 
Perceived level of hope 1 Psycho-social 
Presence of co-morbidities 
  
1 Past medical 
history 
Presence of threat to emotional well-being 1 Psycho-social 
Presence of threat to physical well-being 1 Psycho-social 
Presence of threat to social wellbeing 1 Psycho-social 
Psychosis 1 Psycho-social 
PTSD 1 Psycho-social 
PTSD diagnosis of mother 1 Psycho-social 
QoL (with number of injections per day) 1 Psycho-social 
QoL: Diabetes worry 1 Psycho-social 
QoL: Satisfaction 1 Psycho-social 
QoL: Social worry 1 Psycho-social 
Race 1 Demographics 




Regular Use of I-Port 1 Diabetes 
management 
Report of symptom severity 1 Diabetes 
management 
Response costs 1 Psycho-social 
Response efficacy 1 Psycho-social 
School/work performance 1 Psycho-social 
Self-consciousness 1 Psycho-social 
Self-discipline 1 Psycho-social 
72 
 
Self-report on adherence to BGM 1 Diabetes 
management 
Self-report on adherence to meals 1 Diabetes 
management 
Self-report on adherence to snacks 1 Diabetes 
management 
Sense of normality 1 Psycho-social 
Separation anxiety disorder 1 Psycho-social 
Sociability scores 1 Psycho-social 
Social anxiety 1 Psycho-social 
Social phobia 1 Psycho-social 
Specific (isolated) phobias 1 Psycho-social 
Support from friends 1 Psycho-social 
Support from nurses 1 Psycho-social 
Support from physicians 1 Psycho-social 
Sympathy 1 Psycho-social 
Teacher victimisation 1 Psycho-social 
Threat 1 Psycho-social 
Timeline 1 Psycho-social 








Total meals 1 Psycho-social 
Treatment effectiveness: control 1 Psycho-social 
Treatment effectiveness: prevent 1 Psycho-social 
Trust 1 Psycho-social 




Uses diabetes apps 1 Diabetes 
management 
Uses diabetes websites 1 Diabetes 
management 
Uses meter/pump software 1 Diabetes 
management 
Uses social networking 1 Psycho-social 
Uses text messaging 1 Psycho-social 
Utilising personal and interpersonal resources coping 
strategy 
1 Psycho-social 
Ventilation and avoidance coping strategy 1 Psycho-social 
Vulnerability 1 Psycho-social 
Warmth from family 1 Family dynamics 
Table 3.3 lists these factors, the number of studies that assessed them and the associated theme for 





Factor Checked for Association with Adherence Number of Studies 
Assessing this Factor 
Theme 
Age 33 Demographics 
HbA1c/Glycaemic control 20 Diabetes 
management 
Duration of diabetes 19 Demographics 
Gender 15 Demographics 
Family conflict 8 Family dynamics 
Depression 7 Psycho-social 
Self-Efficacy* 7 Psycho-social 
Support from family 7 Family dynamics 
Cohesion 5 Family dynamics 
Diabetes knowledge 4 Diabetes 
management 
Exercise frequency 4 Psycho-social 
Child's increasing responsibility 3 Family dynamics 




Household income 3 Demographics 
Patient perceptions of family organisation 3 Family dynamics 
Socio-economic status 3 Demographics 
Stress 3 Psycho-social 
Better parent-child relationship 2 Family dynamics 
BGM frequency 2 Diabetes 
management 
BMI SDS 2 Past medical 
history 
Caregiver education level 2 Demographics 
Diabetes adjustment 2 Psycho-social 
Family stress 2 Psycho-social 
Frequency of alcohol consumption 2 Psycho-social 
Perceived impact 2 Psycho-social 
Perceived threat 2 Psycho-social 
Single parent household vs both parents 2 Family dynamics 
Smoking frequency 2 Psycho-social 
Social competence 2 Psycho-social 
"Sweet talk" text message intervention 1 Psycho-social 
Acceptance 1 Psycho-social 
Achievement striving 1 Psycho-social 
Activity level 1 Psycho-social 
ADHD 1 Psycho-social 
Adjustment disorder 1 Psycho-social 
Adolescent diabetes technology index 1 Diabetes 
management 
Adventurousness 1 Psycho-social 
Agoraphobia 1 Psycho-social 
Agreeableness 1 Psycho-social 
Alcohol/drug abuse 1 Psycho-social 
Altruism 1 Psycho-social 
Amount of sleep 1 Psycho-social 
74 
 
Anger 1 Psycho-social 
Anxiety 1 Psycho-social 
Any psychiatric disorder 1 Psycho-social 
Artistic interests 1 Psycho-social 
Assertiveness 1 Psycho-social 
Attitude 1 Psycho-social 
Authoritarian family function 1 Family dynamics 
Barriers to adherence 1 Psycho-social 
Behavioural support 1 Family dynamics 
Benefits - costs 1 Psycho-social 
Binging 1 Psycho-social 
Boluses delivered day before clinic visit (designed to 
assess white coat adherence)  
1 Diabetes 
management 
Cautiousness 1 Psycho-social 
Cheerfulness 1 Psycho-social 
Child's executive functioning 1 Psycho-social 
Clinical/subclinical eating disorders 1 Psycho-social 
Communication 1 Psycho-social 
Compliance in the first 9 months' association with 
compliance in the second 9 months 
1 Diabetes 
management 
Conduct disorder 1 Psycho-social 
Conscientiousness 1 Psycho-social 
Consequences 1 Psycho-social 
Control group vs intervention (trained by 
professionals who received a communication 
training plan) group 
1 Psycho-social 
Co-operation 1 Psycho-social 
Coping measures: ego defense level 1 Psycho-social 
Cues 1 Psycho-social 





Diabetes Social Support Questionnaire: frequency 1 Psycho-social 
Diabetes Social Support Questionnaire: 
individualised 
1 Psycho-social 
Discipline 1 Psycho-social 




DSMP subscale: glucose testing 
   
1 Diabetes 
management 




Dutifulness 1 Psycho-social 
Dysthymia 1 Psycho-social 
Eating Attitudes Test 26 1 Psycho-social 
Eating disorders (clinical/subclinical) 1 Psycho-social 
Eating Disorders Inventory - Body Dissatisfaction 
Scale 
1 Psycho-social 





Education intervention 1 Psycho-social 
Emergency (hypoglycaemia) precautions 1 Diabetes 
management 
Emotional adjustment 1 Psycho-social 
Emotionality 1 Psycho-social 
Energy and willpower 1 Psycho-social 
Excitement seeking 1 Psycho-social 
Experience of results  1 Psycho-social 
Expressiveness 1 Psycho-social 
Externalising behaviour 1 Psycho-social 
Extraversion 1 Psycho-social 
Family relations 1 Family dynamics 
Family support: affective 1 Family dynamics 
Family support: control 1 Family dynamics 
Family support: indirect 1 Family dynamics 
Family support: no support 1 Family dynamics 
Father negative 1 Family dynamics 
Father-absent vs father-present 1 Family dynamics 
Feel that diabetes affects their mental wellbeing 1 Psycho-social 
Feel that diabetes affects their physical wellbeing 1 Psycho-social 
Feel that they have support from nurses 1 Psycho-social 
Feel that they have support from their physician 1 Psycho-social 
Frequency of breakfast 1 Psycho-social 
Frequency of dinner 1 Psycho-social 
Frequency of evening snack 1 Psycho-social 
Frequency of help  1 Psycho-social 
Frequency of lunch 1 Psycho-social 
Frequency of mid-afternoon snack 1 Psycho-social 
Frequency of mid-morning snack 1 Psycho-social 
Friendliness 1 Psycho-social 
Functional enuresis 1 Psycho-social 
General monitoring 1 Psycho-social 
Generalised anxiety disorder 1 Psycho-social 
Gregariousness 1 Psycho-social 
HBM: Benefits 1 Psycho-social 
HBM: costs 1 Psycho-social 
HBM: cues to action 1 Psycho-social 
HBM: Susceptibility 1 Psycho-social 
Health Belief Model (HBM): Severity 1 Psycho-social 
HFS: Behaviour 1 Psycho-social 
HFS: worry/fear 1 Psycho-social 
Identity 1 Psycho-social 
Imagination 1 Psycho-social 
Immigrant vs French Native mother: General insulin 
adherence 
1 Demographics 
Immigrant vs French Native mother: Percentage that 
adjust insulin dose during illness  
1 Demographics 
Impulsiveness 1 Psycho-social 




Increased severity of risks 1 Psycho-social 
Increased treatment complexity 1 Diabetes 
management 
Increased vulnerability to risks 1 Psycho-social 
Increasing lack of responsibility from mother or child 1 Family dynamics 
Independence 1 Psycho-social 
Independence and encouragement 1 Psycho-social 




Insulin dosage calculator use regularity 1 Diabetes 
management 
Intellect 1 Psycho-social 




Internalising behaviour 1 Psycho-social 
Intervention group (12 play sessions) vs control 
group 
1 Psycho-social 
Intervention group (monthly diabetes education 
session) vs control group 
1 Diabetes 
management 
Intrusive support 1 Psycho-social 
Liberalism 1 Psycho-social 
Locus of control (internal/external etc.) 1 Psycho-social 
Maternal Involvement 1 Family dynamics 
Mean daily blood glucose 1 Diabetes 
management 
Mean diabetes-specific stress (DSS) severity 1 Psycho-social 
Method of insulin delivery 1 Diabetes 
management 
Modesty 1 Psycho-social 
Morality 1 Psycho-social 
Mother negative 1 Family dynamics 
Mother report of social functioning 1 Psycho-social 
Mother's age 1 Demographics 
Mother's education 1 Demographics 
Mother's increasing responsibility for management 
of daily regimen tasks 
1 Family dynamics 
Mother's increasing responsibility for management 
of general health 
1 Family dynamics 
Mother's increasing responsibility for social 
presentation (talking to family and friends about 
disease etc.) 
1 Family dynamics 
Mother's sense of empowerment 1 Psycho-social 
Motivation level 1 Psycho-social 
Negative communication 1 Psycho-social 
Negotiated Telephone Support 1 Psycho-social 
Negotiated Telephone Support, yearly clinical 
review, 3-monthly measurement of HbA1c 
1 Diabetes 
management 
Neuroticism 1 Psycho-social 
Non-supportive family 1 Family dynamics 
Non-white adolescent 1 Demographics 
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Number of adverse life events 1 Psycho-social 
Number of children in family 1 Family dynamics 
Number of hospital admissions 1 Past medical 
history 
OCD 1 Psycho-social 
Openness to experience 1 Psycho-social 
Oppositional defiant disorder 1 Psycho-social 
Orderliness 1 Psycho-social 
Overall QoL 1 Psycho-social 
Parent perception of child’s independence 1 Family dynamics 
Parent perception of control 1 Psycho-social 
Parent perception of family organisation 1 Family dynamics 
Parental marital status 1 Family dynamics 
Parents' health literacy 1 Psycho-social 
Parents perceptions of expressiveness 1 Psycho-social 
Parents' reading comprehension 1 Psycho-social 
Patient perception of control 1 Psycho-social 
Patient perception of independence 1 Family dynamics 
Patient perceptions of expressiveness 1 Psycho-social 
Perceived competence 1 Psycho-social 
Perceived level of hope 1 Psycho-social 
Presence of co-morbidities 
  
1 Past medical 
history 
Presence of threat to emotional well-being 1 Psycho-social 
Presence of threat to physical well-being 1 Psycho-social 
Presence of threat to social wellbeing 1 Psycho-social 
Psychosis 1 Psycho-social 
PTSD 1 Psycho-social 
PTSD diagnosis of mother 1 Psycho-social 
QoL (with number of injections per day) 1 Psycho-social 
QoL: Diabetes worry 1 Psycho-social 
QoL: Satisfaction 1 Psycho-social 
QoL: Social worry 1 Psycho-social 
Race 1 Demographics 




Regular Use of I-Port 1 Diabetes 
management 
Report of symptom severity 1 Diabetes 
management 
Response costs 1 Psycho-social 
Response efficacy 1 Psycho-social 
School/work performance 1 Psycho-social 
Self-consciousness 1 Psycho-social 
Self-discipline 1 Psycho-social 
Self-report on adherence to BGM 1 Diabetes 
management 




Self-report on adherence to snacks 1 Diabetes 
management 
Sense of normality 1 Psycho-social 
Separation anxiety disorder 1 Psycho-social 
Sociability scores 1 Psycho-social 
Social anxiety 1 Psycho-social 
Social phobia 1 Psycho-social 
Specific (isolated) phobias 1 Psycho-social 
Support from friends 1 Psycho-social 
Support from nurses 1 Psycho-social 
Support from physicians 1 Psycho-social 
Sympathy 1 Psycho-social 
Teacher victimisation 1 Psycho-social 
Threat 1 Psycho-social 
Timeline 1 Psycho-social 








Total meals 1 Psycho-social 
Treatment effectiveness: control 1 Psycho-social 
Treatment effectiveness: prevent 1 Psycho-social 
Trust 1 Psycho-social 




Uses diabetes apps 1 Diabetes 
management 
Uses diabetes websites 1 Diabetes 
management 
Uses meter/pump software 1 Diabetes 
management 
Uses social networking 1 Psycho-social 
Uses text messaging 1 Psycho-social 
Utilising personal and interpersonal resources coping 
strategy 
1 Psycho-social 
Ventilation and avoidance coping strategy 1 Psycho-social 
Vulnerability 1 Psycho-social 
Warmth from family 1 Family dynamics 
Table 3.3 List of factors checked for association for adherence and the number of studies that assessed them. Legend; 
DSMP: Diabetes Self-Management Profile, QoL: Quality of Life, DSS: Diabetes Social Support questionnaire, ADHD: Attention 
Deficit Hyperactivity Disorder, OCD: Obsessive Compulsive Disorder, PTSD: Post-Traumatic Stress Disorder, HbA1c: glycated 
haemoglobin, BMI: Body Mass Index, RCT: Randomised Control Trial, BGM: Blood Glucose Monitoring, GAD: Generalised 
Anxiety Disorder. *Self-efficacy refers to the ability of the child/young person to complete a range of diabetes management 











































Number of times a factor was assessed for association with adherence
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3.6. Primary Outcome: Factors Affecting Adherence to Insulin Therapy 
 
In the majority of cases, effects upon adherence were calculated using regression analysis with the 
strength of the relationship being expressed as Pearson correlations (r). Some studies also quantified 
the size of the effect using beta (β) values.  
 
For Pearson correlation coefficients (r) and beta values (β), a positive value can be interpreted that 
adherence improved with the assessed factor and a negative value that adherence worsened with 
the assessed factor, unless otherwise specified.  
 
If results are not published using Pearson correlations and/or β values, this will be explained 
alongside the result. 
 
Due to the heterogeneity of the studies involved, as a result of the large number of different 
methods used to assess adherence and the different factors that were assessed for correlation with 
adherence, meta-analysis of the studies was not possible. 
 
Due to the large number of factors that were only assessed by 1 study, only factors that were 
assessed by 4 or more studies have been discussed in detail below. A briefer summary of the 





145,148,150,151,153,154,156,158,160,163,165–169,177,178,192,193) examined the effect of age 
upon treatment adherence. These studies are summarised in Table 3.4. To allow for a quick visual 
estimate of the overall message of the results, the “effect on adherence” column is coloured orange 
with significant results that suggest adherence worsens with age, and coloured green with significant 
results that suggest adherence improves with age. Results that are not statistically significant have 
been left white. 
 
The studies contained a total of 6 134 children and young people with an average of 192 children per 
study and a range of 31 to 2011. Almost half (3 039/6 134; 49.4%) of these participants came from 




The 33 studies used 23 different methods of measuring adherence. 
 
24/33 (73%) of these studies (122,123,125,132–134,136–138,140,143–145,151,153,158,163,166–
169,177,178,192) had results showing a significant effect for age in at least one of their methods of 
measuring adherence.  
 
All but two (66.66% of studies) (128) (193) of the papers with statistically significant results 
suggested that adherence became worse with age in childhood. In addition to demonstrating 
worsening adherence with advancing age through childhood, two studies (167,178) found that 
adherence begins to improve once participants exited adolescence into adulthood.  
 
One study (126) found that the strength of the correlation (r) between age and adherence was 
negative and statistically significant, but that when looking at the size of the effect (β), this was not 
statistically significant. 
 
The weighted mean (mean of means, taking into account sample size) of the two papers showing 
adherence improves with age was 11.4 years and the weighted mean of the papers (where both 
mean age and sample size was known) showing that adherence worsens with age was 13.4 years. 
 
Seven of the studies used an objective measure of adherence (132,138,143,151,165–167), with the 
remaining 25 studies using a subjective measure; the majority of these were self-report measures, 
though one (178) had the participant’s healthcare providers rating the adherence of the participant. 
 
Of the studies that used objective measures to measure adherence, 2 used BOLUS scores (132,165), 
2 used MPR (166,167) (with one of these (166) also using HbA1c and 3 used data retrospectively 
taken from insulin pumps (137,138,143). Note that BOLUS scores do require retrieving data from 
insulin pumps, but convert this data into a standardised score, so cannot be considered to be the 
same thing. Of the 2 studies that used MPR, each study expressed their results differently, with 1 
(167) giving the individual scores for each group and the other (166) using Pearson scores. The 
heterogeneity of the methods of assessing and reporting adherence makes meta-analysis difficult. 
Just two studies (137,138) used the same method of measuring and reporting adherence 
(retrospectively collected pump data and Pearson correlations respectively). These two studies had 
slightly different outcomes, with one (137) assessing the effect of age on two different aspects of 
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adherence to insulin therapy and the other (138) assessing adherence at two different timepoints, 
again making meta-analysis not possible. 
 
All of the studies assessing the relationship between age and adherence were observational studies, 
which according to the GRADE framework (see section 2.2.7), begins the body of evidence at “low 
certainty”. There were insufficient studies that demonstrated either a large magnitude of effect, a 
dose-response gradient, or a reduction in the effect size with additional confounders in order to 
increase the grading for this factor. Reduction of the grade by reason of risk of bias (including 
publication bias), imprecision, inconsistency or indirectness was also not considered necessary, 


























NK 61 Self-created 4-
















N r= -0.4 Y <0.007  





116 BOLUS score Y r=-0.054 N >0.05  
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Y β= -0.435 Y <0.05 MPR equals 
the total number 
of days of supply 
for all claims 
during the study 
period 
divided by a total 





16 (NK) 89 Medication 
Possession Ratio 
(MPR) 
Y <10 years old 
mean score: 
~725 
Y 0.0001 Results 
published were 





are listed here as 
approximations 
as they were 
only published in 


































NK (6-19) 78 24-hour recall 
interviews 














101 Summary of Self-
Care Activities 
Questionnaire 
N R1,2= -0.06 N >0.05  Used zero-order 
correlations 
(r1,2), indcating 










report: r= 0.26 








































N r= -0.21 Y 0.008  
Nakamura, 
2019 (128) 
13.1 (NK) 123 Revised Diabetes 
Self-Care 
Inventory (SCI-R) 












90 BOLUS scores Y r= -0.27 Y <0.01  
La Greca, 1995 
(133) 
14.2 (11-18) 74 Interview 
(developed by 
Hanson et al., 
1992) 
N r= -0.24 Y <0.05  
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N r= 0.221 Y <0.01 Higher scores on 
the 
questionnaire 


























































report at T1: 
R2=  -0.28 
Y <0.01 Used Multiple 
Regression 
Analysis (MRA; 
R2). Child’s report 




report at T2: 
R2=  -0.23 
Y <0.05 
Child’s report 
at T2:  




14.4 (NK) 93 Self-report and 
observation 
(Cerkoney and 
Hart and Schlenk 
and Hart) 
N r= -0.21 Y <0.05  




13 (8-18) 88 Self-report diary N Parent’s 
report: r= -0.3 






































Littlefield et al., 
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Y r= -0.22 bolus 
events each 
day per year 
of age 
Y 0.001  
Schober, 2011 
(144) 
NK (10-21) 2011 Diabetes Self-
Management 
Profile (DSMP; 
Y Mean age of 
compliant 
group: 14.00 
Y <0.01 Participants 
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the responses to 
the 
questionnaire, 
with the mean 
age of each 
group being 
calculated to try 




























12.8 (9-15) 57 Rated by 
healthcare 
providers 
N “Patients aged 
10-20 years 






10 years or 




Y <0.001 The results were 
published as 














161 Summary of Self-
Care Activities 
(Schafer et al. 
1983) 




11.8 (2-17) 201 Self-created 
survey 
Y MDI users: 
r= 0.04 
N 0.7  

























La Greca, 2002 
(134) 
14.2 (11-18) 74 Interview 
(developed by 
Hanson et al., 
1992) 
Y r= -0.34 Y <0.01  
Bond, 1992 
(153) 






Duffeck et al., 
1987) 
Y r= -0.28 Y <0.05 Used several 
questionnaires, 
but only one of 
them had 
published results 







(Glasgow et al., 
1987) 
N r= -0.16 N >0.05  
Maliszewski, 
2017 (151) 









N r= -0.02  N >0.05  








N R2= -0.18 Y <0.05 Used MRA. 
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Y T1: r= -0.271 Y <0.01  
T2: r= -0.243 Y <0.01 
Moret, 1995 
(193) 
10.2 (7-13) 165 Insulin 
adjustment 
score 
Y r= 0.28 Y <0.001  
Van Dongen, 
2005 (192) 
12.7 (10-15) 53 Insulin Required 
of Adherence 
Scale 
Y r= -0.4 Y <0.01  
Table 3.4 Summary of results of studies that assessed the association between adherence and age. Legend: ADQ: Adherence in Diabetes Questionnaire, DRCQ: Diabetes Regimen Compliance 
Questionnaire, DFRQ: Diabetes Family Responsibility Questionnaire, MPR: Medication Possession Ratio, SCI: Self-Care Inventory, SCI-R: Revised Self-Care Inventory,  Y: yes, N: No, r: Pearson 
correlation coefficient value, β: beta-value, R2: multiple regression analysis value, R1,2: zero order correlation value, HbA1c: glycated haemoglobin,  MRA: Multiple Regression Analysis.  
Significant results indicating a positive relationship between increasing age and adherence are coloured green and significant results indicating a negative relationship between increasing age 
and adherence are coloured orange. Results that were not significant have been left white. 
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3.6.2. HbA1c/Glycaemic Control 
 
Twenty studies (121,123,125,126,128,132,135,137,139–141,144,145,151,154,155,159,160,173,176) 
assessed the correlation between treatment adherence and HbA1c. For one of these studies, the 
phrasing used was “glycaemic control”. A summary of the studies and their results can be found in 
Table 3.5. Statistically significant results that suggest HbA1c decreases/glycaemic control improves 
with improved adherence have been coloured green. Results that were not statistically significant 
have been left white. One result is yellow as 1 of the domains that it assessed was significant while 
the other was not significant. 
 
All of the included studies suggested that HbA1c decreased/glycaemic control improved with better 
adherence. 15 studies (121,123,125,126,128,132,135,137,141,145,151,154,155,160,173) found the 
relationship to be statistically significant, unanimously across all of their assessed domains.  
 
The studies included a total of 3 365 children and young people with diabetes with a mean of 168 
children and a range of 31 to 1028. 
 
The 20 studies used 15 different methods of measuring adherence. 
 
One study (176) found that adherence at study entry was not significantly associated with HbA1c at 
follow-up, but that the relationship was significant across all other domains (adherence at study 
entry vs HbA1c at study entry and adherence at follow-up vs HbA1c at both study entry and follow-
up).  
 
Another study (159) found that the relationship was not significant when looking at specific age 
groups (aged 8-11 and 12-17) but was significant when looking at the total sample.  
 
One study (144) found that the relationship was significant when comparing those that were 
compliant (group A) versus those that were intentionally non-compliant (group B), but not when 
comparing those that were unintentionally non-compliant (group C) with either of the other groups. 
 
Two studies (139,140) found the relationship to be not significant in the one domain assessed (that 
being the sample as a whole). One of these studies (139) was approaching significance, with a p-




No studies - significantly or not significantly - demonstrated that HbA1c increases with improved 
adherence. 
 
Statistically significant results that demonstrate HbA1c decreases/glycaemic or metabolic control 
improves with improved treatment adherence are coloured in green. Results that were not 
statistically significant have been left white. 
 
Studies differed considerably in their methods of measuring adherence and sample populations, so 
meta-analysis was not considered appropriate. 
 
All of the studies assessing the relationship between HbA1c/glycaemic control and adherence were 
observational studies, which according to the GRADE framework (see section 2.2.7), begins the body 
of evidence at “low certainty”. There were insufficient studies that demonstrated either a large 
magnitude of effect, a dose-response gradient, or a reduction in the effect size with additional 
confounders in order to increase the grading for this factor. Reduction of the grade by reason of risk 
of bias (including publication bias), imprecision, inconsistency or indirectness was also not 































based on the Self-
Care Inventory 
(SCI) 









N Child’s report:  
r= -0.36 








34 Rated by two 
members of clinic 
staff (5-point 
Likert-like scale) 
N r= 0.28 N 
(approaching 
significance) 
0.056 Assessed “metabolic 
control” as opposed to 
HbA1c, so the positive 
correlation should be 
interpreted as 
“metabolic control 






123 Revised Diabetes 
Self-Care 
Inventory (SCI-R) 
N r= 0.266 Y <0.01 Assessed “glycaemic 
control” as opposed to 
HbA1c, so the positive 
correlation should be 
interpreted as 
“glycaemic control 














































(Horne et al. 1999) 







N Adherence at 
entry vs HbA1c at 
entry: r= -0.28 
Y <0.01  
Adherence at 














































Y Adherence to 
bolus frequency: 
r= -0.37 
Y <0.05  
Adherence to 
carbohydrate 







93 Self-report and 
observation 
(Cerkoney and 
Hart and Schlenk 
and Hart) 
N r= -0.3 Y <0.01 One of two papers with 
this lead author written 
during this year and as 
such, this will be 
denoted as “Hanson, 






























88 Self-report diary Y r= -0.22 N >0.05 Note that elsewhere 
where results of this 
paper have been 
published, it has not 
specifically reported 
insulin adherence; 
some of its assessed 
factors were reported 
as a composite index 

















upon Littlefield et 
al., 1992 












N Of the group who 
had a HbA1c 
below 
53mmol/mol, 
56% were classed 
as having good 
adherence. 

























Of the group who 
had a HbA1c 
above 
53mmol/mol, 9% 










Harris et al., 2000) 




(Group A) was 
62mmol/mol 









when participants had 
unintentionally been 
non-compliant. 




(Group B) was 
72mmol/mol 
Y (A vs B), N 
for other 
correlations 
<0.01 (A vs 
































(Group C) was 
62mmol/mol 
N for all 
correlations 











Hart, 1980 and 
Schenk and Hart, 
1984) 
N r= -0.28 Y <0.001 One of two papers with 
this lead author written 
during this year and as 
such, this will be 
denoted as “Hanson, 







(Glasgow et al., 
1987) 


















Y Total sample:  
r= -0.159 





























Harris et al., 2000) 
Aged 8-11:  
r= -0.072 
N >0.05 
Age 12-17:  
r= -0.154 
N >0.05 
Table 3.5 Studies that assessed the relationship between adherence and HbA1c/glycaemic control and their results. Legend; HbA1c: glycated haemoglobin, mmol/mol: millimoles per mole, 
DSMP: Diabetes Self-Management Profile, SCI: Self-Care Inventory, SCI-R: Revised Self-Care Inventory, r: Pearson correlation coefficient value, ADQ: Adherence in Diabetes Questionnaire, Y: 
yes, N: no. Statistically significant results that demonstrate HbA1c decreases/glycaemic or metabolic control improves with improved treatment adherence are coloured in green. Results that 
were not statistically significant have been left white. One study assessed correlations between 3 groups, with 1 of these correlations being significant and the others not significant; this result 
has been coloured yellow.
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3.6.3. Duration of Diabetes 
 
19 studies (116,120–123,128,131,133,136,144,145,148,150,154,158,160,163,169,178) assessed the 
association between the duration of diabetes and treatment adherence. Table 3.6 summarises these 
studies and their results. 
 
The studies contained a total of 3 527 children and young people with diabetes, with a mean of 196 
children per study and a range of 57 to 1 028. 29.1% of participants came from one study. One study 
did not indicate their sample size and was left out of this calculation.  
 
The 19 studies used 16 different methods of measuring adherence. 
 
Nine studies (120–123,128,131,136,145,154) had statistically significant results that suggested that 
adherence worsens with increasing disease duration, with the remainder of the studies reporting a 
relationship that was not significant. 
 
No studies - significantly or not significantly - suggested that adherence improves with increased 
disease duration. 
 
No studies with statistically significant results shared the same method of measuring and reporting 
adherence or had similar sample sizes and mean population ages, so meta-analysis was not possible. 
 
All of the studies assessing the relationship between duration of diabetes and adherence were 
observational studies, which according to the GRADE framework (see section 2.2.7), begins the body 
of evidence at “low certainty”. There were insufficient studies that demonstrated either a large 
magnitude of effect, a dose-response gradient, or a reduction in the effect size with additional 
confounders in order to increase the grading for this factor. Reduction of the grade by reason of risk 
of bias (including publication bias), imprecision, inconsistency or indirectness was also not 


































N Mother’s report:  
r= 0.17 
N >0.05 Higher scores in this 
questionnaire confer to 
worse adherence, so the 
positive relationship should 
be interpreted as 
“adherence decreased with 
increasing duration of 
diabetes”. 







289 Questionnaire (not 
otherwise 
specified) 
N 36% of participants 
with a disease 
duration of 1-3 years 
were rated as having 
“good” compliance 
Y <0.001 Study stated the 
percentages as written here 
but did not express this as a 
Pearson correlation. They 
did state that the 
relationship was significant. 17% of participants 
with a disease 
duration of 3-6 years 
were rated as having 
“good” compliance 
12% of participants 
with a disease 
duration of longer 
than 6 years were 


























NK 61 Self-created 4-point 
scale (1-4; poor-
excellent), used by 
paediatricians or 
diabetes nurse 
specialists to make 
an assessment. 
Validated by 







N No numerical value 




N >0.05 Factor was specifically 
stated as “time between 
diagnosis and study entry”. 
Hanson, 
1989 (122) 
NK 135 Self-report 
questionnaire 
based on Cerkoney 
and Hart, 1980 







Y MDI users: r= -0.09 N 0.37  





123 Revised Diabetes 
Self-Care Inventory 
(SCI-R) 


































Profile (DSMP - 
Harris et al., 2000) 







Hanson et al., 1992) 
N NK (no value given, 
but relationship was 
stated as 
insignificant) 








(Almeida & Pereira, 
2003) 
N r= 0.308 Y <0.001 Result was expressed as a t-
test; these serve a similar 
purpose to Pearson 
correlations, indicating the 
direction of a relationship 
and the likelihood that the 
null hypothesis can be 
rejected, with results further 
from 0 in either direction 
increasing likelihood that it 
can be rejected. They are 
generally expressed 























β= 0.273 Y <0.001 Higher scores in this 
questionnaire confer to 
worse adherence, so the 
positive relationship should 
be interpreted as 
“adherence decreased with 











upon Littlefield et 
al., 1992 



























289 Questionnaire (not 
otherwise 
specified) 
N No numerical value 
was given, but it was 
stated within the 
body of text that 
those with 1-3 years 




those with more 
than 3 years disease 
duration. 








Harris et al., 2000) 
Y Mean disease 
duration in 
compliant patients 
was 6.2 years. 
N >0.05 The study stated that “non-
compliance” occurred when 
participants had deliberately 
been non-compliant with 
insulin therapy and 
“management problems” 
occurred when participants 





was 6.2 years. 
Mean disease 
duration in patients 
with management 




























57 Rated by healthcare 
providers 


















161 Summary of Self-
Care Activities 
(Schafer et al. 1983) 








(Glasgow et al., 
1987) 





174 Self-Care Inventory 
- Revised (SCI-R) 






101 Summary of Self-
Care Activities 
Questionnaire 
(Schafer et al. 1983) 
N R1,2: = -0.11 N >0.05 Used zero order 
correlations. 
Table 3.6 Studies assessing the relationship between disease duration and treatment adherence and their results.  Legend; ADQ: Adherence in Diabetes Questionnaire, SCI-R: Revised Self-Care 
Inventory, DSMP: Diabetes Self-Management Profile, DFRQ:  Diabetes Family Responsibility Questionnaire, MRA: Multiple Regression Analysis, MDI: Multiple Daily Injections, CSII: Continuous 
Subcutaneous Insulin Infusion, Y: yes, N: no, NK: Not Known, r: Pearson correlation coefficient value, R1,2: zero order correlation value, R2: Multiple Regression Analysis score. Statistically 
significant results suggestive of worsening adherence with increasing disease duration are coloured orange. Results left in white are not statistically significant.
110 
 
Table 3.7. Significant results suggesting that males have better adherence are coloured blue and 
significant results suggesting that females have better adherence are coloured orange. Results that 
were not statistically significant have been left white. Note that where Pearson correlations (r) or β-
values have been used, results may be positive or negative even when showing the same 
relationship, depending upon the value assigned to each gender in the respective studies.  
 
The studies contained a total of 2 647 children and young people with diabetes with a mean of 176 
children in each study and a range of 34 to 1 028. 1 028/2 647 (38.8%) of these participants came 
from a single study. 
 
The 15 studies used 15 different methods of measuring adherence; MPR was used twice, but one 
study used two different methods. 
 
Of the 15 studies, 6 (136,144,154,161,166,168) found a significant association with gender. Five out 
of these 6 studies (136,144,154,166,168) (83.3%) suggested that males had better adherence and 
one (161) (17.7%) suggested that adherence was better in females. 
 
Of the five studies that suggested adherence was better in males, three were European (Portuguese, 
Austrian and Dutch) studies, one was American and one was Malaysian with a weighted mean 
participant age of 14.9 years old (calculated from the 3 mean ages published). The study that 
suggested adherence was better in females took place in Kuwait and had a significantly lower mean 
age, with a mean age of 9.1 years old for the case group and 9.7 years old for the control group. 
 
Studies differed considerably in their methods of measuring adherence and sample populations, so 
meta-analysis was not considered appropriate. 
 
All of the studies assessing the relationship between gender and adherence were observational 
studies, which according to the GRADE framework (see section 2.2.7), begins the body of evidence at 
“low certainty”. There were insufficient studies that demonstrated either a large magnitude of 
effect, a dose-response gradient, or a reduction in the effect size with additional confounders in 
order to increase the grading for this factor. Reduction of the grade by reason of risk of bias 
(including publication bias), imprecision or indirectness was also not considered necessary. The 
inconsistency of the results warranted reducing the grading, leaving the body of evidence for this 






























57 Rated by healthcare 
providers 
N NK N >0.05 No specific value for effect 
on adherence given, but it 













Y “tendencies for 
boys to report 





N >0.05 Adherence in this context is 








N r= 0.07 (girls more 
adherent) 








Y β= -0.861 (males 
had better 
adherence) 
Y <0.05  
Morris, 
1997 (167) 
16 (NK) 89 Medication 
Possession Ratio 
(MPR) 
Y NK N >0.05 No specific value for effect 
on adherence given, but it 




NK (6-19) 78 24-hour recall 
interviews 
Y F=4.61 (males had 
better adherence) 



































N Mothers’ report: r= 
-0.17 (females had 
better adherence) 
N >0.05  
Child’s report:  





13.1 (NK) 123 Revised Diabetes 
Self-Care Inventory 
N Males’ mean score: 
11.2, females’ 
mean score: 10.7, 
with higher scores 
conferring to 
better adherence. 
N >0.05 Question where insulin 
adherence was assessed 
also assessed dietary 
adherence (“regularity of 








Hanson et al., 1992) 
N NK N >0.05 No specific value for effect 
on adherence given, but it 









(Almeida & Pereira, 
2003) 
N β= -0.198 (males 
had better 
adherence) 










upon Littlefield et 
al., 1992 
N r= -0.26 (females 
had better 
adherence) 
































Profile (Harris et al., 
2000) 




N/A N/A The study stated that “non-
compliance” occurred 
when participants had 
deliberately been non-
compliant with insulin 
therapy and “management 
































of Life Inventory 
(PedsQL) 3.0 
Diabetes Module 
(of which 7 items 
out of 28 relate to 
adherence) 
N Males’ mean score: 
69.7, females’ 
mean score: 76.6, 
with higher scores 
conferring to 
better adherence. 
Y <0.05 Gender was the only factor 
specifically assessed for 
adherence; this was still a 
composite index and not 
specifically regarding 








(Glasgow et al., 
1987) 
N r= -0.24 (males had 
better adherence) 






53 Insulin Required of 
Adherence Scale 
Y r= -0.2 (females 
had better 
adherence) 
N >0.05  
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Table 3.7 Summary of results of studies that assessed the association between adherence and age. Legend; Y: yes, N: no, NK: not known, N/A: not applicable, PedsQL: Paediatric Quality of Life 
Inventory, DFRQ: Diabetes Family Responsibility Questionnaire, MPR:  Medication Possession Ratio, ANOVA: Analysis of Variance, r:Pearson correlation coefficient value.  Significant results 
where adherence was shown to be better in males have been highlighted in blue and significant results where adherence was shown to be better in females have been highlighted in orange. 
Result that were not statistically significant have been left in white. NB: whether the numerical value is positive or negative is not always consistent depending on the number each respective 
study assigned to which gender.
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3.6.4. Perceptions of Family Conflict 
 
Eight studies (123,136,140,151,160,162,164,192) assessed the impact of perceived family conflict 
upon treatment adherence. These eight studies and their results are summarised in Table 3.8. 
Statistically significant results suggesting that family conflict has a negative effect upon adherence 
are coloured orange. Results that were not statistically significant have been left white.  
 
The studies included a total of 702 children and young people with diabetes with a mean of 88 
children per study and a range of 34 to 157. 
 
The eight studies used nine different methods of measuring adherence; the number of methods is 
greater than the number of studies due to one study using two methods. 
 
Five studies (123,140,151,162,192) assessed the perceptions of both the child and a parent of family 
conflict and 3 studies (136,160,164) assessed only the child’s perception of conflict. Subjective 
reports of adherence are from the perspective of the child unless otherwise specified.  
 
One study (140) assessed 12 correlations so is discussed separately here. This study had two 
participant groups: parents and children receiving treatment in private hospitals and parents and 
children receiving treatment in public hospitals. Both parents and children gave reports on their 
perceptions of family conflict and treatment adherence. The patients’ nurses also gave a report on 
the adherence of the patient.  
 
In the public hospital group, the parent’s perceptions of family conflict were significantly negatively 
correlated with the parent’s and nurse’s report of adherence but was not correlated with the child’s 
report of adherence. The child’s perceptions of family conflict were significantly negatively 
correlated with the parent’s and child’s reports of adherence, but not the nurse’s.  
 
In the private hospital group, only the parent’s report of family conflict with the parent’s report of 
adherence was significantly negatively associated. All other correlations were insignificant. Of all the 
correlations assessed in this study, 5/12 (42%) of them suggested that adherence worsens with 
family conflict. The remaining 7/12 (58%) showed no significant interaction. Of the significant 




Of the remaining studies that assessed the relationship between the child’s perceptions of family 
conflict and adherence, 3/7 (43%) (123,162,192) had statistically significant results that suggest 
adherence worsens with family conflict. The remaining 4/7 (57%) (136,151,160,164), had results that 
were not statistically significant. One of these studies (160) assessed the frequency and intensity of 
conflict as separate domains (with both having insignificant results). 
 
Of the remaining studies (123,151,162,192) that examined the effect of the parent’s report of family 
conflict, 2/4 (50%) (151,192) had statistically significant results suggesting that adherence worsens 
with family conflict, with the other 2/4 (50%) (123,162) having statistically insignificant results.  
 
When looking at the effect of whether the report of family conflict comes from the child or their 
parents, 42% of the results based on children’s reports were statistically significant versus 50% when 
the report came from parents, with all suggesting that family conflict has a negative effect upon 
adherence.  
 
As a composite analysis of all studies that assessed family conflict and its effect on adherence, 
including all parents’ and children’s reports of both conflict and adherence and nurses’ reports of 
adherence, there were 24 correlations assessed. 10/24 (42%) of these correlations had statistically 
significant results suggesting that adherence worsens with family conflict, with the remaining 14/24 
(58%) having statistically insignificant results. 0/24 (0%) of the correlations assessed had statistically 
significant results that suggested adherence improves with family conflict.  
 
Studies differed considerably in their methods of measuring adherence and sample populations, so 
meta-analysis was not considered appropriate. 
 
All of the studies assessing the relationship between family conflict and adherence were 
observational studies, which according to the GRADE framework (see section 2.2.7), begins the body 
of evidence at “low certainty”. There were insufficient studies that demonstrated either a large 
magnitude of effect, a dose-response gradient, or a reduction in the effect size with additional 
confounders in order to increase the grading for this factor. Reduction of the grade by reason of risk 
of bias (including publication bias), imprecision, inconsistency or indirectness was also not 
considered necessary, leaving the body of evidence for this factor as “low certainty”. 
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conflict: r= -0.38 
Y <0.01  
Parent’s 
perception of 




12.8 52 Questionnaire 
(validated by Jacobson 
et al., 1987) 
Y Child’s 
perception of 
conflict: r= -0.41 
Y <0.004  
Parent’s 
perception of 











conflict: r= 0.1 
N >0.05 Adherence in this 
context is “care 
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Summary of Self-Care 
Activities 
Questionnaire 






157 Interview N Child’s 
perception of 
conflict: r= -0.3 
Y <0.0001 Specifically assessed 
mother’s 
perceptions, where 
other papers have 
















conflict: r= 0.053 










r= -0.59, β= -0.54 

























r= -0.37, β= -0.5 
















































































upon Littlefield et al., 
1992 
N Child’s report, 
frequency of 
conflict: r= 0.07 
N >0.05  
Child’s report, 
intensity of 
conflict: r= 0.01 
N >0.05 
Table 3.8 Studies assessing the relationship between family conflict and adherence and their results. Legend; Y: yes, N: no. r: Pearson correlation coefficient value, β: beta value. Statistically 





Seven studies (117,132,142,146,151,173,195) assessed the relationship between 
depression/depressive symptoms in children and treatment adherence and one (177) assessed the 
relationship between depression in the child’s mother and treatment adherence.  
 
The studies contained a total of 3 527 children and young people with diabetes, with a mean of 196 
children per study and a range of 57 to 1 028.  29.1% of participants came from one study. One study 
did not indicate their sample size and was left out of this calculation.  
 
The seven studies used six different methods of measuring adherence and four different measures 
for assessing depression. These four methods were: 
• Centre for Epidemiologic Studies – Depression Scale (132,151,173,177) 
• Children’s Diagnostic Interview for Psychiatric Disorders (117) 
• M5-336 Questionnaire (142) 
• Children’s Depression Inventory (146) 
 
All seven studies that assessed depression in the child had significant results that suggest adherence 
worsens with depression. Three of these studies (132,142,151) specifically assessed adherence to 
insulin treatment and presented this component of adherence separately with the others assessing 
adherence to insulin but presenting the results as a composite measure of all aspects of adherence. 
 
Two of these studies (132,151) used the same measure of adherence, that being BOLUS scores, but 
did not control for the same variables, so meta-analysis was not possible. 
 
No studies had results – significant or not significant – suggesting that treatment adherence 
improved with depression.  
 
The study assessing maternal depression assessed depression and adherence at study entry (T1) and 
follow-up (T2) and tested for correlations between all of these variables and times. No relationships 
were statistically significant except the relationship between maternal depression at T2 and 




Table 3.9 summarises all of the above studies and their results. Significant results that suggest 
adherence worsens with depression have been coloured orange. Results that were not statistically 
significant have been left white. 
 
Studies differed considerably in their methods of measuring adherence and sample populations, so 
meta-analysis was not considered appropriate. 
 
All of the studies assessing the relationship between depression and adherence were observational 
studies, which according to the GRADE framework (see section 2.2.7), begins the body of evidence at 
“low certainty”. There were insufficient studies that demonstrated either a large magnitude of 
effect, a dose-response gradient, or a reduction in the effect size with additional confounders in 
order to increase the grading for this factor. Reduction of the grade by reason of risk of bias 
(including publication bias), imprecision, inconsistency or indirectness was also not considered 
































N 4.9% of the 
participants who 
were classed as 
being adherent had 
depression 
Y <0.005  
13.4% of the 
participants who 




18.3% of the 
participants who 












based on the 
Self-Care 
Inventory (SCI) 












82 SCI N Maternal depression 
at study entry with 
adherence at study 
entry: Child’s report: 
R2: -0.04.  
N >0.05 Maternal depression. 
 
Used multiple regression 
analysis (MRA). 
Maternal depression 
at study entry with 
adherence at study 
entry: Parent’s 
report: R2: -0.06. 
N >0.05 
Maternal depression 




adherence at follow 
up: Child’s report:  
R2: -0.15.  
Maternal depression 
at study entry with 
adherence at follow 




at follow up with 
adherence at study 
entry: Child’s report: 
R2:  0.01. 
N >0.05 
Maternal depression 
at follow up with 
adherence at study 
entry: Parent’s 
report: R2: -0.04. 
N >0.05 
Maternal depression 
at follow up with 
adherence at follow 






at follow up with 
adherence at follow 































N r= 0.342 Y <0.01 "Adherence" in this case is 
actually the perceived 
difficulty of performing 
management tasks, so this 
result should be interpreted 
as “depressive state is 
associated with more 
128 
 
difficulty in performing 
management tasks”. 
Table 3.9 Studies assessing the relationship between depression in children and their mothers and treatment adherence, and their results. Legend; SCI: Self-Care Inventory, Y: yes, N: no, NK: 
Not Known, r: Pearson correlation coefficient value, R2: multiple regression analysis value.  Significant results suggesting that adherence worsens with depression are coloured in orange. 






Seven studies (116,135,141,142,146,148,160) assessed the relationship between the child’s self-
efficacy and adherence. Self-efficacy in this context refers to a child’s confidence in their abilities to 
perform various diabetes management tasks. These studies and their results are summarised in 
Table 3.10. Statistically significant results that suggest a positive relationship between self-efficacy 
and adherence are coloured green. Results that were not statistically significant have been left 
white. 
 
The studies included 869 children and young people with diabetes with a mean of 124 children and a 
range of 28-252. 
 
The seven studies used six different methods of measuring adherence. Self-efficacy was assessed 
within these methods. 
 
5/7 (71%) (141,142,146,148,160) of these studies had statistically significant results that suggest 
increased self-efficacy is associated with improved adherence unanimously across all of their 
published results. 
 
1/7 (14%) (116) found the relationship to be statistically significant when looking at the Pearson 
correlation (r), but that the size of the effect (β) was not significant. 
 
1/7 (14%) (135) had results that were not statistically significant. 
 
0/7 (0%) had results suggesting that increased self-efficacy is associated with worse adherence. 
 
Studies differed considerably in their methods of measuring adherence and sample populations, so 
meta-analysis was not considered appropriate. 
 
All of the studies assessing the relationship between self-efficacy and adherence were observational 
studies, which according to the GRADE framework (see section 2.2.7), begins the body of evidence at 
“low certainty”. There were insufficient studies that demonstrated either a large magnitude of 
effect, a dose-response gradient, or a reduction in the effect size with additional confounders in 
order to increase the grading for this factor. Reduction of the grade by reason of risk of bias 
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(including publication bias), imprecision, inconsistency or indirectness was also not considered 
necessary, leaving the body of evidence for this factor as “low certainty”.  
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101 Summary of Self-
Care Activities 
Questionnaire 
N R1,2 = 0.24 Y <0.05 Used zero order correlations. 
β= 0.1 N >0.05 
Griva, 
2000 (135) 
20.6 (NK) 64 Questionnaire based 
on the Reported 
Adherence to 
Medication Scale 
(Horne et al. 1999) 
N r= -0.25 N >0.05 Higher scores in the self-efficacy 
scale used by this study 
conferred to lower self-efficacy, 
so this result should be 
interpreted as “lower self-
efficacy was negatively 
associated with adherence” 






252 Self-Care Inventory 
(SCI) 










upon Littlefield et 
al., 1992 






constructed by study 
authors 






constructed by study 
authors 







161 Summary of Self-
Care Activities 
(Schafer et al. 1983) 
N R1,2 = 0.21 Y <0.01 Used zero order correlations. 
Table 3.10 Summary of studies assessing the relationship between the child’s self-efficacy and adherence. Legend; SCI: Self-Care Inventory, Y: yes, N: no, R1,2: zero order correlation value, r: 
Pearson correlation coefficient value, β: beta value.  Statistically significant results that suggest a positive relationship between self-efficacy and adherence are coloured green. Statistically 




3.6.7. Perceptions of Family Support 
 
Seven studies (120,126,133,134,136,148,164) assessed the relationship between support from 
family members and adherence. Their results are summarised in Table 3.11. Statistically significant 
results indicative of a positive relationship between familial support and adherence have been 
coloured green. Results that were not statistically significant have been left white. 
 
The studies included a total of 882 children and young people with diabetes with a mean of 126 
children in each study and a range of 34 to 289. 
 
The seven studies used seven different methods of measuring adherence; the interview developed 
by Hanson et al., was used twice, but one study used two different methods. Perceptions of family 
support was assessed within these measures. 
 
5/7 (71%) (120,126,133,136,148) of these studies had statistically significant results suggesting a 
positive relationship between familial support and adherence.  
 
The remaining 2/7 (29%) (134,164) had statistically insignificant results. 
 
The five studies that had results suggestive of a statistically significant positive relationship 
expressed the relationship of familial support to a composite index of all aspects of adherence. The 
two studies that did not have statistically significant results expressed the relationship of familial 
support to adherence to insulin therapy specifically.  
 
0/7 (0%) of studies had statistically significant results suggestive of a negative relationship between 
familial support and adherence. 
 
Studies differed considerably in their methods of measuring adherence and sample populations, so 
meta-analysis was not considered appropriate. 
 
All of the studies assessing the relationship between family support and adherence were 
observational studies, which according to the GRADE framework (see section 2.2.7), begins the body 
of evidence at “low certainty”. There were insufficient studies that demonstrated either a large 
magnitude of effect, a dose-response gradient, or a reduction in the effect size with additional 
confounders in order to increase the grading for this factor. Reduction of the grade by reason of risk 
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of bias (including publication bias), imprecision, inconsistency or indirectness was also not 






























34 Barriers to Adherence 
and Problem-Solving 
Questionnaire and 
Summary of Self-Care 
Activities Questionnaire 
Y Supportiveness of mother:  
r= -0.14 
N >0.05  








289 Questionnaire (not 
otherwise specified) 
N Children deemed to have 
parental support: 33% were 
classed as having “good” 
adherence, 67% 
“satisfactory” and 0% as 
“poor” 
Y <0.001  
Children deemed to not 
have parental support: 2% 
were classed as having 
“good” adherence, 84% as 







74 Interview (developed by 
Hanson et al., 1992) 








Adherence (Almeida & 
Pereira, 2003) 







161 Summary of Self-Care 
Activities (Schafer et al. 
1983) 








93 Self-report and 
observation (Cerkoney 
and Hart and Schlenk 
and Hart) 






74 Interview (developed by 
Hanson et al., 1992) 
Y r= 0.11 N >0.05  
Table 3.11 Summary of studies that assess the relationship between familial support and adherence. Legend; Y: yes, N: no, r: Pearson correlation coefficient value, R1,2: zero order correlation 




3.6.8. Perceptions of Family Cohesion 
 
Five studies (123,134,136,162,164) assessed the correlation between the perceptions of family 
cohesion and treatment adherence. Their results are summarised in Table 3.12. Statistically 
significant results that suggest that adherence improves with increasing family cohesion are 
coloured in green. Results that are not statistically significant have been left white. Correlations are 
based upon the child’s perceptions of family cohesion unless otherwise specified. 
 
The studies included a total of 474 children and young people with a mean of 95 children and a 
range of 34 to 157. 
 
The five studies used six different methods of measuring adherence; the number of methods used is 
greater than the number of studies due to one study using two methods to measure adherence. 
 
All 5 studies assessed the association of the child’s perception of family cohesion with adherence, 
with 2/5 (40%) (123,134) having statistically significant results that suggested that adherence 
improves as the child’s perceptions family cohesion increases. 1/5 (20%) (162) had statistically 
significant results that suggested adherence worsens as the child’s perceptions of family cohesion 
increases. The remaining 2/5 (40%) (136,164) had results that were not statistically significant.  
 
Two of these studies (123,162) also assessed the associations between treatment adherence and a 
parent’s perceptions of family cohesion. 2/2 (100%) had statistically significant results that 
suggested adherence improves as parent’s perceptions of family cohesion increases. It is worth 
noting that 1 of these studies (162) suggested the inverse relationship when looking at the child’s 
perceptions of family cohesion. 
 
Studies differed considerably in their methods of measuring adherence and sample populations, so 
meta-analysis was not considered appropriate. 
 
All of the studies assessing the relationship between family cohesion and adherence were 
observational studies, which according to the GRADE framework (see section 2.2.7), begins the body 
of evidence at “low certainty”. There were insufficient studies that demonstrated either a large 
magnitude of effect, a dose-response gradient, or a reduction in the effect size with additional 
confounders in order to increase the grading for this factor. Reduction of the grade by reason of risk 
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of bias (including publication bias), imprecision, inconsistency or indirectness was also not 





















































& Pereira, 2003) 
N r= -0.014 N >0.05 Higher scores in the adherence 
questionnaire confer to worse 
adherence, so the negative 
relationship here should be 
interpreted as “increasing family 
cohesion was associated with 
improved adherence” (though it 






74 Interview (developed 
by Hanson et al., 
1992) 




12.8 52 Questionnaire 
(validated by 





















34 Barriers to Adherence 
and Problem-Solving 
Questionnaire and 
Summary of Self-Care 
Activities 
Questionnaire 
Y r= 0.11 N >0.05  
Table 3.12 Studies assessing the relationship between perceptions of family cohesion and adherence. Legend; Y; yes, N: no, r: Pearson correlation coefficient value. Statistically significant 
results that suggest that adherence improves with increasing family cohesion are coloured in green and statistically significant results suggesting that adherence worsens with increasing 




3.6.9. Diabetes Knowledge 
Four studies (125,156,193,196) assessed the association between diabetes knowledge and adherence. 
Table 3.13 summarises these studies and their results. Statistically significant results suggesting a 
positive relationship between diabetes knowledge and adherence have been coloured green. Results 
that were not statistically significant have been left white. 
 
The studies included 348 children and young people with a mean of 87 children and a range of 36-165. 
 
The four studies used each used a different method of measuring adherence. 
 
2/4 (50%) (193,196) of the studies found that knowledge of diabetes was significantly positively 
associated with adherence, with one of these studies (193) being the only study that specifically 
assessed adherence to insulin therapy and expressed these results separately.  
 
1/4 (25%) (125) of these studies found that the correlation (r) between diabetes knowledge and 
adherence was positive and statistically significant, but the effect size (β) was not statistically 
significant. 
 
The remaining study (156) did not find a statistically significant association between diabetes 
knowledge and adherence.  
 
No studies suggested that diabetes knowledge has a negative effect on treatment adherence. 
 
 
Studies differed considerably in their methods of measuring adherence and sample populations, so 
meta-analysis was not considered appropriate. 
 
 
All of the studies assessing the relationship between diabetes knowledge and adherence were 
observational studies, which according to the GRADE framework (see section 2.2.7), begins the body 
of evidence at “low certainty”. There were insufficient studies that demonstrated either a large 
magnitude of effect, a dose-response gradient, or a reduction in the effect size with additional 
confounders in order to increase the grading for this factor. Reduction of the grade by reason of risk 
of bias (including publication bias), imprecision, inconsistency or indirectness was also not 




Study Mean age 
(range) 


























N r=0.28,  Y <0.01  









N r= 0 N >0.05  
β= 0.02 N >0.05 
Moret, 1995 
(193) 
10.2 (7-13) 165 Insulin 
adjustment 
score 
Y r= 0.47 Y <0.001  
Olivares, 1994 
(196) 
10.29 (9.12) 36 Questionnaire 
(not otherwise 
specified) 
N t-score= 2.71 Y <0.05  
Table 3.13 Studies assessing the association between diabetes knowledge and treatment adherence. Legend; Y: Yes, N: No, NK: Not Known, DRAQ: Diabetes Regimen Adherence Questionnaire, 
r: Pearson correlation value, β: beta-value. Statistically significant results suggesting a positive relationship between diabetes knowledge and adherence have been coloured green. Results that 
were not statistically significant have been left white.
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3.6.10. Exercise Frequency 
 
Four studies (120,121,159,176) assessed the association between exercise frequency and adherence. 
Table 3.14 summarises these studies and their results. Statistically significant results that suggest 
adherence improves with exercise frequency are coloured green. Results that were not statistically 
significant have been left white. Note that two of these studies (120,121) appeared to be from the 
same data set but have different publication years and methods of publishing their results. They 
have been included as a single row in the table below but referenced separately. 
 
The four studies included 850 children and young people with a mean of 213 children per study and 
a range of 105-289. Note that two of these studies appeared to use the same sample; combining 
these two studies results in a mean of 187 children per study. 
 
One of these studies (159) specifically reported the association with insulin adherence, with the 
other studies assessing insulin adherence, but reporting their results as a composite index. 
 
3/4 of these studies (75%) (120,121,159) found that exercise was significantly positively associated 
across all of their assessed domains. 
 
The one remaining study (176) found that exercise at study entry was significantly positively 
associated with adherence at study entry, but not statistically significant when assessing exercise 
frequency at study entry with adherence at follow-up and exercise frequency at follow-up with 
adherence at both study entry and follow-up. 
 
0/4 (0%) studies suggested that exercise frequency was significantly negatively associated with 
adherence.  
 
Studies differed considerably in their methods of measuring adherence and sample populations, so 
meta-analysis was not considered appropriate. 
 
All of the studies assessing the relationship between age and adherence were observational studies, 
which according to the GRADE framework (see section 2.2.7), begins the body of evidence at “low 
certainty”. There were insufficient studies that demonstrated either a large magnitude of effect, a 
dose-response gradient, or a reduction in the effect size with additional confounders in order to 
increase the grading for this factor. Reduction of the grade by reason of risk of bias (including 
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publication bias), imprecision, inconsistency or indirectness was also not considered necessary, 
































N Of the participants who 
regularly exercise, 90% 
were classed as having 
good adherence, 10% 
satisfactory adherence 
and 0% poor adherence 
Y <0.001 The way the levels of 
“good”, “satisfactory” 
and “poor” adherence 
were classified was 
not clear from the 
study manuscript. 
Of the participants who 
occasionally exercise, 
68% were classed as 
having good adherence, 
29% satisfactory 
adherence and 3% poor 
adherence 
Of the participants who 
did not exercise at all, 
5% were classed as 
having goof adherence, 
0% as having 
satisfactory adherence 








N Exercise at study entry 
(T1) with adherence at 
T1: 0 
.33 
Y <0.001  
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Exercise at T1 with 
adherence at follow-up 
(T2): r= 0.11 
N >0.05 
Exercise at T2 with 
adherence at T1: r= -
0.04 
N >0.05 
Exercise at T2 with 










Harris et al., 
2000) 
Y Sample age 8-11: 0.234 Y <0.01  
Sample age 12-17: r= 
0.219 
Y <0.05 
Total sample: r= 0.245 Y <0.05 
Table 3.14 Studies assessing the association between exercise frequency and adherence. Legend; Y: Yes, N: No, T1: Time 1 (study entry), T2: Time 2 (follow-up), SCI: Self-Care Inventory, DSMP: 
Diabetes Self-Management Profile, r: Pearson correlation coefficient score. Statistically significant results that suggest adherence improves with exercise have been coloured green. Statistically 




3.6.11. Less Frequently Assessed Factors 
 
Table 3.15 contains a summary of factors that were assessed by 3 or fewer studies and their 





(number of studies if 
n>1) 






252 Male: r= 0.29 Y (141) 
Female: r= 0.34 Y 
Achievement striving 28 r= 0.382 N (142) 
Activity level r= 0.33 N 
ADHD 322 AG: 1.9%, EG: 3%, MG: 4.2% N (117) 
Adjustment disorder AG: 1%, EG: 0%, MG: 2.8% N 
Adolescent diabetes 
technology index 
174 β= 0.23 Y (158) 
Adventurousness 28 r= 0.089 N (142) 
Agoraphobia 322 AG: 1.9%, EG: 4.5%, MG: 2.8% N (117) 
Agreeableness 28 r= 0.46 N (142) 
Alcohol/drug abuse 322 AG: 0%, EG: 0%, MG: 0% N/A (117) 
Altruism 28 r= 0.225 N (142) 
Amount of sleep 45 Every 1-minute increase/decrease in 
sleep resulted in 1.2% increase/decrease 
in the total number of daily boluses/20 
minutes per bolus 
Y (149) 
Anger 28 r= -0.542 Y (142) 
Anxiety r= -0.441 N 
Any psychiatric 
disorder 
322 AG: 17.5%, EG: 29.6%, MG: 46.5% Y (117) 
Artistic interests 28 r= 0.009 N (142) 
Assertiveness r= 0.09 N 
Attitude 
  
289 Positive attitude: Good: 31%, 
satisfactory: 69%, poor: 0% 
Y (120) 
Negative attitude: Good: 0%, satisfactory: 




70 0.17 N (160) 




(number of studies if 
n>1) 






37 Increase in questionnaire score by a 




88 Public hospital sample: r=Parent’s (P) 
report on adherence: 0.46, Child’s (C) 
report on adherence: 0.18, Nurse’s (N) 
report on adherence: 0.32. β =P: 0.55, C: 
0.23, N: 0.25 
P and N 
reports: Y, 
C report: N 
(140) 
Private hospital sample: r=P: 0.16, C: 




Public hospital sample: r=P: 0.32, C: 0.4, 
N: 0.35. β=P: 0.17, C:0.22, N: 0.23 
Y 
Private hospital sample: r=P: 0.05, C: 
0.15, N: -0.12. β=P: 0.12, C: 0.03, N: -0.03. 
N 
Benefits - costs 
  
  
56 DRCQ: 0.17 N (153) 
DSCQ: 0.31 Y 
CCTI: -0.05 N 




DRCQ: -0.38 Y 
DSCQ: NK N 
CCTI: NK N 
Better parent-child 
relationship (n=2) 
101 r=0.23, β=0.23 Y (116) 
53 Child’s report of adherence:  
r= 0.49 
Y (192) 
Parent’s report of adherence:  
r= 0.38 
Y 
BGM frequency 88 r= 0.24 N (140) 
BGM frequency T1 105 T1: r= 0.26, T2: r= 0.25 Y (176) 
BGM frequency T2 T1: r= 0.21, T2: r= 0.27 Y 
Binging 193 r= -0.36 Y (146) 




(number of studies if 
n>1) 




r= -0.19, Group B (intentionally non-
compliant group): r= 0.18, Group C 
(unintentionally non-compliant): r= -0.06 
75 r= -0.19 N (155) 
Boluses delivered day 
before clinic visit 
(designed to assess 
white coat adherence) 
  
98 Visit 1: r= -0.06 Y (138) 
Visit 2: r= -0.096 Y 
Boluses delivered day 
before clinic visit x age 
  
Visit 1: r= 0.0027 Y 
Visit 2: r= 0.005 Y 
Caregiver education 
level (n=2) 
1028 r= 0.05 N (145) 
201 MDI: NK N (150) 
CSII: NK N 
Cautiousness 28 0.517 Y (142) 




NK β= -0.274 (child report of adherence) Y (131) 
β= -0.191 (parent report of adherence) N 
Child's increasing 
responsibility (n=3) 
121 Mother’s report of adherence report: r= 
0.14 
N (169) 
Child’s report of adherence: r= 0.2 Y 
161 r= 0.19 Y (148) 
34 r= 0.32 Y (139) 
Clinical/subclinical 
eating disorders 
322 AG: 1.9%, EG: 6%, MG: 12.7% Y (117) 




(number of studies if 
n>1) 




  Female: r= 0.25 Y 
Compliance in the first 
9 months' association 
with compliance in the 
second 9 months 
57 r= 0.53-0.64 Y (178) 
Conduct disorder 322 AG: 1%, EG: 1.5%, MG: 2.8% N (117) 
Conscientiousness 28 0.488 Y (142) 
Consequences 64 r= -0.12 N (135) 
Control group vs 
intervention (trained 
by professionals who 
received a 
communication 
training plan) group 
208 -1.4 score difference control vs 
intervention group 
N (183) 
Co-operation 28 r= 0.324 N (142) 
Coping measures: ego 
defence level 
61 Mean change = -0.05 (with higher ego 
defence score) 
Y (163) 
CSII vs MDI (n=3) 
  
1028 r= 0.18 (CSII better adherence) N (145) 
123 Mean difference between scores, MDI vs 
CSII: 0 
N (128) 
34 “CSII patients had better compliance” (no 





56 DRCQ: 0.2 N (153) 
DSCQ: 0.34 Y 
CCTI: 0.36 Y 
Cure-control 64 r= 0.41 Y (135) 
Diabetes adjustment 
(n=2) 
57 0-9 months: r= 0.24 N (178) 




(number of studies if 
n>1) 




  52 Mean change of 0.27 in adherence score 
for those deemed to have better 




252 Male: r= 0.38 Y (141) 










r= 0.27 Y 
Discipline (child’s 
report) 
88 Public: P: 0.23, C: 0.22, N: 0.23. b=P: 0.09, 
C: 0.14, N: 0.22 
N (140) 
Private: r=P: 0.03, C: 0.1, N: 0.08. b=P: 




Public hospital sample: r= P: 0.21, C: 0.08, 
N: 0.01. b=P: 0.08, C: -0.17, N: -0.22. 
N 
Private hospital sample: r=P: 0.05, C: 







167 Total sample: 0.403 Y (159) 
Age 8-11: 0.407 Y 





Total sample: 0.309 Y 
Age 8-11: 0.176 N 




(number of studies if 
n>1) 









Total sample: 0.154 Y 
Age 8-11: 0.061 N 
Age 12-17: 0.185 Y 
Dutifulness 28 0.419 N (142) 
Dysthymia 322 AG: 0%, EG: 0%, MG: 4.2% Y (117) 
Eating Attitudes Test 
26 
75 r= -0.45 Y (155) 
Eating disorders 
(clinical/subclinical) 
322 AG: 1.9%, EG: 6%, MG: 12.7% Y (117) 
Eating Disorders 
Inventory - Body 
Dissatisfaction Scale 
75 r= -0.43 Y (155) 
Education group vs 
positive affect (PA) 
text message group 
48 NK (insignificant) N (174) 
Education 
intervention 
40 Pre-intervention adherence score: 36.78 
(SD 10.12), post -intervention adherence 




precautions at study 
entry 





T1: 0.26, T2: 0.33 Y 
Emotional adjustment 28 r= -0.28 Y (142) 




(number of studies if 
n>1) 




Energy and willpower 
  
289 Has energy and willpower: Good: 39%, 
satisfactory: 61%, poor: 8% 
Y (120) 
No energy and willpower: Good: 3%, 
satisfactory: 86%, poor: 11% 
Y 
Excitement seeking 28 r= -0.146 N (142) 
Experience of results 
  
289 Positive experience: Good: 26%, 
satisfactory: 72%, poor: 3% 
Y (120) 
Negative experience: Good: 1%, 
satisfactory: 83%, poor: 16% 
Y 
Expressiveness NK r= 0.02 N (131) 
Externalising 
behaviour 
197 r= -0.24 Y (175) 
Extraversion 289 0.151 N (120) 
Family relations 93 r=0.32, β=0.194 r=Y, b=N (125) 
223 r= 0.64 NK (127) 
Family stress (n=2) 197 Maternal report: r= -0.24 Y (175) 
Child’s report: r= -0.09 N 
322  Parent’s report: β: -0.333  Y (117) 
Family support: 
affective 
157 r= 0.234 Y (136) 
Family support: 
control 
r= 0.148 N 
Family support: 
indirect 
r= 0.144 N 
Family support: no 
support 
r= -0.095 N 
Father negative 34 r= -0.01 N (164) 
Father-absent vs 
father-present 






(number of studies if 
n>1) 




Feel that diabetes 
affects their mental 
wellbeing 
289 7.68 times more likely to be adherent 
than those who did not 
Y (121) 
Feel that diabetes 
affects their physical 
wellbeing 
2.95 times more likely to be adherent 
than those who did not 
Y 
Feel that they have 
support from nurses 
6.28 times more likely to be adherent 
than those who did not 
Y 
Feel that they have 
support from their 
physician 
6.69 times more likely to be adherent 
than those who did not 
Y 




322 Regularly drinks alcohol: Good: 5%, 
satisfactory: 62%, poor: 33% 
Y (117) 
Occasionally drinks alcohol: Good: 9%, 
satisfactory: 78%, poor: 13% 
Doesn't drink alcohol: Good: 68%, 
satisfactory: 31%, poor: 1% 
28 NK (insignificant) N (142) 
Frequency of 
breakfast 
104 r= -0.369 Y (129) 
Frequency of dinner r= -0.28 Y 
Frequency of evening 
snack 
r= 0.01 N 
Frequency of help 
  
252 Male: 0.04 N (141) 
Female: 0.12 N 
(marginal) 
Frequency of lunch 104 r= -0.127 N (129) 
Frequency of mid-
afternoon snack 




(number of studies if 
n>1) 






r= -0.095 N 
Friendliness 28 0.263 N (142) 
Functional enuresis 64 AG: 3.9%, EG: 1.5%, MG: 2.8% N (135) 
General monitoring 
  
252 Male: r= 0.46 Y (141) 
Female: r= 0.26 Y 
Generalised anxiety 
disorder 
28 AG: 0%, EG: 0%, MG: 1.4% N (142) 
Gregariousness 34 r= 0.072 N (164) 
HBM: Benefits 54 r=0.02, β=0.32 N (156) 
HBM: costs r=0.25, β =-1.19 N 
HBM: cues to action r=0, β =-0.43 N 
HBM: Susceptibility r=0.01, β =-0.29 Y 
Health Belief Model 
(HBM): Severity 
r=0, β =0.07 Y 
HFS: Behaviour 
  
76 Boys: r= 0.12 N (157) 
Girls: r= 0.15 N 
HFS: worry/fear 
  
Boys: r= -0.5 Y 
Girls: r= -0.02 N 
Household income 
(n=3) 
101 r= 0.04 N (116) 
1028 r= 0.18 Y (145) 
174 β= 0.08 N (158) 
Identity 28 r= -0.24 N (142) 
Imagination -0.183 N 




165 Immigrant mother score: 3.9, French 
native mother score: 4.6 
Y (147) 
Immigrant vs French 
Native mother: 
Immigrant mothers: 29.2%, Native 





(number of studies if 
n>1) 




Percentage that adjust 
insulin dose during 
illness:  
Impulsiveness 28 -0.348 N (142) 
Increased disease 
severity (n=3) 
101 r= -0.22, b= -0.2 Y (116) 
161 r= -0.16 N (148) 
54 r=0, β=0.07 N (156) 
Increased severity of 
risks 
101 r=0.21, b=0.3 Y (116) 
Increased treatment 
complexity 
r= -0.17 N 
Increased vulnerability 
to risks 
r=-0.01, b=-0.14 N 
Increasing lack of 
responsibility from 
mother or child 
121 Mother’s (M) report of adherence: -0.23, 
Child’s (C) report of adherence: -0.06 
M report: 
Y, C report: 
N 
(169) 




252 Male: r= 0.27 Y (141) 
Female: r= 0.28 Y 
Insulin dosage 
calculator use: control 
group (manual 
calculations) 










calculator use: regular 
Average adherence score change after 6 
months: +0.12 
N 




(number of studies if 
n>1) 




Intensity of insulin 
regimen (2 vs 4 
injections per day) 
89 No correlation N (167) 
Internalising 
behaviour 
252 r= -0.11 N 
(marginal) 
(141) 
Intervention group (12 
play sessions) vs 
control group 
30 Post-test: 0.156 N (185) 
Intervention group 
(monthly diabetes 










Intervention post-test: 94.4 
Control pre-test: 63.9 
Control post-test: 51.23 
Intrusive support 
  
252 Male: 0.1 N (141) 
Female: 0.14 Y 
Liberalism 161 0.21 N (148) 
Locus of control 
  
57 0-9 months: r= 0.24 N (178) 
10-18 months: r= 0.34 Y 
Locus of control: 
chance 
174 r= -0.06 N (158) 
Locus of control: 
internal 
r= 0.17 N 
Locus of control: 
powerful others 




82 P report T1: r= 0.09. C report T1: r= 0.05. 





(number of studies if 
n>1) 







P report T1: r= 0.03. C report T1: r= 0.01. 
P report T2: r= 0.17. C report T2: r= -0.06. 
N 
Mean daily blood 
glucose 
91 r= -0.428 Y (151) 
Mean diabetes-
specific stress (DSS) 
severity 
175 r= -0.11 N (173) 
Method of insulin 
delivery 
207 Inhaled insulin usability score: 74.2, S/C 
insulin usability score: 67 
Y (179) 
Modesty 28 r= 0.13 N (142) 
Morality r= 0.603 Y 
Mother negative 34 -0.14 N (164) 
Mother report of 
social functioning 
  
57 0-9 months: 0.45, 10.25 Y (178) 
10-18 months: 0.43, 9.37 Y 
Mother's age 88 r= -0.07 N (154) 
Mother's education 0.13 N 
Mother's increasing 
responsibility for 
management of daily 
regimen tasks 
121 Mother’s report of adherence: r= -0.01, 






Mother’s report of adherence: r= 0, 





(talking to family and 
Mother’s report of adherence: r=: -0.16, 





(number of studies if 
n>1) 




friends about disease 
etc.) 
Mother's sense of 
empowerment 
88 0.2 Y (154) 
Motivation level 
  
289 Good motivation: Good: 39%, 
satisfactory: 61%, poor: 0% 
Y (120) 
No motivation: Good: 2%, satisfactory: 




75 r= -0.39 Y (155) 
Negotiated Telephone 
Support 
91 Adherence score mean change: 4.81 (SD 
10.74). Barriers to Adherence mean 
change: 4.12 (SD 21.7) 
N (180) 
Negotiated Telephone 




Adherence score mean change: 7.32 (SD 
9.1). Barriers to Adherence mean change: 
-0.64 (SD 11.9) 
N 
Neuroticism 322 r= -0.505 Y (117) 
Non-supportive family r= -0.29 Y 
Non-white adolescent β= -0.13 N 
Number of adverse 
life events 
178 0-1 adverse life events: Mean adherence 
score, C report: 75. P report: 74. 2-3 
adverse life events: Mean adherence 
score, C report: 71. P report: 71. 4+ 
adverse life events: Mean adherence 
score, C report: 68. P report: 68. 
Y (118) 
Number of children in 
family 




(number of studies if 
n>1) 




Number of hospital 
admissions 
89 No correlation N (167) 
OCD 322 AG: 0%, EG: 3%, MG: 1.4% N (117) 
Openness to 
experience 
28 r= 0.051 N (142) 
Oppositional defiant 
disorder 
57 AG: 1.9%, EG: 0%, MG: 5.6% N (178) 
Orderliness 28 -0.018 N (142) 
Overall QoL 
  
76 Boys: r= -0.44 Y (157) 
Girls: r= -0.09 N 
Parent perception of 
control 
52 r= -0.12 N (162) 
Parent perception of 
family organisation 
r= 0.21 N 
Parent perception of 
independence 
r= 0.04 N 
Parental marital status 
  
201 MDI: NK N (150) 
CSII: NK N 
Parents' health 
literacy 
93 r = 0.2 N (172) 
Parents perceptions of 
expressiveness 




regimen); P report on 
adherence 
93 Parents' report on adherence: r = 0.31, 
child's report on adherence: r = 0.32 
Y (172) 
Patient perception of 
control 
52 -0.05 N (162) 




(number of studies if 
n>1) 




Patient perceptions of 
family organisation 
(n=3) 
157 r= 0.053 N (136) 
52 r= 0.25 N (162) 
Patient perception of 
independence 
r= 0.16 N 
Patient perceptions of 
expressiveness 
r= 0.17 N 
Perceived barriers to 
site rotation 
  
201 MDI: r= -0.28 Y (150) 
CSII: r= -0.21 N 
Perceived competence 57 0-9 months: r= 0.22; 10-18 months: r= 0.3 N (178) 
Perceived impact 
(n=2) 
105 T1: 0.01, T2: -0.03 N (176) 
76 Boys: r= -0.38 Y (157) 
Girls: r= -0.11 N 
Perceived level of 
hope 
90 r= 0.26 Y (132) 
Perceived threat (n=2) 105 T1: r= -0.22, T2: r=-0.16 T1: Y, T2: N (176) 
56 DRCQ: r= -0.08 N (153) 
DSCQ: r= -0.05 N 




57 Yes: 27.8% of non-adherence N (166) 
No: 72.2% of non-adherence N 
Presence of threat to 
emotional well-being 
  
289 No threat to emotional well-being: Good: 
29%, satisfactory: 66%, poor: 5% 
Y (120) 
Threat to emotional well-being: Good: 
7%, satisfactory: 85%, poor: 8% 
Y 
Presence of threat to 
physical well-being 
No threat to physical well-being: Good: 





(number of studies if 
n>1) 




  Threat to physical well-being: Good: 2%, 
satisfactory: 143%, poor: 0% 
Y 
Presence of threat to 
social wellbeing 
  
No threat to social well-being: Good: 
36%, satisfactory: 64%, poor: 0% 
Y 
Threat to social well-being: Good: 3%, 
satisfactory: 82%, poor: 15% 
Y 
Psychosis 201 AG: 0%, EG: 0%, MG: 0% N/A (150) 
PTSD AG: 0%, EG: 4.5%, MG: 1.4% N 
PTSD diagnosis of 
mother 
60 Overall: r = -0.115, aged 0-8: r = -0.519, 
aged 9-16: r = 0.062 
N (171) 
QoL (with number of 
injections per day) 
503 chi-squared value: 6.73 Y (184) 
QoL: Diabetes worry 
  
76 Boys: r= -0.24 N (157) 
Girls: r= -0.14 N 
QoL: Satisfaction 
  
Boys: r= -0.42 Y 
Girls: r= -0.12 N 
QoL: Social worry 
  
Boys: r= -0.3 N 





57 Malaysian: 35.2% of non-adherence N (166) 
Chinese: 51.9% of non-adherence N 
Indian: 11.1% of non-adherence N 
Other: 1.9% of non-adherence N 
Recent change in 
insulin dose 
  
Yes: 70.4% of non-adherence N 
No: 29.6% of non-adherence N 
Regular Use of I-Port 55 Mean number of missed insulin doses in 
past three months down to 0.26 (SD 





(number of studies if 
n>1) 




Report of symptoms 
(from child) 
322 0-9 months: r= 0.22 N (117) 
10-18 months: r= 0.32 Y 
Report of symptoms 
(from mother) 
0-9 months: r= 0.3 Y 
10-18 months: r= 0.33 Y 
Response costs 101 r=-0.45, β=- 0.36 Y (116) 
Response efficacy r=0.3, β= 0.18 Y 
School/work 
performance 
223 r= 0.66 NK (127) 
Self-consciousness 28 r= -0.133 N (142) 
Self-discipline r= 0.482 Y 
Self-report on 
adherence to BGM 
88 r= 0.24 N (140) 
Self-report on 
adherence to meals 
r= -0.27 N 
Self-report on 
adherence to snacks 
r= 0.11 N 
Sense of normality 
  
289 Strong sense of normality: Good: 29%, 
satisfactory: 71%, poor: 0% 
Y (120) 
Poor sense of normality: Good: 3%, 




88 AG: 1%, EG: 3%, MG: 4.2% N (154) 
Single parent 
household vs both 
parents (n=2) 
NK t-score= -2.38 (worse adherence in 
single-parent households) 
Y (131) 





289 Regularly smokes: Good: 0%, satisfactory: 





(number of studies if 
n>1) 






Occassionally smokes: Good: 2%, 
satisfactory: 91%, poor: 7% 
Y 
Doesn't smoke: Good: 64%, satisfactory: 
35%, poor: 11% 
Y 
197 r= -0.08 Y (175) 
Sociability scores 223 r= 0.46 NK (127) 
Social anxiety 
  
76 Boys: r= -0.39 Y (157) 
Girls: r= 0.21 N 
Social competence 
(n=2) 
93 r=0.25, β=-0.067 r=Y, b=N (125) 
104 r= 0.2 Y (126) 
Social phobia 322 AG: 0%, EG: 1.49%, MG: 7% Y (117) 
Socio-economic status 
(n=3) 
104 Lower socioeconomic status related to 
poorer adherence; no numerical figure 
given 
Y (126) 
93 r= -0.14 N (125) 





175 AG: 2.9%, EG: 9%, MG: 21.1% Y (173) 
Stress (n=3) 56 r= -0.08 N (153) 
64 r=-0.11, β=-0.033 N (135) 
174 r= -0.09 N (158) 
Support from friends 74 r= 0.05 N (133) 
Support from nurses 
  
289 Has support from nurses: Good: 37%, 
satisfactory: 63%, poor: 0% 
Y (120) 
No support from nurses: Good: 1%, 




Has support from physicians: Good: 39%, 





(number of studies if 
n>1) 




  No support from physicians: Good: 7%, 
satisfactory: 87%, poor: 12% 
Y 




90 Self-reported adherence score increased 










167 Total sample: -0.135 N (159) 
Age 8-11: -0.343 Y 




174 DRCQ: r= -0.08 N (158) 
DSCQ: r= -0.05 N 
CCTI: r= 0.09 N 
Timeline r= 0.18 N 
Total DSMP score 
  
  
167 Total sample: r= 0.65 Y (159) 
Age 8-11: r= 0.667 Y 
Age 12-17: r= 0.629 Y 
Total HFS 
  
76 Boys: r= -0.38 Y (157) 
Girls: r= 0.04 N 
Total meals 104 r= -0.332 Y (129) 
Treatment 
effectiveness: control 
105 T1: r= 0.12, T2: r= 0.15 N (176) 
Treatment 
effectiveness: prevent 
T1: r= 0.08, T2: r= 0.24 T1 : N, T2: 
Y 
Trust 28 r= 0.382 N (142) 




116 Solostar pen: Percentage of participants 
completing all tasks successfully: 98% 
Y (119) 
FlexPen: Percentage of participants 





(number of studies if 
n>1) 




Lilly Disposable Pen: Percentage of 
participants completing all tasks 
successfully: 72% 
N 
Pen X: Percentage of participants 
completing all tasks successfully: 79% 
N 
Uses diabetes apps 174 β= 0.12 N (158) 
Uses diabetes 
websites 
β= 0.15 Y 
Uses meter/pump 
software 
88 β= 0.15 Y (140) 
Uses social networking 157 β= 0.18 Y (136) 
Uses text messaging 52 β= 0.11 N (162) 








r= -0.367 Y 
Vulnerability 28 r= -0.378 N (142) 
Warmth (child’s 
report) 
34 Public hospital group: r=Parent’s (P) 
report of adherence: 0.4, Child’s (C) 
report of adherence: 0.35, Nurse’s (N) 
report of adherence: 0.37. b=P: 0.02, C: 
0.11, N: 0.22. 
Y (164) 
Private hospital group: r=P: 0.03, C: 0.19, 




Public hospital group: r=P: 0.55, C: 0.48, 





(number of studies if 
n>1) 




Private hospital group: r=P: 0.2, C: 0.13, 
N: -0.17. b=P: 0.11, C: 0.08, N: -0.14. 
N 
Table 3.15 Summary of factors that were assessed by 3 or fewer studies. Legend; N: sample size, n: number of studies, C: 
child, P: parent, N: nurse, r: correlation, β: beta-value, Y: yes, N: no, DSMP: Diabetes Self-Management Profile, HFS: 
Hypoglycaemia Fear Score, AG: Agreement Group, EG: Error Group, MG: Management Group, DRCQ: Diabetes Regimen 
Compliance Questionnaire, DSCQ: Diabetes Self-Care Activities Questionnaire, CCTI: Child Compliance Telephone Interviews, 
CSII: Continuous Subcutaneous Insulin Infusion, MDI: Multiple Daily Injections. Those in the “Agreement Group” were 
deemed as being compliant. Those in the “Error Group” were deemed as being intentionally non-compliant. Those in the 
“Management Group” were deemed as being unintentionally non-compliant. Groups A and B were statistically identical 




3.6.12. Agreement of Studies 
 
Table 3.16 contains the factors that were assessed more than once and summarises the agreement 
of the results of these studies.  
 
Studies were deemed as having results of “mixed significance” if they assessed the factor in multiple 
domains (and published these domains separately), with some of them being statistically significant 
and others not significant. For example, they assessed the factor’s effect upon adherence in boys 
and girls, but the effect was only significant in boys. This includes studies with a significant 
correlation (r) but a not significant effect size (β). For a study’s results to be deemed as showing a 
positive or negative relationship, it would need to demonstrate this same relationship across all of 
its assessed domains; this includes studies that only assessed a single domain.  
 
Each factor was colour coded according to the predominant result. If the predominant result 
suggested a positive relationship between the factor and adherence, it was coloured dark green 
(strong agreement of studies). If there were an equal number of results suggesting a positive 
relationship and not significant/mixed significance results, it was coloured light green (relative 
agreement of studies). If the predominant result was not statistically significant/of mixed 
significance, the result was left white. If there were an equal number of results suggesting a negative 
relationship and not significant/mixed significance results, it was coloured orange (relative 
agreement of studies). If the predominant result suggested a negative relationship, it was coloured 
red (strong agreement of studies). 
 
There were no factors that had an even split of studies suggesting significant positive and negative 
relationships. 
 
For single-parent versus dual-parent households, the light green colouration indicates an even 
number of studies suggesting adherence was better in dual-parent households and those suggesting 










Factor Number of Studies Percentage References 







Negative relationship: 22/33 66.66% 
Results not statistically significant: 7/33 21.21% 
Results of mixed significance: 2/33 6.06% 
Glycaemic 
Control 




Negative relationship: 0/20 0% 
Results not statistically significant: 3/20 15% 
Results of mixed significance: 2/20 10% 
Duration of 
Diabetes 




Negative relationship: 9/19 47.37% 
Results not statistically significant: 10/19 52.63% 
Results of mixed significance: 0/19 0% 
Gender Better adherence in males:  5/15 33.33% (128,133,136,144,145,
154,160,161,164,166–
169,178,192) 
Better adherence in females:1/15 6.67% 
Results not statistically significant: 9/15 60% 
Results of mixed significance: 0/15 0% 
Family 
Conflict 
Positive relationship: 0/8 0% (123,136,140,151,160,
162,164,192) Negative relationship: 1/8 12.5% 
Results not statistically significant: 3/8 37.5% 





Positive relationship: 0/7 0% (117,132,142,146,151,
173,195) Negative relationship: 7/7 100% 
Results not statistically significant: 0/7 0% 
Results of mixed significance: 0/7 0% 
Self-Efficacy Positive relationship: 5/7 71.42% (116,135,141,142,146,
148,160) Negative relationship: 0/7 0% 
Results not statistically significant: 1/7 14.29% 
Results of mixed significance: 1/7 14.29% 
Family 
Support 
Positive relationship: 5/7 71.42% (120,126,133,134,136,
148,164) Negative relationship: 0/7 0% 
Results not statistically significant: 2/7 28.57% 
Results of mixed significance: 0/7 0% 
Family 
Cohesion 
Positive relationship: 2/5 40% (123,134,136,162,164) 
Negative relationship: 0/5 0% 
Results not statistically significant: 2/5 40% 
Results of mixed significance: 1/5 20% 
Diabetes 
Knowledge 
Positive relationship: 2/4 50% (125,156,193,196) 
Negative relationship: 0/4 0% 
Results not statistically significant: 1/4 25% 
Results of mixed significance: 1/4 25% 
Exercise 
Frequency 
Positive relationship: 3/4 75% (120,121,159,176) 
Negative relationship: 0/4 0% 
Results not statistically significant: 0/4 0% 
Results of mixed significance: 1/4 25% 
Positive relationship: 2/3 66.67% (139,148,169) 
Negative relationship: 0/3 0% 
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Results not statistically significant: 1/3 33.33% 
Results of mixed significance: 0/3 0% 
CSII vs MDI Better adherence with MDI: 0/3 0% (128,145,197) 
Better adherence with CSII: 1/3 33.33% 
Results not statistically significant: 2/3 66.67% 
Results of mixed significance: 0/3 0% 
Disease 
Severity 
Positive relationship: 0/3 0% (116,148,156) 
Negative relationship: 1/3 33.33% 
Results not statistically significant: 2/3 66.67% 
Results of mixed significance: 0/3 0% 
Household 
Income 
Positive relationship: 1/3 33.33% (116,145,158) 
Negative relationship: 0/3 0% 
Results not statistically significant: 2/3 66.67% 




Positive relationship: 2/3 66.67% (125,126,136) 
Negative relationship: 0/3 0% 
Results not statistically significant: 1/3 33.33% 
Results of mixed significance: 0/3 0% 
Stress Positive relationship: 0/3 0% (135,153,158) 
Negative relationship: 0/3 0% 
Results not statistically significant: 3/3 100% 




Positive relationship: 2/2 100% (116,192) 
Negative relationship: 0/2 0% 
Results not statistically significant: 0/2 0% 
Results of mixed significance: 0/2 0% 
BGM 
Frequency 
Positive relationship: 1/2 50% (140,176) 
Negative relationship: 0/2 0% 
Results not statistically significant: 1/2 50% 
Results of mixed significance: 0/2 0% 
BMI Positive relationship: 0/2 0% (144,155) 
Negative relationship: 0/2 0% 
Results not statistically significant: 2/2 100% 




Positive relationship: 0/2 0% (145,150) 
Negative relationship: 0/2 0% 
Results not statistically significant: 2/2 100% 
Results of mixed significance: 0/2 0% 
Diabetes 
Adjustment 
Positive relationship: 1/2 50% (162,178) 
Negative relationship: 0/2 0% 
Results not statistically significant: 0/2 0% 
Results of mixed significance: 1/2 50% 
Family 
Relations 
Positive relationship: 0/2 0% (125,127) 
Negative relationship: 0/2 0% 
Results not statistically significant: 1/2 50% 
Results of mixed significance: 1/2 50% 
Family Stress Positive relationship: 1/2 50% (117,175) 
Negative relationship: 0/2 0% 
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Factor Number of Studies Percentage References 
Results not statistically significant: 0/2 0% 




Positive relationship: 0/2 0% (117,142) 
Negative relationship: 1/2 50% 
Results not statistically significant: 1/2 50% 
Results of mixed significance: 0/2 0% 
Perceived 
Impact 
Positive relationship: 0/2 0% (157,176) 
Negative relationship: 0/2 0% 
Results not statistically significant: 1/2 50% 
Results of mixed significance: 1/2 50% 
Perceived 
Threat 
Positive relationship: 0/2 0% (153,176) 
Negative relationship: 0/2 0% 
Results not statistically significant: 1/2 50% 




Adherence better in single-parent 
household: 0/2 
0% (131,145) 
Adherence better in dual-parent 
household: 1/2 
50% 
Results not statistically significant: 1/2 50% 
Results of mixed significance: 0/2 0% 
Smoking 
Frequency 
Positive relationship: 0/2 0% (120,175) 
Negative relationship: 2/2 100% 
Results not statistically significant: 0/2 0% 
Results of mixed significance: 0/2 0% 
Social 
Competence 
Positive relationship: 1/2 50% (125,126) 
Negative relationship: 0/2 0% 
Results not statistically significant: 0/2 0% 
Results of mixed significance: 1/2 50% 
Table 3.16 Factors assessed by multiple studies and the agreement of those studies. Legend; CSII: Continuous Subcutaneous 
Insulin Infusion, MDI: Multiple Daily Injections, BMI: Body Mass Index. Colour coding: dark green: predominant result 
suggests a positive relationship, light green: equal number of results suggesting a positive relationship and not 
significant/mixed significance results, white: predominant result is lack of statistical significance and/or mixed significance, 
orange: equal number of results suggesting a negative relationship and not significant/mixed significant results, red: 




3.7. Secondary Outcomes 
3.7.1. Reasons for Non-Adherence 
One of the secondary outcomes of this study was to find some of the common reasons for non-
adherence as reported by children and young people and/or their parents. 
 
The 4 studies (117,130,139,140) reported 22 reasons for non-adherence. No two studies assessed 
the same reason. 
 
Two studies (117,140) compared the reported reasons in CSII users versus MDI users. One of these 2 
studies (140) was specifically asking for reasons that the child did not rotate their injection site. 
 
One study (130) sorted participants into two groups (A and B) and asked for their reasons for non-
adherence. There were no clear differences between these two groups. 
 
One study (139) simply reported the percentage of their sample that reported a given reason. 
 








Comfort with existing routine MDI users: 49%, CSII 
users: 64% 
(117) 
Counting exchanges difficulties A: 15%, B: 7% (130) 
Denial: wants to be like others, does not admit to being diabetic 26.50% (139) 
Diabetes misunderstanding A: 23%, B: 36% (130) 
Eating many meals A: 18%, B: 28% 
Estimation of food difficulties A: 23%, B: 28% 
Fear of hypoglycaemia A: 50%, B: 39% 
Feels bad; disease is responsible 17.60% 
Frequent blood monitoring A: 24%, B: 25% 
Frequent infections A: 24%, B: 23% 
Hedonism: Hungry or not hungry, concerned about weight, too 
much bother 
35.30% (139) 
Interpersonal reasons: peer pressure, rebelling against parents 17.60% 
Lack of time A: 26%, B: 18% (130) 
New sites would be painful MDI: 49%, CSII: 64% (140) 
Parents' tiredness A: 50%, B: 55% (130) 
Poor material conditions A: 20%, B: 28% 
Problems with care at kindergarten/school A: 32%, B: 37% 
Shame of diabetes A: 6%, B: 3.5% 
Snacking without parents’ permission A: 17%, B: 43% 
Stress related pain A: 36%, B: 39% 
Stubborn, lazy, careless 38.20% (139) 
Taking care of other children A: 17%, B: 16% (130) 
Table 3.17 Reported reasons for non-adherence. Legend; MDI: Multiple Daily Injection, CSII: Continuous Subcutaneous 
Insulin Infusion, A: group A, B: group B. 
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4. Thematic Analysis 
 
Across the 5 identified themes: 
• 12 of the factors identified were relating to demographics 
• 4 were related to past medical history. 
• 32 were factors related to diabetes management and diabetes test results 
• 159 were psycho-social factors and 
• 29 were factors related to family dynamics. 
 
Demographic factors were assessed in 38 studies with a total of 5 415 children and young people. 
This is a mean of 143 children per study, with a range of 31 to 1 028. The 38 studies used a total of 
26 different measures of adherence. 
 
Factors relating to past medical history were assessed in 2 studies with a total of 146 children and 
young people, with 57 in one study and 89 in the other. Both studies used MPR as their measure of 
adherence. 
 
Factors relating to diabetes management were assessed in 31 studies with a total of 4 607 children 
and young people. This is a mean of 149 children per study, with a range of 31 to 1 028. The 31 
studies used a total of 21 different measures of adherence. 
 
Psycho-social factors were assessed in 54 studies with a total of 6 534 children and young people. 
This is a mean of 121 children per study with a range of 34 to 503. The 54 studies used a total of 33 
different measures of adherence.  
 
Factors relating to family dynamics were assessed in 21 studies with a total of 2 840 children and 
young people. This is a mean of 135 children per study with a range of 34 to 1 028. The 21 studies 
used a total of 16 different measures of adherence. 
 
The variability between themes is illustrated as a bar chart in Figure 4.1. 
 
Despite being the theme with the second-fewest number of individual factors (with 12), 
demographic factors were assessed in the second highest number of children. This is likely as a result 
of age being the most frequently assessed factor, being a variable in 33 studies. It is also the theme 
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with the greatest proportion of its factors being assessed by multiple studies, with 6/12 (50%) 
featuring in 2 or more studies. 
 
Past medical history was the least assessed theme, with its four factors appearing between two 
studies. Just one of the four factors (BMI) was assessed in both studies, with both studies finding the 
effect upon adherence to be not statistically significant. 
 
The second most commonly assessed factor across all studies was HbA1c/glycaemic control, which is 
in the diabetes management theme. Though it is a frequently assessed factor, it is the only factor 
that is definitively the result of adherence and not the other way around. While assessing HbA1c has 
limited usefulness when trying to identify factors that affect adherence, it may still be useful to 
measure to correlate improved adherence with improved glycaemic control, to highlight that this 
area of research can have significant physiological implications. The remaining factors were assessed 
fairly heterogeneously, with just 3/31 (9.7%) being assessed by multiple studies. Of these three 
factors, diabetes knowledge and BGM frequency had a potential positive correlation with adherence 
to insulin, with all studies finding a positive correlation, but only some of the studies finding the 
relationship to be statistically significant.  
 
While the psycho-social theme was the most assessed theme, in terms of number of factors and 
total number of children, it was also the theme that had the lowest proportion of its factors assessed 
by multiple studies, with only 11/159 (6.9%) of psycho-social factors being assessed in 2 or more 
studies. Of these factors, exercise frequency and self-efficacy displayed some of the greatest 
agreement between studies regarding their effect, with 5/7 (71.42%) of studies assessing self-
efficacy and 3/4 (75%) of studies assessing exercise frequency finding that they were significantly 
associated with adherence. The only factor with unanimous agreement between studies (assessed 
by 4 or more studies) was a psycho-social factor, that being depression. 
 
Of the factors that were assessed multiple times, 6/7 (85.7%) of family dynamics factors were 
assessed by studies either in relative or strong agreement regarding the nature of the relationship 


































Demographics Past medical history Diabetes management Psycho-social Family dynamics
Number of factors Number of studies Number of measures of adherence
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5. PENDANT Study 
5.1. Introduction 
As explored in previous sections, there are many things that can affect treatment adherence in 
children and young people with diabetes, with many of the assessed factors relating to the 
psychology of children and young people. A new diagnosis of diabetes especially can have significant 
psychological effects on both the patient and the patient’s parents (198) (199). 
 
As well as the event of a new diagnosis being directly stressful to the patient and their parents, poor 
mental health in parents have been associated with increased risk of poor mental health in their 
children (200).  
 
Mental health is an important consideration in the management of diabetes, as it can exert both 
direct effects upon their glycaemic control (199) as well as indirect effects through poorer adherence 
to treatment (201). 
 
Glycaemic control is the best predictor of long-term outcomes in diabetes, with the risk of all 
complications being reduced with better glycaemic control (77). 
 
This study was set-up prior to the development of the systematic review contained within sections 2, 
3 and 4, based on an a priori hypothesis from the local diabetes and diabetes psychology team that 
the psychological impact of a new diagnosis of diabetes was correlated with later treatment 
adherence. As the systematic review carried out shows, there are currently no data on the 
psychological impact on children and their families of the diagnosis of T1DM, with current research 
examining those with already established disease, so this study was set up to try and support this 
hypothesis. 
 
Given that the psychology of parents and their child can both directly affect glycaemic control and 
indirectly affect glycaemic control (through reduced treatment adherence) and that reduced 
treatment adherence can result in worse glycaemic control - which is the best predictor of long-term 
outcomes - a better understanding of the psychological stressors that children and their families face 





The study protocol was written by a consultant paediatrician with extensive academic experience 
(DH) and a consultant paediatric diabetologist (MD) with assistance from a paediatric clinical 
psychologist (LC) who works with children and young people with diabetes.  
 
My contribution to the protocol was making the amendments to it and supporting documentation, 
including writing new patient information leaflets (PISs) for different age groups in order to gain the 
initial ethical approval, as well as making the later ethical amendments as detailed in section 5.4. The 
PIS for the youngest patients (aged 3-6) and the PIS for parents can be found in Figure 5.1 and Figure 
5.2, respectively, to illustrate the different ways study information was communicated to 
prospective participants. There were also versions for older children, adolescents, and participants 
competent to consent (aged 16-18) which can be found in Appendix 11, Appendix 12 and Appendix 
13, respectively. I was also responsible for creating the study master file, creation of the case record 
form (CRF), creation of the database to input data, recruiting patients, issuing the questionnaires, 








Figure 5.2 Participant Information Sheet (PIS) for parents. 
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5.3. Ethical Approval 
Ethical approval for this study was granted by the West Midlands-South Birmingham Research Ethics 
Committee (REC) and the UK Health Research Authority (HRA) on the 25th October 2019 and 1st 
November 2019, respectively. 
 
5.4. Ethical Amendments 
Two ethical amendments were made to the initial study protocol. Amendment 1 was made on 13th 
December 2019 and amendment 2 on 11th March 2020. Full details of each amendment can be 
found in Appendix 14 and  Appendix 15, respectively. 
 
The original study protocol stated that participants would be consented and interviewed at their first 
clinic appointment, however, to be most in keeping with the study objectives, the appointment 
nearest to 3-months post-diagnosis was more appropriate. Thus, the first amendment was to reflect 
this change. A Notification of Non-Substantial/Minor Amendment(s) for NHS Studies was submitted 
to the HRA and was approved. 
 
Most parents and children and young people had been willing to participate but were unable to take 
the extra time to complete the extensive number of questionnaires after/before their clinic 
appointment due to work or school commitments. Therefore, a second amendment was submitted 
with the aim of boosting recruitment rates. In version 2 of the study protocol, it was stated that 
parents and children who were willing to participate but were unable to due to time constraints 
could be contacted via telephone. However, early experience of issuing the large number of 
questionnaires in person suggested that completion would not be suitable over the phone. In order 




The majority of existing studies examine psychological factors in children who have been diagnosed 
for at least 6 months and often for over a year. Studies have shown that the adjustment period for 
children following a new diagnosis is 6-9 months (and 9-12 months for parents) (199), meaning that 
the time where psychological distress may be most prevalent is currently under-researched. 
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Therefore, the aim of this study was to assess the psychological impact of a new diagnosis of T1DM 
on children and young people. 
 
5.6. Methods 
The study has a prospective cohort design. 
 
Newly diagnosed patients with T1DM have an outpatient hospital appointment within three months 
of diagnosis. Leading up to this appointment, there are also contacts with other members of the 
diabetes team, such as specialist nurses, to ensure that the disease is being appropriately managed.  
 
Ideally, at one of these contacts, either as an outpatient or during the initial inpatient stay, the 
child/young person and their family will have the study discussed with them by one of the clinical 
members of the diabetes team. If they express interest, Participant Information Sheets (PISs) will be 
provided.   
 
In some situations, if the young person and their family are willing, the study may be mentioned to 
them on the same day as the outpatient appointment where the questionnaires are being 
completed. Details on the questionnaires being issued can be found in section 5.7. 
 
On the day of questionnaire completion, the young person and their family will give written 
informed consent/assent to a member of the study team. This includes permission to review 
historical health information on the hospital computer system. This will usually be at a clinic 
appointment within the first 3 months of diagnosis, but it may also be at a house visit previously 
arranged with the patient. 
 
The questionnaires are estimated to take 30-45 minutes to complete.  
 
After consent has been given and the questionnaires have been completed, a case record form for 
that participant is completed. The CRF was created by a postgraduate research Masters student (JC) 
in correspondence with a consultant paediatrician with extensive academic experience (DH), a 
consultant paediatric diabetologist (MD) and a paediatric clinical psychologist (LC) who works with 




Families will have the opportunity to have follow-up questionnaires taken at subsequent clinic visits, 
but this is optional.  
 
The normal pathway of care is maintained throughout the study.  
 
The diabetes team will have had training on the study and so will know who to direct questions to in 
the event of queries from the family.  
 
The completed questionnaires are reviewed by a trained clinical psychologist (LC) to identify any 
patients experiencing significant distress so that the appropriate support can be offered.  
 
5.7. Psycho-social measures 
Different questionnaires were issued to children/young people and parents depending on the age of 
their child to assess different psychological factors. Table 5.1 and Table 5.2 summarises the 
questionnaires that children and parents were expected to complete, respectively. 
 
To assess trauma in the child, the Trauma Symptom Checklist for Children (TSCC) and the Trauma 
Symptom Checklist for Young Children (TSCYC) was used for participants aged 8-16 and 3-8 
respectively. The TSCC is a 54 item self-report measure completed by the child, while the TSCYC 
contains 90 items and is completed by parents.  
 
To assess trauma in the parent, the Paediatric Inventory for Parents (PIP) was used.  
 
To assess diabetes distress, the Problem Areas in Diabetes (PAID) questionnaire is used. This 
questionnaire has a different version for children aged 8-12 (Problem Areas in Diabetes – Child; 
PAID-C) and young people aged 12-18 (Problem Areas in Diabetes – Teen; PAID-T). There is a 
corresponding parental version for parents of children in each age group (P-PAID-C and P-PAID-T, 
respectively). 
 
To assess how the parent and child are coping with diabetes, the Response to Stress Questionnaire 
(RSQ) was used. This was a self-report measure for the child and was to be completed only by 
children aged 9 and over. For parents, there were two versions; one self-report regarding their own 




Quality of life was assessed only in the parent with the Wellbeing and Satisfaction of Caregivers of 
Children with Diabetes Questionnaire (WE-CARE). 
 
Mental health was also assessed only in the parent. To assess depression, the Patient Health 





Factor Assessed Age 3-8 Age 9-12 Age 12+ 
Trauma  TSCC TSCC 
Diabetes Distress  PAID-C PAID-T 
Coping  RSQ RSQ 
Table 5.1 Questionnaires to be completed by the child. Legend; TSCC: Trauma Symptoms Checklist for Children, PAID-C: Problem Areas in Diabetes – Child version, PAID-T: Problem Areas in 
Diabetes – Teen version, RSQ: Response to Stress Questionnaire.  
 
Factor Assessed Age 3-8 Age 9-12 Age 12+ Parent Measures 
Child Trauma TSCYC    
Diabetes Distress P-PAID-C P-PAID-C P-PAID-T  
Child Coping RSQ Type 1 Diabetes 
(parent report on 
child) 
RSQ Type 1 Diabetes 
(parent report on 
child) 
RSQ Type 1 Diabetes 
(parent report on 
child) 
 
Parental Coping    RSQ Type 1 Diabetes (Parent) 
Parental Anxiety    GAD-7 
Parental Depression    PHQ-9 
Parental 
Trauma/Stress 
   PIP 
Quality of Life    WE-CARE 
Table 5.2 Questionnaires to be completed by the parent. Legend; TSCYC: Trauma Symptoms Checklist for Young Children, P-PAID-C: Problem Areas in Diabetes – Parent of Child version, P-PAID-
T: Problem Areas in Diabetes – Parent of Teen version, RSQ: Response to Stress Questionnaire, GAD-7: General Anxiety Disorder 7, PHQ-9: Patient Health Questionnaire 9, PIP: Paediatric 




Contact was attempted with a view to recruitment into the study for 12 patients/their parents. 2/12 
(16.7%) of the patients contacted agreed to participate in the study. 3/12 (25%) of the patients were 
not contactable by telephone after 3 attempts and answer phone messages. The remaining 7/12 
(58.3%) of participants declined to participate. All of these patients cited a lack of time as their 
reason for not wishing to participate. They felt that the additional 30-45 minutes on top of the 
roughly an hour or more that they spend in the hospital for their clinic appointment was too much 
time due to work, school, and childcare commitments.  
 
After the fourth patient had cited a lack of time on the day of the clinic visit as their reason for non-
participation, an ethical amendment that would allow for home visits was submitted (see section 5.4 
and  Appendix 15).  
 
The approval of this amendment coincided with the increasing number of COVID-19 cases in the UK 
and the resulting lockdown. As a result, for the safety of the participants and researchers, 
recruitment at this point was halted. The possibility of posting questionnaires to participants to 
complete at home was explored, but as this was not mentioned in the protocol submitted for ethical 
approval, this was not possible. It was also considered that this could reduce the quality of our data 
collection, as participants would not be able to immediately ask questions if they were unsure how 
to complete a section and may just complete a section incorrectly instead of spending more time 
attempting to get in touch with a member of the research team. Recruitment for this study will 
continue during the 2020-21 academic year, providing it is safe to do so. 
 
5.9. Results 
For the two recruited participants, patient A was a 14-year-old female and patient B was a 5-year-old 
male. Both participants had been diagnosed in the 3-months preceding their recruitment and for 
both participants, their mother was the person completing the parent measures. Table 5.3 contains 
the results of the measures for each participant and parent pairing.  
 
Higher scores for each of the measures indicate increased severity in that domain. For the trauma 
measures (TSCC and TSCYC), the raw scores (which scale differently to each domain) have been 




Note that parents also completed the WE-CARE questionnaire to assess their quality of life and 
versions of the RSQ questionnaire to assess coping; these results have not been published here as 
for some questions, higher scores indicate a better quality of life and for others, higher scores 
indicate a worse quality of life. These questionnaires require more in-depth analysis that is not 




Participant Assessed Domain Measure Used Score 


















Child diabetes distress PAID-T 35/84 
Parental anxiety GAD-7 15/21 



































– avoidance: 44/110 
Post-traumatic stress 
– arousal: 47/110 
Post-traumatic stress 







Child diabetes distress PAID-C (completed by 
parent) 
39/96 
Parental anxiety GAD-7 3/21 





















Difficulty total: 66/210 
Table 5.3 Summary of questionnaire results completed by participants. Legend; TSCC: Trauma Symptoms Checklist for 
Children, TSCYC: Trauma Symptoms Checklist for Young Children, P-PAID-T: Problem Areas in Diabetes – Parent of Teen 
version, P-PAID-C: Problem Areas in Diabetes – Parent of Child version, PAID-C: Problem Areas in Diabetes  child version, 
PAID-T: Problem Areas in Diabetes – teen version, GAD-7: General Anxiety Disorder 7, PHQ-9: Patient Health Questionnaire 





6.1. Systematic Review 
This study has identified many factors that are associated with adherence/non-adherence to insulin 
therapy. Studies were in strong agreement that age, depression, and smoking history were all 
negatively associated with adherence to insulin therapy and that glycaemic control, self-efficacy, 
family support, exercise frequency, increasing responsibility taken by the child/young person, socio-
economic status and better parent-child relationship were all positively associated with adherence. 
Summaries of all assessed factors can be found in Table 3.15 and Table 3.16. 
 
22/33 (66.66%) of the studies that assessed the association between age and treatment adherence 
found that adherence worsened with age. This is compared with just 2/33 (6.06%) that found 
adherence improves with age. The weighted mean age of participants in the studies suggesting that 
adherence worsens with age was 13.4 years, versus 11.4 years in the two studies suggesting that 
adherence improves with age. This supported the anecdotal hypothesis of the research team that 
the negative association between age and adherence begins during adolescence. There are several 
possible reasons for this association. When children are younger, more/the entirety of their care will 
be performed by their parents who are more likely to be able to maintain good adherence than just 
the child alone. As they become older, they will begin to take more responsibility for their care but 
will still likely be closely supervised by parents. As they enter adolescence, this supervision becomes 
more difficult and children will have times where they have the sole responsibility for their diabetes 
care, which they may not be accustomed to. Additionally, children and young people with diabetes 
still face all of the usual trials of adolescence, with increasing academic and personal life pressures 
potentially making adherence more difficult. The idea that it is the unique situation of adolescence 
that causes the decrease in adherence during this time is supported by the fact that adherence tends 
to improve again in the late teens/early twenties (167,178). 
 
The strong negative association between depression and adherence could be of particular 
significance, as it is a modifiable factor with an established guideline for management (202). The 
reasons for the strong negative relationship between depression and adherence are likely linked to 
the symptoms of depression, which include a lack of motivation and even potentially a disregard for 




The findings of the association between gender and adherence were somewhat surprising; the 
anecdotal hypothesis of the diabetes and research teams was that females generally have worse 
adherence than males in childhood, but this was only partially supported by the studies in this 
review, with 5/15 (33.33%) of studies finding that males had better adherence, 1/15 (6.67%) that 
females had better adherence and 9/15 (60%) having results that were non-significant. The weighted 
mean age of participants in the studies that suggested adherence was better in males was 14.9 
years, versus 9.7 years in the study that suggested adherence was better in females. This difference 
in mean ages could indicate that it is not until adolescence that gender begins to play a part in 
adherence, but this cannot be assumed from such a small number of studies. Future studies could 
aim to clarify this relationship, perhaps via a longitudinal cohort study that assesses adherence, 
starting in pre-adolescence and continuing into adolescence. It is possible that the size of the effect 
of gender is reduced by the pre-adolescents in the samples, as during times of their life where most 
care is being performed by parents, it is less likely that their gender will make a difference. 
 
The vast majority of studies that assessed glycaemic control found that better glycaemic control was 
associated with better treatment adherence. Despite its clear association, the inclusion of this factor 
in the study was a point of contention, due to the fact that improved glycaemic control is most likely 
a result of better adherence, not the other way around. The factor was ultimately included for 
several reasons. Firstly, it was felt that it was important to highlight the positive association between 
the two, to show that better adherence can indeed have dramatic physiological consequences. It 
was also included as while better adherence definitively results in improved glycaemic control, it 
could not be ruled out for glycaemic control to then have a knock-on effect upon further adherence. 
For example, if a patient had consistently good or improving HbA1c, this could motivate them to 
continue to have good adherence and vice versa. More research would need to be done that 
included questions on how HbA1c results affect the mindset of children and their parents, in order 
for this question to be definitively answered. 
 
There are several limitations to this study. Firstly, as a result of the heterogeneity of the body of 
evidence, meta-analysis was not possible for any of the identified factors. Secondly, while all of the 
studies included in this review assess insulin adherence, they do not all express this aspect of 
adherence separately, with many studies presenting their results as a composite index. There were 
studies that were published in other languages, but we have overcome this by using fluent native 
speakers to extract these data, so no studies were excluded by reason of being written in a foreign 
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language. Any foreign language study that was screened and not included in the final data extraction 
was excluded due to not fitting the inclusion criteria. 
 
Furthermore, one of the biggest issues facing studies that seek to identify factors associated with 
adherence is lack of an agreed and validated method of doing so. Many of the existing validated 
methods of measuring adherence to other medications are not appropriate when considering insulin 
use. For example, direct measurement of drug levels in the blood is invasive, unpopular with 
children and young people, technically difficult with the short half-life of insulin, as well as giving no 
indication of the patterns of adherence (204). Most general adherence questionnaires are 
predominantly designed to assess adherence to oral medications and as such do not factor in the 
additional difficulties a regular subcutaneous medication with such a potentially dangerous side 
effect (hypoglycaemia) may have. Medication Possession Ratio (MPR) is a validated measure used 
for all types of medication and has been used by some of the studies in this review, but even this 
assumes that all of the medication that the patient collects gets used and gets used in the correct 
way. 
 
In the 76 studies contained within this review, there were 38 different methods used to assess 
adherence, with the most popular method being classed as “questionnaire not otherwise specified”, 
meaning that this figure itself is likely composed of multiple methods. Since the details of these 
questionnaires were not clear, this contributed to the difficulties in meta-analysis. 
 
The next most common method of measuring adherence, being used by 7 studies, was the Self-Care 
Inventory (SCI). The SCI was first developed in 1988 (205) and was revised in 2005 (188). In 2009, a 
study (206) assessed the validity of the SCI for use as an adherence measure and found that it had 
both good internal consistency (α=0.8) and good test-retest reliability (r=0.77, p=<0.05). In the 21 
years from the development of the SCI in 1988, to its validation in 2009, no studies in this review 
used it as their measure of adherence. Since the validation of the tool in 2009, 7/30 (23.3%) of 
studies published in this time have used it as their measure of adherence, making it the joint most 
commonly used measure along with data from insulin pumps/BOLUS scores (both during this time 
period and overall). This suggests that the development of adherence measures without validation 
of those measures is largely not useful and that earlier validation of adherence measures could 




Studies prior to 2009 were far more heterogenous in their method of adherence measuring, with the 
most common measure (aside from questionnaires and interviews that were not otherwise 
specified) being the Barrier to Adherence (BAQ) questionnaire, which was used by 4/46 (8.7%) of 
studies published in this time. This suggests that agreement on the best methods to use to assess 
adherence is slowly increasing with time.  
 
Another issue when measuring adherence – particularly when relating to insulin adherence – is the 
number of components of taking insulin that are required to be correct in order to have good 
adherence. For example, in order to be fully adherent, a patient needs to take their insulin at the 
correct time, the correct amount of time before food, with the correct dose (often based on a 
calculation of the amount of carbohydrates in their food), into the correct site (rotating sites to 
avoid lipohypertrophy and malabsorption) and then perform the injection correctly. All of these 
steps are without even considering the changes made to insulin during hypoglycaemia management, 
which adds another layer of complexity. The systematic review has identified studies that have all 
measured these areas, but never all together. 
 
To summarise the issues surrounding measuring adherence: self-report measures such as the SCI can 
result in reporting bias from the participants, objective measures such as MPR do not actually assess 
the use of the medication and observation of the patient administering their medication does not 
assess when the insulin is taken in their day-to-day life. Downloading of insulin pump data is perhaps 
the single method that solves most of these issues, however it does not account for all of the 
patients who receive treatment through MDI and so results in a sample that is not representative of 
the whole population. Each of these issues is solved by another method, but no studies have used 
these methods in combination with each other. Therefore, one of the recommendations for future 
research of this study is that multiple methods to measure adherence are used, but to ensure that 
each of these methods assesses a different component of adherence. For example, the SCI could be 
issued to measure the patient’s general adherence in day-to-day life, MPR could be used to see if the 
patient’s self-report is feasibly accurate, another questionnaire could be issued to assess the 
patient’s competence in carbohydrate counting an insulin calculations, a third questionnaire or 
physical examination could assess the patient’s rotation of the injection sites and lastly, the patient 
could be observed performing an injection to assess if they administer their injections correctly. This 
combination of methods would address the issues previously mentioned but has not been seen in 




While a large proportion of the factors identified in this study are only assessed by a single study, 
that does not diminish the usefulness of identification of the factors that have been assessed by 
greater number of studies. As seen in Table 3.16, there are clear groups of patients where additional 
resources could be directed to try and improve their adherence. For example, adherence has been 
shown to decrease with age in children; if interventions such as the “Sweet Talk” text messaging 
system (181), which was shown in an RCT to have a beneficial effect upon adherence, were targeted 
to this age group, it could mitigate the reduction in adherence. All seven studies assessing the effect 
of depression found that it had a statistically significant negative effect upon adherence, suggesting 
that investment in identification of these patients and psychological services to help them could be 
beneficial.  
 
As well as trying to target the areas where adherence has shown to be worse, efforts could be 
directed to promote the factors that have shown to have a positive effect. For example, presence of 
family support was shown to have a statistically significant positive effect upon adherence, but none 
of the interventions proposed by the seven RCTs within this review were aimed at promoting 
supportive family environments.  
 
The fact that only 7/76 (9.2%) of the studies included in this review are RCTs suggests that huge 
efforts are being devoted to identifying the factors that affect adherence to insulin therapy, but far 
less efforts are being directed towards addressing the issues that can be altered. Becoming a 
teenager is inevitable, as is longer duration of disease, but intervention studies should be developed 
for the modifiable factors, or around key times in the children and young people’s lives, to assess the 
potential to improve adherence. 
 
There was no specific funding associated with this review. 
 
6.2. PENDANT Study 
As a result of the COVID-19 pandemic halting recruitment to this study, it is clearly grossly 
underpowered and no real conclusions regarding the data can be drawn. Despite this, there were 
still many learning points, from both the first stages of the study itself and from the systematic 
review, that can be taken forward that will improve this study overall. 
 
Firstly, there were no issues regarding completion of the measures from either the child participants 
or their parents, suggesting good usability.  
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The early difficulties with recruitment due to time constraints on the day of the patient’s outpatient 
appointments have hopefully been addressed with the implementation of ethical amendments.  
 
With the benefit of hindsight as a result of the systematic review, there are some improvements that 
can be made. In its current form, the study assesses eight different domains between the child and 
their parent, with multiple reports for some measures such as the RSQ, which has a child report 
upon themselves, a parent report on themselves and a parent report on the child. This creates a 
huge mass of data, with many of the measures asking similar questions, making parts of the data 
somewhat redundant. The large number of measures could be another contributing factor to the 
poor response rate during this initial phase. 
 
While the measures all assess a clearly defined area, for some of these measures, it is not clear how 
they would be best compared with each other when analysing the data as a whole. For example, the 
WE-CARE questionnaire (which assesses the quality of life of the parent) has some questions where 
a higher score would indicate a better quality of life and some questions where a higher score would 
indicate a worse quality of life. It is therefore difficult to find a way to make valid correlations 
between this method and methods such as the TSCC/TSCYC (which assess trauma in the child) or the 
GAD-7 and PHQ-9 (which assess anxiety and depression in the parent, respectively), where higher 
scores always confer to greater severity in the assessed domain.  
 
Therefore, a possible change to this study going forwards would be to choose measures where the 
scores are always comparable or where the direction of individual questions is represented by a sub-
scale. For example, the Stark QoL questionnaire (207) is consistent in higher scores conferring to 
better quality of life. The disadvantage to this questionnaire when compared to the WE-CARE is that 
the WE-CARE is specifically designed for parents of children with diabetes, whereas the Stark QoL is 
not. 
 
In considering other methods, such as a structured interview, it is likely that questionnaires are more 
practical as they do not require as much training for researchers to deliver and are less time-
consuming as both parents and children can complete their measures simultaneously, which is an 





An anecdotal observation based on the small sample size to date is that the large number of 
questionnaires could result in reduced accuracy, particularly in the child measures. Participant A 
appeared to be getting somewhat bored by the final questionnaire, with some questions seeming to 
be completed without actually reading them. Since participant B was too young to complete any 
questionnaires, this meant that all measures needed to be completed by their mother, meaning that 
they took much longer to complete. While the mother was completing these questionnaires, her 
child was clearly getting bored and was becoming restless, again resulting in the questionnaires 
being completed in a hurried fashion. 
It is possible that with such a small sample, these are not problems that would be seen in a 
significant capacity going forward. However, this possibility, combined with the aforementioned 
similarity of some questions between questionnaires suggests that in the future, a more focused 
approach to a smaller number of domains may be desirable. The time constraints of the 
questionnaires would be in-part addressed by the possibility of home visits. 
 
If assessment of adherence was desired and needed to be done through a single measure, the SCI 
would likely be the best option, with it being a validated measure of adherence that is used in the 




To the best of our knowledge, at the time of writing, this is the first study that has attempted to 
review factors that affect adherence to insulin therapy.  
 
This study has identified many factors that are associated with adherence, with many being 
modifiable factors that could be potential areas for future interventions. It has also highlighted that 
while adherence to insulin requires adherence to many individual components, it is frequently 
assessed in ways that do not necessarily reflect this complex nature. By virtue of collecting together 
such a large number of studies and the methods that these studies use, this study has been able to 
make suggestions for future research that combines methods in order to get the most accurate 
reflection of adherence. 
 
It has also provided an opportunity to improve ongoing primary research, so that it may make a 
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Section/topic  # Checklist item  
Reported 
on page # 
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  50 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: background; objectives; data sources; study 
eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic review registration number.  
2-3 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  49 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
49 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if 
available, provide registration information including registration number.  
51 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
52 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last searched.  
53 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it 
could be repeated.  
54, 374-
376 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 




10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
55 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any 




Section/topic  # Checklist item  
Reported 
on page # 
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether 





13 State the principal summary measures (e.g., risk ratio, difference in means).  55 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
60 
Risk of bias across 
studies  
15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
57-58 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if 
done, indicating which were pre-specified.  
N/A 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 




18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
63-64 
Risk of bias within 
studies  





individual studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for 
each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
78-167, 
172-173 




Section/topic  # Checklist item  
Reported 
on page # 
Risk of bias across 
studies  








Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see 
Item 16]).  
N/A 
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
168-171, 
190-192 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
192 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
194 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of 
funders for the systematic review.  
192 



































































































Appendix 3 Appraisal Tool for Cross-Sectional Studies (AXIS) and results for all cross-sectional studies.  
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Domain Question Options Star 
awarded? 
Selection 1) Is the case definition 
adequate? 
a) Yes, with independent validation Yes 
b) Yes, e.g.- record linkage or based on 
self-reports 
No 
c) No description No 
2) Representativeness of 
the cases. 
a) Consecutive or obviously 
representative series of cases 
Yes 
b) Potential for selection biases or not 
stated 
No 
3) Selection of controls. a) Community controls Yes 
b) Hospital controls No 
c) No description No 
4) Definition of controls. a) No history of disease (endpoint) Yes 
b) No description of source No 
Comparability 1) Comparability of cases 
and controls on the 
basis of the design or 
analysis. 
a) Study controls for most important 
factor 
Yes 
b) Study controls for any additional factor Yes 
Exposure 1) Ascertainment of 
exposure. 
a) Secure record (e.g.- surgical record) Yes 
b) Structured interview where blind to 
case/control status 
Yes 
c) Interview not blinded to case/control 
status 
No 
d) Written self-report or medical record 
only 
No 
e) No description No 
2) Same method of 
ascertainment for 
cases and controls. 
a) Yes Yes 
b) No No 
3) Non-response rate. a) Same rate for both groups Yes 
b) Non-respondents described. No 
c) Rate different and no designation. No 




   
  
Appendix 5 Completed case-control study Newcastle-Ottawa scale bias assessments. 
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Domain Question Options Star 
awarded? 
Selection 1) Representativeness of 
the exposed cohort. 
a) Truly representative of the average 
cohort in the community 
Yes 
b) Somewhat representative of the 
average cohort in the community 
Yes 
c) Selected group of users, e.g.- nurses, 
volunteers 
No 
d) No description of the derivation of the 
cohort 
No 
2) Selection of the non-
exposed cohort. 
a) Drawn from the same community as 
the exposed cohort 
Yes 
b) Drawn from a different source No 
c) No description of the derivation of the 
non-exposed cohort 
No 
3) Ascertainment of 
exposure. 
a) Secure record (e.g.- surgical records) Yes 
b) Structured interview Yes 
c) Written self-report No 
d) No description No 
4) Demonstration that the 
outcome of interest 
was not present at the 
start of the study. 
a) Yes Yes 
b) No No 
Comparability 1) Comparability of 
cohorts on the basis of 
the design or analysis. 
a) Study controls for most important 
factor 
Yes 
b) Study controls for any additional factor Yes 
Outcome 1) Assessment of 
outcome. 
a) Independent blind assessment Yes 
b) Record linkage Yes 
c) Self-report No 
d) No description No 
e) No description No 
2) Was follow-up long 
enough for outcomes 
to occur? 
a) Yes Yes 
b) No No 
3) Adequacy of follow-up 
of cohorts. 
a) Complete follow-up; all subjects 
accounted for 
Yes 
b) Subjects lost to follow-up unlikely to 
introduce bias; small number lost to 
follow-up or description provided of 
those lost 
Yes 
c) Follow up rate low enough to 
potentially result in bias and no 
description of those lost 
No 
d) No statement No 










Domain Questions Howells, 2002 Franklin, 
2006 















Y Y Y Y NI N Y 








Y PY PY PY NI PN PY 




groups suggest a 
problem with the 
randomisation 
process? 
PN N PN PN N N PN 
Overall risk of bias for 
this domain 












PY PY PY PY PY PY PY 
247 
 
Domain Questions Howells, 2002 Franklin, 
2006 








2.2) Were carers and 




during the trial? 
Y Y PY PY PY Y PY 
2.3) If Y/PY/NI to 2.1 
or 2.2: Were there 
deviations from the 
intended intervention 
that arose because of 
the experimental 
context? 
PN PN PN PN PN PY PN 
2.4) If Y/PY to 2.3: 
Were these 
deviations likely to 
have affected the 
outcome? 
N/A N/A N/A N/A N/A PN N/A 






N/A N/A N/A N/A N/A N/A N/A 
2.6) Was an 
appropriate analysis 
used to estimate the 
effect of assignment 
to intervention? 
Y Y Y PY PY PY PY 
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Domain Questions Howells, 2002 Franklin, 
2006 








2.7) If N/PN/NI to 2.6: 
Was there potential 
for a substantial 
impact (on the result) 
of the failure to 
analyse participants 
in the group to which 
they were 
randomized? 
N/A N/A N/A N/A N/A N/A N/A 
Overall risk of bias for 
this domain 






3.1) Were data for 
this outcome 
available for all, or 
nearly all, participants 
randomised? 
Y Y PN Y PY NI y 
3.2) If N/PN/NI to 3.1: 
is there evidence that 
the result was not 
biased by missing 
outcome data? 
N/A N/A PN N/A N/A PY N/A 
3.3) If N/PN to 3.2: 
could missingness in 
the outcome depend 
on its true value? 
N/A N/A PN N/A N/A N/A N/A 
3.4) If Y/PY/NI to 3.3: 
Is it likely that 
missingness in the 
outcome depended 
on its true value? 
N/A N/A N/A N/A N/A N/A N/A 
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Domain Questions Howells, 2002 Franklin, 
2006 








Overall risk of bias for 
this domain 





4.1) Was the method 
of measuring the 
outcome 
inappropriate? 
PN PN PN PN PN PN PN 
4.2) Could 
measurement or 




PN PN PN PN PN PN PN 
4.3) If N/PN/NI to 4.1 
and 4.2: Were 
outcome assessors 
aware of the 
intervention received 
by study participants? 
PY PY PY PY PY PY PY 
4.4) If Y/PY/NI to 4.3: 
Could assessment of 
the outcome have 




PY PY PN PN PY PN PN 
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Domain Questions Howells, 2002 Franklin, 
2006 








4.5) If Y/PY/NI to 4.4: 
Is it likely that 






PN PN N/A N/A PN N/A N/A 













5.1) Were the data 
that produced this 
result analysed in 
accordance with a 
pre-specified analysis 
plan that was 
finalized before 
unblinded outcome 
data were available 
for analysis? 
Y PY Y Y PY Y Y 
5.2) Is the numerical 
result being assessed 
likely to have been 
selected on the basis 





time points) within 
the outcome domain? 
Y Y Y PN PY PY PN 
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Domain Questions Howells, 2002 Franklin, 
2006 








5.3) Is the numerical 
result being assessed 
likely to have been 
selected on the basis 
of the results from 
multiple eligible 
analyses of the data? 
PY PY PY PN PY PY PN 
Overall risk of bias for 
this domain 
High High High Low High High Low 




Low High High Low 
Appendix 8 Completed Cochrane risk of bias for randomised trials tool (RoB 2) for RCTs included in systematic review. Legend; Y: yes, PY: probably yes, NI: no information, PN: probably no, N: 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1. "I Don't Want Them to Feel 
Different": A Mixed Methods 
Study of Parents' Beliefs and 
Dietary Management 
Strategies for Their Young 
Children with Type 1 Diabetes 
Mellitus. 
Title Intervention: not related to insulin treatment 
 2. "Sweet Talk": Text 
Messaging Support for 
Intensive Insulin Therapy for 
Young People with Diabetes 
Full Text Outcome: not related to insulin treatment 
adherence 
 4. "Symptom-based insulin 
adjustment for glucose 
normalization" (SIGN) 
algorithm: a pilot study. 
Title Outcome: not related to insulin treatment 
adherence 
 5. 'Diabulima' through the lens 
of social media: a qualitative 
review and analysis of online 
blogs by people with Type 1 
diabetes mellitus and eating 
disorders. 
Title Outcome: not related to insulin treatment 
adherence 
 6. 'It's not for me'-patterns of 
glycaemia in youth who 
discontinue CSII 
Abstract Wrong study type (review, conference abstract 
etc.) 
 7. 640g minimed system 
effectiveness in children and 
adolescents with type 1 
diabetes: Education plus 
technology ensure higher 
%time in target range (70-160 
mg/dl) 
Title Intervention: not related to insulin treatment 
 8. [Analysis of the quality of 
primary therapeutic-preventive 
care rendered to patients with 
type I diabetes mellitus]. 
Title Outcome: not related to insulin treatment 
adherence 
 9. [Basal bolus therapy in 
adolescent diabetic patients]. 
Abstract Outcome: not related to insulin treatment 
adherence 
 10. [Clinical evaluation of 
glycohemoglobin and serum 
glycoproteins using affinity 
chromatography in children 
with type I diabetes mellitus]. 
Title Outcome: not related to insulin treatment 
adherence 
 11. [Compliance of children 
and adolescents with type 1 
diabetes (juvenile diabetes 
mellitus)]. 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 13. [Compliance of young 
diabetic patients with 
therapeutic regimens and 
participation by the family]. 
    
 14. [Current and future care 
for diabetes in children: from 
insulin to immunotherapy]. 
Abstract Wrong study type (review, conference abstract 
etc.) 
 15. [Current aspects in therapy 
of insulin-dependent diabetes 
mellitus in children and 
adolescents]. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 16. [Daytime flexible 
application of Insulin degludec 
in patients with type 1 diabetes 
or type 2 diabetes]. 
Abstract Outcome: not related to insulin treatment 
adherence 
 18. [Development and 
outcome of motivational 
support during inpatient 
education of insulin-dependent 
diabetic patients--a pilot 
project]. 
Full Text Population: not children (adults/foetuses) 
 19. [Diabetes mellitus and 
cellular immunity]. 
Title Outcome: not related to insulin treatment 
adherence 
 20. [Diet composition along 
the evolution of type 1 diabetes 
mellitus]. 
Title Outcome: not related to insulin treatment 
adherence 
 21. [Evaluation of a program 
for the care of the diabetic. A 
40-month continuity study]. 
Abstract Population: not children (adults/foetuses) 
 22. [Exploration of left 
ventricular function in insulin-
dependent diabetics (relation 
with retinopathy)]. 
Title Outcome: not related to insulin treatment 
adherence 
 23. [French version and 
validation of a scale evaluating 




 24. [Glibenclamide instead of 
insulin: a new chance for MODY 
3 type diabetes patients: case 
report]. 
Title Population: do not have T1DM 
 26. [How I assess ... home 
glycemic control in diabetic 
patients]. 
Title Outcome: not related to insulin treatment 
adherence 
 27. [Hypoglycemia provoked 
by clandestine injections of 
insulin in the diabetic child]. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 28. [Insulin pump treatment in 
children and adolescents with 
type 1 diabetes]. 
Abstract Wrong study type (review, conference abstract 
etc.) 
 29. [Intensified conventional 
insulin therapy. The long-term 
successes and reasons for 
failure of this therapeutic 
concept]. 
Full Text Population: not children (adults/foetuses) 
 31. [Intensive insulin therapy 
in adolescents with type 1 
diabetes mellitus: initial 
experiences with a 
semiautomatic insulin injection 
device (the insulin pen)]. 
    
 32. [Juvenile onset diabetes: 
the effect of education for 
metabolic control]. 
Abstract Outcome: not related to insulin treatment 
adherence 
 34. [Mauriac syndrome--a rare 
complication of type 1 diabetes 
mellitus]. 
Title Outcome: not related to insulin treatment 
adherence 
 35. [Modern methods for 
controlling type-1 diabetes?]. 
Title Outcome: not related to insulin treatment 
adherence 
 36. [Needs of schoolchildren 
with type 1 diabetes in 
Extremadura: Family 
perceptions]. 
Abstract Outcome: not related to insulin treatment 
adherence 
 37. [New aspects of the diet in 
type 1 diabetes mellitus]. 
Title Intervention: not related to insulin treatment 
 38. [Predictors of treatment 
adherence in children with type 
1 diabetes mellitus]. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 39. [Psychological aspects of 
treatment compliance in the 
insulin- dependent diabetic 
child]. 
  
 40. [Psychological factors 
associated to patient's 
treatment compliance in 
Chilean diabetic teenagers]. 
    
 41. [Quality of diabetes care in 
Norwegian general practice]. 
Title Outcome: not related to insulin treatment 
adherence 
 42. [Self-monitoring blood 
glucose in type 2 diabetes: for 
whom? And why? Which 
proofs?]. 
Title Population: do not have T1DM 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 43. [Self-monitoring of blood 
glucose in type 2 diabetic 
patients. What could we 
propose according to their 
treatment?]. 
Title Population: do not have T1DM 
 44. [The Aide to Juvenile 
Diabetes Association: its role in 
the management and 
education of patients with 
insulin-dependent diabetes]. 
Title Outcome: not related to insulin treatment 
adherence 
 45. [The selection of insulin 
and adjustment of the dosage 
in diabetic children and 
adolescents: personal 
experiences]. 
Abstract Outcome: not related to insulin treatment 
adherence 
 47. [The usage of the personal 
insulin pump for treatment of a 
7 week infant with neonatal 
diabetes mellitus]. 
Title Outcome: not related to insulin treatment 
adherence 
 48. [Therapeutic education 
regarding type 1 diabetes 
(DM1)]. 
Abstract Outcome: not related to insulin treatment 
adherence 
 49. [Treatment of young 
patients with type 1 diabetes in 
an adult diabetes clinic]. 
Title Population: not children (adults/foetuses) 
 50. [Why is that the response 
to treatment of type 1 diabetes 
is not improving?]. 
Abstract Wrong study type (review, conference abstract 
etc.) 
 51. A 3-year prospective study 
of parent-child communication 
in early adolescents with type 1 
diabetes: relationship to 
adherence and glycemic 
control. 
Full Text Outcome: not related to insulin treatment 
adherence 
 52. A biopsychosocial model of 
glycemic control in diabetes: 
stress, coping and regimen 
adherence. 
Abstract Population: not children (adults/foetuses) 
 53. A case report of a 14 year 
old female with a known 
history of type 1 diabetes 
mellitus who developed 
tracheal stenosis as a result of 
prolonged intubation from 
diabetic ketoacidosis and 
subsequently developed acute 
pancreatitis 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 54. A clinical pilot to assess 
improvement in health related 
quality of life (QOL), treatment 
satisfaction, and glycemic 
control in adolescents with 
type 2 diabetes (T2DM) using 
continuous subcutaneous 
insulin injection therapy (CSII) 
Title Population: do not have T1DM 
 55. A comparison of IDeg + 
IAsp versus IDet + IAsp in 
subjects with type 1 diabetes: 
subgroup analysis of Japanese 
subjects. 
Abstract Population: not children (adults/foetuses) 
 56. A Comparison of 
Pharmacokinetic and 
Pharmacodynamic Properties 
Between Faster-Acting Insulin 
Aspart and Insulin Aspart in 
Elderly Subjects with Type 1 
Diabetes Mellitus. 
Title Population: not children (adults/foetuses) 
 57. A comparison of the use of 
premixed insulins in pen-
injectors with conventional 
patient-mixed insulin 
treatment in children and 
adolescents with IDDM. Is 
there a decreased risk of night 
hypoglycemia? 
Title Outcome: not related to insulin treatment 
adherence 
 58. A computer insulin 
titration protocol is associated 
with a reduction of 
hypoglycemia in the PIC U 
Title Outcome: not related to insulin treatment 
adherence 
 59. A discrete choice 
experiment evaluation of 
patients' preferences for 
different risk, benefit, and 
delivery attributes of insulin 
therapy for diabetes 
management. 
Full Text Population: not children (adults/foetuses) 
 60. A focus on blood glucose 
monitoring: relation to 
glycemic control and 
determinants of frequency. 
Title Intervention: not related to insulin treatment 
 61. A group approach to the 
management of diabetes in 
adolescents and young adults 
Abstract Population: not children (adults/foetuses) 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 62. A hypnotherapeutic 
approach to the improvement 
of compliance in adolescent 
diabetics. 
  
 63. A Large Difference in Dose 
Timing of Basal Insulin 
Introduces Risk of 
Hypoglycemia and Overweight: 
A Cross-Sectional Study. 
Title Outcome: not related to insulin treatment 
adherence 
 64. A longitudinal analysis of 




 65. A model for promoting 
adolescents' adherence to 
treatment for type 1 diabetes 
mellitus 
Full Text Wrong study type (review, conference abstract 
etc.) 
 66. A multi-disciplinary 
education process related to 
the discharging of children 
from hospital when the child 
has been diagnosed with type 1 
diabetes--a qualitative study. 
Abstract Outcome: not related to insulin treatment 
adherence 
 67. A Multidisciplinary 
Evaluation of a Virtually 
Supervised Home-Based High-
Intensity Interval Training 
Intervention in People With 
Type 1 Diabetes. 
Abstract Population: not children (adults/foetuses) 
 69. A multivariate model 
exploring the predictive value 
of demographic, adolescent, 
and family factors on glycemic 
control in adolescents with 
type 1 diabetes. 
Full Text Outcome: not related to insulin treatment 
adherence 
 70. A multivariate model of 
demographic and psychosocial 
predictors of HBA1c in 
adolescents with type 1 
diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 71. A new indwelling catheter, 
I-PORT advance, to improve 
adherence to basal-bolus 
treatment in children and 
adolescents with type 1 
diabetes: A randomized, 
crossover pilot study 
comparing glycemic control 
and satisfaction 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 72. A new paediatric diabetes 
knowledge test - M-WIKAD 
development and factor 
analysis 
Title Outcome: not related to insulin treatment 
adherence 
 73. A novel method for 
measuring patients' adherence 
to insulin dosing guidelines: 




 74. A novel tool to predict 
youth who will show 
recommended usage of 
diabetes technologies. 
Title Outcome: not related to insulin treatment 
adherence 
 75. A pilot study of factors 
associated with glycaemic 
control in adults with Type 1 
diabetes mellitus on insulin 
pump therapy. 
Title Population: not children (adults/foetuses) 
 76. A prime example of high 
compliance 
Abstract Population: do not have T1DM 
 77. A profile of self-care 
behaviors in emerging adults 
with type 1 diabetes. 
Title Population: not children (adults/foetuses) 
 78. A prototype of a new 
noninvasive device to detect 
nocturnal hypoglycemia in 
adolescents with type 1 
diabetes--a pilot study. 
Title Outcome: not related to insulin treatment 
adherence 
 79. A qualitative study 
exploring patients' experiences 
regarding insulin pump use. 
Abstract Population: not children (adults/foetuses) 
 80. A randomized clinical trial 
aimed at preventing poor 
psychosocial and glycemic 
outcomes in teens with type 1 
diabetes (T1D). 
Full Text Outcome: not related to insulin treatment 
adherence 
 81. A randomized control trial 
of the effect of negotiated 
telephone support on 
glycaemic control in young 
people with Type 1 diabetes 
Included 
 
 83. A randomized controlled 
trial of Sweet Talk, a text-
messaging system to support 





Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 85. A randomized study and 
open-label extension 
evaluating the long-term 
efficacy of pramlintide as an 
adjunct to insulin therapy in 
type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 87. A randomized trial of 
regular standardized telephone 
contact by a diabetes nurse 
educator in adolescents with 
poor diabetes control. 
Full Text Outcome: not related to insulin treatment 
adherence 
 88. A randomized, crossover 
pilot study comparing glycemic 
control and satisfaction with an 
indwelling catheter (i-port 
advance) for insulin 
administration in children and 
adolescents with type 1 
diabetes on basal-bolus 
treatment* 
Full Text Wrong study type (review, conference abstract 
etc.) 
 89. A rare complication of 
T1DM in a female teenager: 
Mauriac syndrome? 
Title Outcome: not related to insulin treatment 
adherence 
 90. A study of type 1 diabetes 
mellitus from South India 
Abstract Wrong study type (review, conference abstract 
etc.) 
 91. A systematic review of 
non-genetic predictors and 
genetic factors of glycated 
haemoglobin in type 1 diabetes 
one year after diagnosis. 
Title Outcome: not related to insulin treatment 
adherence 
 92. A Systematic Review of 
Patients' Perspectives on the 
Subcutaneous Route of 
Medication Administration 
Title Wrong study type (review, conference abstract 
etc.) 
 93. A thematic approach to 
enhance clinical content in a 
cell and tissue biology course 
Title Outcome: not related to insulin treatment 
adherence 
 94. Abnormal left ventricular 
diastolic function during cold 
presser test in uncomplicated 
insulin-dependent diabetes 
mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 95. Accelerated complications 
in Type 2 diabetes mellitus: the 
need for greater awareness 
and earlier detection. 
Title Population: do not have T1DM 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 96. Accuracy and preference 
assessment of prefilled insulin 
pen versus vial and syringe with 
diabetes patients, caregivers 
and healthcare professionals. 
Abstract Population: not children (adults/foetuses) 
 97. Accuracy of blood glucose 
estimates in adolescents with 
diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 98. Accuracy of Blood Glucose 
Meters for Self-Monitoring 
Affects Glucose Control and 
Hypoglycemia Rate in Children 
and Adolescents with Type 1 
Diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 100. Accuracy of insulin pump 
therapy usage in pediatric 
patients with type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 101. Achievement of 
internationally established 
metabolic goals in Spanish 
paediatric patients with type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 102. Achievement of 
metabolic control among 
children and adolescents with 
type 1 diabetes in Spain 
Title Outcome: not related to insulin treatment 
adherence 
 103. Achievement of 
metabolic control goals set by 
the American Diabetes 
Association and the 
International Society for 
Pediatric and Adolescent 
Diabetes in pediatric patients 
with type 1 diabetes from Spain 
Title Outcome: not related to insulin treatment 
adherence 
 105. Achieving glycemic 
control: cornerstone in the 
treatment of patients with 
multiple metabolic risk factors. 
Title Outcome: not related to insulin treatment 
adherence 
 106. Achieving optimal 
diabetic control in adolescence: 
the continuing enigma. 
Title Outcome: not related to insulin treatment 
adherence 
 107. Acid peptic disease in 
children with type I diabetes 
mellitus: A complicating 
relationship 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 108. Acute Hyperglycemia 
Associated with Psychotic 
Symptoms in a Patient with 
Type 1 Diabetes Mellitus: A 
Case Report. 
Title Outcome: not related to insulin treatment 
adherence 
 109. Acute painful neuropathy 
(insulin neuritis) - Case report 
Title Outcome: not related to insulin treatment 
adherence 
 110. ADAPTATION EN LANGUE 
FRANCAISE ET VALIDATION 
D'UNE ECHELLE MESURANT 
L'ADHESION AU TRAITEMENT 
DES ENFANTS 
DIABETIQUESFrench version of 
a scale evaluating adherence 
to diabetes regimen in children 
Abstract Outcome: not related to insulin treatment 
adherence 
 111. Adequate prescribing of 
medication does not 
necessarily translate into good 
control of diabetes mellitus. 
Abstract Outcome: not related to insulin treatment 
adherence 
 112. Adesao ao tratamento de 
diabetes mellitus tipo 1 
atendidos em um programa 
especializado em Porto 
AlegreAdherence to treatment 
in diabetes mellitus type 1 
treated in a specialized 
program in Porto Alegre 
Included 
 
 113. Adherence among 
children and adolescents with 
insulin-dependent diabetes 
mellitus over a four-year 
longitudinal follow-up: I. The 




 114. Adherence among 
children and adolescents with 
insulin-dependent diabetes 
mellitus over a four-year 
longitudinal follow-up: II. 
Immediate and long-term 
linkages with the family milieu 
Included 
 
 115. Adherence among Saudi 
adolescents with type 1 
diabetes: A qualitative study 
Abstract Wrong study type (review, conference abstract 
etc.) 
 116. Adherence behavior 
among adolescents with type I 
insulin-dependent diabetes 
mellitus: The role of cognitive 
appraisal processes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 117. Adherence behaviors in 
research protocols: comparison 
of two interventions 
Abstract Outcome: not related to insulin treatment 
adherence 
 118. Adherence behaviours in 
Taiwanese children and 
adolescents with type 1 
diabetes mellitus. 
Full Text Outcome: not related to insulin treatment 
adherence 
 119. Adherence challenges in 
the management of type 1 
diabetes in adolescents: 
prevention and intervention. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 121. Adherence in adults with 
type 1 diabetes mellitus 
correlates with treatment 
satisfaction but not with 
adverse events. 
Title Population: not children (adults/foetuses) 
 122. Adherence is suboptimal 
in adolescents with type 1 
diabetes participating in a 
clinical trial 
Abstract Outcome: not related to insulin treatment 
adherence 
 123. Adherence to a pediatric 
diabetic ketoacidosis protocol 
in children presenting to a 
tertiary care hospital 
Title Outcome: not related to insulin treatment 
adherence 
 124. Adherence to blood 
glucose monitoring in children 
and young people with type 1 
diabetes on insulin pump 
therapy in a teaching hospital 
Title Outcome: not related to insulin treatment 
adherence 
 125. Adherence to clinic visits 
is not improved by insulin use in 
metformin-treated children 
and teens with type 2 diabetes 
Title Population: do not have T1DM 
 126. Adherence to clinical care 
guidelines for cystic fibrosis-
related diabetes in 659 
German/Austrian patients 
Title Population: do not have T1DM 
 127. Adherence to diabetes 
care in children and 
adolescents with type 1 
diabetes mellitus in Spain: 
Results from the chrystal study 
Abstract Wrong study type (review, conference abstract 
etc.) 
 128. Adherence to Diet in 
Youth with Type 1 Diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 131. Adherence to guidelines 
in the treatment of diabetic 
ketoacidosis in children: A 
nationwide survey 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 132. Adherence to IDDM 
regimens: relationship to 




 133. Adherence To Insulin In 
Singaporean Pediatric Type 1 
Diabetes Patients And Its 
Association With Glycemic 
Control And Healthcare 
Utilization 
Abstract Wrong study type (review, conference abstract 
etc.) 
 134. Adherence to Insulin Pen 
Therapy Is Associated with 
Reduction in Healthcare Costs 
Among Patients with Type 2 
Diabetes Mellitus. 
Title Population: do not have T1DM 
 135. Adherence to insulin 
pump behaviors among young 
children with type 1 diabetes 
(T1D): Opportunities for 
intervention 
Abstract Wrong study type (review, conference abstract 
etc.) 
 136. Adherence to Insulin 
Pump Behaviors in Young 




 137. Adherence to insulin 
pump behaviors in young 
children with type 1 diabetes 
mellitus: Opportunities for 
intervention 
    
 138. Adherence to insulin 
pump treatment declines with 
increasing age in adolescents 
with type 1 diabetes mellitus 
Full Text Outcome: not related to insulin treatment 
adherence 
 139. Adherence to insulin 
therapeutic regimens in 
patients with type 1 diabetes. A 
nationwide survey in Brazil. 
Full Text Population: not children (adults/foetuses) 
 140. Adherence to insulin 
therapeutic regims in patients 
with type 1 diabetes. A 
nationwide survey in brazil-
Comment on Gomes et al. 
Abstract Wrong study type (review, conference abstract 
etc.) 
 141. Adherence to insulin 
treatment in children with type 




 142. Adherence to insulin 
treatment in diabetes: can it be 
improved? 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 143. Adherence to insulin 
treatment, glycaemic control, 
and ketoacidosis in insulin-
dependent diabetes mellitus 
Included 
 
 144. Adherence to insulin 
treatment, glycaemic control, 
and ketoacidosis in insulin-
dependent diabetes mellitus. 
The DARTS/MEMO 
Collaboration. Diabetes Audit 
and Research in Tayside 
Scotland. Medicines 
Monitoring Unit. 
    
 145. Adherence to medical 
regimens 
Abstract Wrong study type (review, conference abstract 
etc.) 
 146. Adherence to metformin 
is reduced during school 
holidays and weekends in 
children with type 1 diabetes 
participating in a randomised 
controlled trial 
Title Outcome: not related to insulin treatment 
adherence 
 147. Adherence to pediatric 
diabetic ketoacidosis 
guidelines by community 
emergency departments' 
providers 
Title Outcome: not related to insulin treatment 
adherence 
 148. Adherence to physical 
activity in young people with 
Type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 150. Adherence to self-care 
and glycaemic control among 
people with insulin-dependent 
diabetes mellitus 
Full Text Population: not children (adults/foetuses) 
 151. Adherence to the ISPAD 
guidelines 2009 in acute 
management of diabetic 
ketoacidosis in children and 
adolescents in Austria 
Title Outcome: not related to insulin treatment 
adherence 
 152. Adherence to the Warsaw 
School of Pump Therapy and 
using of different types of 
boluses for meals in children 
and adolescent with type 1 
diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 153. Adherence-health status 






Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 154. Adherencia al 
tratamiento en adolescentes 
diabeticos tipo 1 chilenos: Una 
aproximacion 
psicologicaPsychological 
factors associated to patient's 
treatment compliance in 
Chilean diabetic teenagers 
Full Text Outcome: not related to insulin treatment 
adherence 
 155. Adolescent adherence in 
type 1 diabetes 
Included 
 
 157. Adolescent non-
adherence reveals a genetic 
cause for diabetes 
Abstract Population: do not have T1DM 
 159. Adolescent psychosocial 
development and adherence to 
treatment for insulin-
dependent diabetes mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 160. Adolescent use of insulin 
and patient-controlled 
analgesia pump technology: A 
10-year food and drug 
administration retrospective 
study of adverse events 
Abstract Outcome: not related to insulin treatment 
adherence 
 161. Adolescents with diabetes 
and high HbA1c - A 
neurodevelopmental 
perspective 
Title Outcome: not related to insulin treatment 
adherence 
 162. Adolescents with 
diabetes: Attitude towards the 
disease and psychosocial 
impact 
Abstract Outcome: not related to insulin treatment 
adherence 
 163. Adolescents with 
diabetes: Effects of personal 
and social factors on risk, 
health, and illness 
management behaviors 
Abstract Wrong study type (review, conference abstract 
etc.) 
 164. Adolescents' and their 
parents' views on the 
acceptability and design of a 
new diabetes education 
programme: a focus group 
analysis. 
Abstract Outcome: not related to insulin treatment 
adherence 
 165. Adolescents' health 
attitudes and adherence to 
treatment for insulin-





Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 166. Adolescents, parents and 
physicians: a comparison of 
perspectives on type 1 diabetes 
self-care. 
Full Text Outcome: not related to insulin treatment 
adherence 
 167. Adults with type 1 
diabetes eat a high-fat 
atherogenic diet that is 
associated with coronary 
artery calcium. 
Title Population: not children (adults/foetuses) 
 168. Advances in 
pharmacological treatment of 
type 1 diabetes during 
pregnancy. 
Title Population: not children (adults/foetuses) 
 169. Advances in transdermal 
insulin delivery. 
Title Outcome: not related to insulin treatment 
adherence 
 170. Adverse events in 
intensively treated children and 
adolescents with type 1 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 171. Adverse lipid and 
inflammatory changes in 
young nondiabetic first-degree 
relatives of type 1-diabetic 
patients 
Title Outcome: not related to insulin treatment 
adherence 
 172. Algemene ouder-
kindrelatie en 
diabetesgerelateerde ouder-
kindrelatie in de adolescentie: 
Relatie met glykemische 




relationship in adolescence 
Included 
 
 173. Alpha-lipoic acid may 
improve the clinical, endocrine 
and metabolic features of 
polycystic ovary syndrome 
through an insulin-sensitizing 
effect and an antioxidant 
action 
Title Population: do not have T1DM 
 174. Ambulatory 24-hour fast 
using flexible insulin therapy in 
patients with type 1 diabetes. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 175. An analysis of "no effect 
of insulin pen with memory 
function on glycemic control in 
a patient cohort with poorly 
controlled type 1 diabetes: a 
randomized open-label study". 
Full Text Wrong study type (review, conference abstract 
etc.) 
 176. An analysis on the factors 
associated with reuse of insulin 
pen needles in type 2 diabetic 
patients in China 
Title Population: do not have T1DM 
 177. An annual review 
questionnaire in children and 
young people with type 1 
diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 178. An approach to 
prevention of recurrent 
diabetic ketoacidosis in the 
pediatric population 
Title Outcome: not related to insulin treatment 
adherence 
 179. An audit of insulin usage 
and insulin injection practices 
in a large Indian cohort 
Abstract Population: do not have T1DM 
 180. An audit of the dietary 
intake of Australian children 
with type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 181. An evaluation of patient 
preference for an alternative 
insulin delivery system 
compared to standard vial and 
syringe. 
Abstract Population: not children (adults/foetuses) 
 182. An exploratory 
randomised controlled trial 
using short messaging service 
to facilitate insulin 
administration in young adults 
with type 1 diabetes 
Title Population: not children (adults/foetuses) 
 184. An intervention to 
promote family teamwork in 
diabetes management tasks: 
Relationships among parental 
involvement, adherence to 
blood glucose monitoring, and 
glycemic control in young 
adolescents with type 1 
diabetes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 185. Analiz kachestva 
pervichnoi lechebno-
profilakticheskoi pomoshchi 
bol'nym sakharnym diabetom I 
tipaAnalysis of the quality of 
primary therapeutic-preventive 
care rendered to patients with 
type I diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 186. Analysis of the NovoPen 
Echo for the delivery of insulin: 
a comparison of usability, 
functionality, and preference 
among pediatric subjects, their 
parents, and health care 
professionals 
Abstract Outcome: not related to insulin treatment 
adherence 
 188. Analysis of use of an 
automated bolus calculator 
reduces fear of hypoglycemia 
and improves confidence in 
dosage accuracy in type 1 
diabetes mellitus patients 
treated with multiple daily 
insulin injections. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 189. Analyzing the Potential of 
Advanced Insulin Dosing 
Strategies in Patients With 
Type 2 Diabetes: Results From 
a Hybrid In Silico Study. 
Title Population: do not have T1DM 
 190. Anorexia nervosa and 
bulimia in diabetics 
Full Text Population: not children (adults/foetuses) 
 191. Antiphospholipid 
syndrome in children 
Title Population: do not have T1DM 
 192. Anxiety symptoms in 
adolescents with type 1 
diabetes: association with 
blood glucose monitoring and 
glycemic control. 
Title Outcome: not related to insulin treatment 
adherence 
 193. Análisis discriminante de 
la adhesión al tratamiento en 
la diabetes mellitus 
insulinodependiente 
Full Text Population: not children (adults/foetuses) 
 194. Aortic compliance 
measurements using Doppler 
ultrasound: In vivo biochemical 
correlates 
Title Population: do not have T1DM 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 195. Application of novel dual 
wave meal bolus and its impact 
on glycated hemoglobin A1c 
level in children with type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 197. Approach to the obese 
adolescent with new-onset 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 199. Are clinical or metabolic 
variables useful to distinguish 
between an infant of a diabetic 
mother and simple 
macrosomia of the newborn? 
Title Outcome: not related to insulin treatment 
adherence 
 200. Are families of children 
with type 1 DM ready for 
televisits? 
Title Outcome: not related to insulin treatment 
adherence 
 201. Are paediatric patients 
attending their annual diabetic 
retinopathy screening? 
Title Outcome: not related to insulin treatment 
adherence 
 202. Are we using current up-
to-date evidence in the delivery 
and documentation of sick day 
management education to 
children and adolescents with 
type 1 diabetes? 
Title Outcome: not related to insulin treatment 
adherence 
 203. Arterial stiffness as 
measure of cardiovascular risk 
in lean and obese adolescents 
and adolescents with type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 204. Arterial wall thickening 
and stiffening in children and 
adolescents with type 1 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 205. ASPECTS 
PSYCHOLOGIQUES DE LA 
COMPLIANCE AU TRAITEMENT 
CHEZ L'ENFANT DIABETIQUE 
INSULINODEPENDANTPsycholo
gic aspects of compliance with 
therapy in children with insulin-
dependent diabetes mellitus 
  
 206. Assessing diabetes 
support in adolescents: factor 
structure of the Modified 
Diabetes Social Support 
Questionnaire (M-DSSQ-
Family). 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 207. Assessing family sharing 
of diabetes responsibilities. 
Included 
 
 208. Assessing the Impact of 
Excessive Gestational Weight 
Gain Among Women With Type 
1 Diabetes on 
Overweight/Obesity in Their 
Adolescent and Young Adult 
Offspring: A Pilot Study. 
Title Population: not children (adults/foetuses) 
 209. Assessing treatment 
barriers in young adults with 
type 1 diabetes. 
Title Population: not children (adults/foetuses) 
 210. Assessment of adherence 
and healthcare costs of insulin 
device (FlexPen) versus 
conventional vial/syringe 
Full Text Population: not children (adults/foetuses) 
 211. Assessment of patient-
reported outcomes of insulin 
pen devices versus 
conventional vial and syringe. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 213. Assessment of quality of 
life in children with peanut 
allergy 
Title Population: do not have T1DM 
 214. Associated factors with 
the control of type 1 diabetes 
mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 215. Association between 
carotid intima-media 
thickness, buccodental status, 
and glycemic control in 
pediatric type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 217. Association between food 
insecurity and glycemic control 
among youth with type 1 
diabetes in Haiti 
Title Outcome: not related to insulin treatment 
adherence 
 218. Association of HbA1c to 
BOLUS Scores among Youths 
with Type 1 Diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 220. Association of insulin-
manipulation and psychiatric 
disorders: A systematic 
epidemiological evaluation of 
adolescents with type 1 
diabetes in Austria 
Included 
 
 221. Associations between 
family members' perceptions of 
the health care system and the 
health of youths with insulin-
dependent diabetes mellitus 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 222. Associations between 
major life events and 
adherence, glycemic control, 
and psychosocial 
characteristics in teens with 
type 1 diabetes. 
Included 
 
 223. Attitudes towards insulin 
pump therapy among 
adolescents and young people 
Full Text Population: not children (adults/foetuses) 
 225. Attributions of teacher 




 226. Audit of DKA 
management in Wellington 
New Zealand 2005-2013 
Title Outcome: not related to insulin treatment 
adherence 
 227. Audit of screening and 
confirmation of diagnosis of 
coeliac disease in type 1 
diabetes patients 
Title Outcome: not related to insulin treatment 
adherence 
 228. Audit of the use of 
integrated care pathway in the 
management of diabetic Keto 
acidosis in children 
Title Outcome: not related to insulin treatment 
adherence 
 229. Back to school and 
normality after lung 
transplantation in childhood 
and the need for psycho-social 
interventions 
Title Population: do not have T1DM 
 230. Bariatric surgery for 
severe obesity in two 
adolescents with type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 232. Barriers to care in the 
adult patient with cystic 
fibrosis-related diabetes 
Title Population: not children (adults/foetuses) 
 233. Barriers to effective 
management of type 2 
diabetes in primary care : 
qualitative systematic review. 
Title Population: do not have T1DM 
 234. Barriers to regimen 
adherence among persons with 
insulin-dependent diabetes. 
Full Text Population: not children (adults/foetuses) 
 235. Behavior therapy for 
families of adolescents with 
diabetes: Effects on directly 
observed family interactions 
Included 
 
 236. Behavioral Family 
Systems Therapy for 
adolescents with diabetes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 237. Behaviours, thoughts and 
perceptions around mealtime 
insulin usage and wastage 
among people with type 1 and 
type 2 diabetes mellitus: A 
cross-sectional survey study. 
Abstract Population: not children (adults/foetuses) 
 238. Benefits of an insulin 
dosage calculation device for 




 240. Benefits of using the I-




 241. Beta-cell autoimmunity in 
pediatric celiac disease: the 
case for routine screening? 
Title Outcome: not related to insulin treatment 
adherence 
 243. Betreuung von Kindern 
und Jugendlichen mit Diabetes 
mellitusTreatment of children 
and adolescents with diabetes 
mellitus 
Full Text Wrong study type (review, conference abstract 
etc.) 
 244. Bias in food intake 
reporting in children and 
adolescents with type 1 
diabetes: the role of body size, 
age and gender. 
Title Outcome: not related to insulin treatment 
adherence 
 245. Bicentric evaluation of a 
teaching and treatment 
programme for type 1 (insulin-
dependent) diabetic patients: 
improvement of metabolic 
control and other measures of 
diabetes care for up to 22 
months. 
Full Text Population: not children (adults/foetuses) 
 246. Biomedical predictors of 
consistent continuous glucose 
monitoring in youth with type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 247. Biopsychosocial Factors 
Associated With Satisfaction 
and Sustained Use of Artificial 
Pancreas Technology and Its 
Components: a Call to the 
Technology Field. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 248. Blood glucose control and 
compliance of diabetic children 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 249. Blood glucose monitoring 
and glycemic control in 
adolescents with type 1 
diabetes: meter downloads 
versus self-report. 
Title Outcome: not related to insulin treatment 
adherence 
 250. Blood glucose monitoring 
by diabetic adolescents: 
compliance and metabolic 
control 
Title Outcome: not related to insulin treatment 
adherence 
 251. Blood glucose 
monitoring: Which is better: 
Continuous real-time or 
episodic real-time on demand? 
CON 
Abstract Outcome: not related to insulin treatment 
adherence 
 252. Blood glucose self-
monitoring in type 2 diabetes: 
a randomised controlled trial 
Title Population: do not have T1DM 
 253. Blood glucose testing by 
drivers with diabetes: A survey 
of glucose meter users 
Title Population: not children (adults/foetuses) 
 254. Blood or urine glucose-
based insulin therapy and 
control of glycemia. Computer-
simulation study. 
Title Outcome: not related to insulin treatment 
adherence 
 255. Blood pressure lowering 
for the prevention and 
treatment of diabetic kidney 
disease. 
Title Outcome: not related to insulin treatment 
adherence 
 256. Body relationship as a 
predictor of self-care, physical 
health, and psychological well-
being in adolescents with type 
1 diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 257. Bolus calculator and 
wirelessly communicated blood 
glucose measurement 
effectively reduce 
hypoglycaemia in type 1 
diabetic children - randomized 
controlled trial. 
Abstract Outcome: not related to insulin treatment 
adherence 
 258. Brazilian multicenter 
study for the evaluation of 
patients' satisfaction of blood 
glucose self-monitoring with 
BGStar blood glucose meter in 
insulinized patients with 
diabetes mellitus type 1 and 2 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 259. Brief report: Maternal 
posttraumatic stress symptoms 
are related to adherence to 




 260. Brief report: Parent's 
health literacy among high-risk 




 261. Budget Impact of Long-
Acting Insulin Analogues: The 
Case in Brazil. 
Title Outcome: not related to insulin treatment 
adherence 
 262. Burden of Cardiovascular 
Risk Factors Over Time and 
Arterial Stiffness in Youth With 
Type 1 Diabetes Mellitus: The 
SEARCH for Diabetes in Youth 
Study. 
Title Outcome: not related to insulin treatment 
adherence 
 263. Burden of thiamine 
deficiency among children 
presented with diabetic 
ketoacidosis 
Title Outcome: not related to insulin treatment 
adherence 
 264. Can a computer game 
improve adherence to 
treatment in children with type 
1 diabetes? 
Abstract Wrong study type (review, conference abstract 
etc.) 
 265. Can integrated 
technology improve self-care 
behavior in youth with type 1 
diabetes? A randomized 
crossover trial of automated 
pump function. 
Abstract Outcome: not related to insulin treatment 
adherence 
 266. Caracteristicas da dieta 
nas diferentes fases da 
evolucao do diabetes melito 
Tipo 1Diet composition along 
the evolution of Type 1 
diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 267. Carbohydrate counting 
accuracy and blood glucose 
variability in adults with type 1 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 268. Carbohydrate counting 
from onset of diabetes reduced 
insulin requirements but 
increased weight in children 
and adolescents 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 269. Carbohydrate Counting in 
Children and Adolescents with 
Type 1 Diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 270. Carbohydrate 
management 
Title Outcome: not related to insulin treatment 
adherence 
 271. Cardiac and Vascular 
Function in Adolescents and 
Young Adults with Type 1 
Diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 273. Cardiometabolic risk in 
pediatric survivors of childhood 
cancer 
Title Population: do not have T1DM 
 274. Cardiometabolic risk in 
survivors of childhood cancer 
who received hematopoietic 
cell transplant (HCT) 
Title Population: do not have T1DM 
 275. Cardiovascular and 
metabolic effects of metformin 
in patients with type 1 diabetes 
(REMOVAL): a double-blind, 
randomised, placebo-
controlled trial. 
Title Outcome: not related to insulin treatment 
adherence 
 276. Cardiovascular disease 
risk in young people with type 1 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 278. Care of adolescents and 
young adults with diabetes - 
much more than transitional 
care: a personal view. 
Abstract Population: not children (adults/foetuses) 
 279. Care of adolescents with 
type 2 diabetes across the 
North West London pediatric 
diabetes network 
Title Population: do not have T1DM 
 280. Care plans: Part of 
improving ability to self care 
Abstract Wrong study type (review, conference abstract 
etc.) 
 281. Caregiver reports of 
provider recommended 
frequency of blood glucose 
monitoring and actual testing 
frequency for youth with type 1 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 282. Case report: Rare form of 
diabetes mellitus type 1 in 
adolescent patient 
Title Outcome: not related to insulin treatment 
adherence 
 283. Case series of neuropathic 
symptoms in 3 adolescent 
females with diabetes mellitus 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 284. Celiac disease 
arthropathy and autoimmunity 
study 
Title Population: do not have T1DM 
 285. Cell Based Therapy for 
Type 1 Diabetes: Should We 
Take Hyperglycemia Into 
Account? 
Title Outcome: not related to insulin treatment 
adherence 
 286. Challenges in using insulin 
pumps in pediatrics : AAA self 
report by families 
Abstract Wrong study type (review, conference abstract 
etc.) 
 287. Challenges of Diabetes 
Management in Toddlers 
Abstract Outcome: not related to insulin treatment 
adherence 
 288. Changes in treatment 
adherence and glycemic 
control during the transition to 
adolescence in type 1 diabetes. 
Full Text Outcome: not related to insulin treatment 
adherence 
 289. Changes in type 1 
diabetes health indicators from 
high school to college. 
Title Outcome: not related to insulin treatment 
adherence 
 290. Characteristics of 
adolescents with type 1 
diabetes who exhibit adverse 
outcomes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 291. Characteristics of diabetic 
ketoacidosis in Chinese adults 
and adolescents -- a teaching 
hospital-based analysis. 
Title Outcome: not related to insulin treatment 
adherence 
 292. Characteristics of 
pediatric diabetic ketoacidosis 
patients in Saudi Arabia 
Abstract Outcome: not related to insulin treatment 
adherence 
 293. Characterization of 
metabolic responders on CSII 
treatment amongst children 
and adolescents in Denmark 
from 2007 to 2013 
Title Outcome: not related to insulin treatment 
adherence 
 295. Chat line for adolescents 
with type 1 diabetes: A useful 
tool to improve coping with 
diabetes: A 2-year follow-up 
study 
Full Text Outcome: not related to insulin treatment 
adherence 
 297. Children and adolescents 
living with diabetes and celiac 
disease. 
Abstract Outcome: not related to insulin treatment 
adherence 
 298. Children as partners with 
adults in their medical care. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 299. Children with coeliac 
disease and insulin dependent 
diabetes mellitus - Growth, 
diabetes control and dietary 
intake 
Abstract Outcome: not related to insulin treatment 
adherence 
 300. Chronic diseases of 
childhood: Assessing 
compliance with complex 
medical regimens 
Abstract Wrong study type (review, conference abstract 
etc.) 
 301. Clinical and economic 
outcomes among patients with 
diabetes mellitus initiating 
insulin glargine pen versus vial 
Abstract Population: not children (adults/foetuses) 
 302. Clinical case: Berardinelli-
seip syndrome in a 5 month old 
child 
Title Outcome: not related to insulin treatment 
adherence 
 303. Clinical characteristics 
and management of patients 
with type 1 diabetes-a national 
population-based spanish 
study (SED1) 
Abstract Population: not children (adults/foetuses) 
 304. Clinical characteristics of 
non-insulin-dependent 
diabetes mellitus among 
southwestern American Indian 
youths 
Title Population: do not have T1DM 
 305. Clinical Efficacy of Two 
Different Methods to Initiate 
Sensor-Augmented Insulin 
Pumps: A Randomized 
Controlled Trial. 
Abstract Population: not children (adults/foetuses) 
 306. Clinical practice factors 
that define insulin pump 
readiness 
Title Outcome: not related to insulin treatment 
adherence 
 307. Clinical predictors of 
mucormycosis in children with 
type 1 diabetes mellitus. 
Title Outcome: not related to insulin treatment 
adherence 
 308. Clinical profile and 
outcome of children with 
diabetic ketoacidosis: Type 1 
diabetes mellitus a real 
challenge for low income 
Nation 
Abstract Outcome: not related to insulin treatment 
adherence 
 309. Clinical profile and 
outcome of type 1 diabetes 
mellitus in tertiary care center 
of Eastern Nepal 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 310. Clinical profile and 
outcomes of paediatric 
patients with diabetic 
ketoacidosis at a tertiary care 
hospital in Pakistan 
Abstract Outcome: not related to insulin treatment 
adherence 
 311. Clinical profile of type 1 
diabetes mellitus in children 
referred to a tertiary care 
centre 
Abstract Outcome: not related to insulin treatment 
adherence 
 312. Clinical Use of Continuous 
Glucose Monitoring in Adults 
with Type 1 Diabetes. 
Title Population: not children (adults/foetuses) 
 313. Clinical utility of serologic 
testing for celiac disease in 
asymptomatic patients: an 
evidence-based analysis. 
Title Population: do not have T1DM 
 314. Clinical, para-clincal and 
outcomes of diabetes 
ketoacidosis in Vietnam 
national hospital pediatrics 
Abstract Outcome: not related to insulin treatment 
adherence 
 315. Closing the loop in poor 
control 
Abstract Outcome: not related to insulin treatment 
adherence 
 316. Clustering of coronary 
heart disease risk factors 
among obese children 
Title Outcome: not related to insulin treatment 
adherence 
 317. Coated pellets with 
controlled glucose release in 
treatment of children with 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 318. Cognitive and behavioral 
determinants of compliance in 
diabetics 
Full Text Population: not children (adults/foetuses) 
 319. Cognitive-behavioral 
therapy for the treatment of 
depression and adherence in 
patients with type 1 diabetes: 
pilot data and feasibility. 
Full Text Population: not children (adults/foetuses) 
 320. Comparing medical 
utilization between insulin pen 
and vial users within a pediatric 
medicaid accountable care 
organization 
Abstract Wrong study type (review, conference abstract 
etc.) 
 321. Comparing social learning 
and family systems correlates 
of adaptation in youths with 
IDDM 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 322. Comparison of insulin 
detemir in a twice daily insulin 
regimen versus a three times 
daily insulin regimen in children 
with type 1 diabetes: A 
randomized controlled trial 
Abstract Wrong study type (review, conference abstract 
etc.) 
 323. Comparison of insulin 
regimens and administration 
modalities in pregnancy 
complicated by diabetes 
Title Population: not children (adults/foetuses) 
 324. Comparison of 
medication adherence in 
diabetes mellitus patients on 
human versus analogue 
insulins 
Abstract Population: not children (adults/foetuses) 
 325. Comparison of quality of 
life in adolescents with Type 1 
diabetes using different 
treatment modalities; 
Continuous subcutaneous 
insulin infusion (insulin pumps), 
twice daily injections or 
multiple insulin injections 
Abstract Wrong study type (review, conference abstract 
etc.) 
 326. Comparison of usability 
and patient preference for the 
new disposable insulin device 
solostar versus flexpen, lilly 
disposable pen, and a 




 327. Compliance and 
administration methods in 
management of type 1 
diabetes. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 329. Compliance bei Kindern 
und Jugendlichen mit Typ-1-
Diabetes (juveniler Diabetes 
mellitus)Compliance of 
children and adolescents with 
type 1 diabetes (juvenile 
diabetes mellitus) 
Full Text Outcome: not related to insulin treatment 
adherence 
 330. Compliance of 
adolescents with diabetes 
Included 
 
 331. Compliance of young 
diabetics with health regimens 
Full Text Outcome: not related to insulin treatment 
adherence 
 332. Compliance to treatment 
among children with type 1 
diabetes mellitus: Experience in 
Abakaliki 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 333. Compliance with complex 
medical regimens: Assessing 
daily management of 
childhood diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 334. Compliance with dietary 
prescriptions in children and 
adolescents with insulin-
dependent diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 335. Compliance with gluten 
free diet (GFD) is associated 
with better glycemic control in 
children with type 1 diabetes 
(T1D) 
Title Outcome: not related to insulin treatment 
adherence 
 336. Compliance with gluten-
free diet has a positive 
influence on glycemic control in 
children with celiac disease and 
type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 337. Comprehensive 
assessment of long-term 
therapeutic adherence and 
recurrent pain in children and 
adolescents 
Full Text Outcome: not related to insulin treatment 
adherence 
 338. Computerized knowledge 
management in diabetes care 
Title Outcome: not related to insulin treatment 
adherence 
 339. Condition-related 
predictors of successful 
transition from paediatric to 
adult care among adolescents 
with Type 1 diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 340. Consequences of delayed 
pump infusion line change in 
patients with type 1 diabetes 
mellitus treated with 
continuous subcutaneous 
insulin infusion. 
Title Outcome: not related to insulin treatment 
adherence 
 342. Considerations for 
diabetes: treatment with 
insulin pen devices. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 343. Continuous Glucose 
Monitoring (CGM) Adherence 
in Youth with Type 1 Diabetes: 
Associations with Biomedical 
and Psychosocial Variables 
Title Outcome: not related to insulin treatment 
adherence 
 344. Continuous Glucose 
Monitoring Adherence: Lessons 
from a Clinical Trial to Predict 
Outpatient Behavior 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 346. Continuous glucose 
monitoring and pumps. 
Abstract Outcome: not related to insulin treatment 
adherence 
 347. Continuous glucose 
monitoring interventions in 
toddlers with type 1 diabetes 
(T1D) 
Abstract Outcome: not related to insulin treatment 
adherence 
 348. Continuous glucose 
monitoring systems for type 1 
diabetes mellitus. 
Abstract Outcome: not related to insulin treatment 
adherence 
 350. Continuous Glucose 
Monitoring vs Conventional 
Therapy for Glycemic Control in 
Adults With Type 1 Diabetes 
Treated With Multiple Daily 
Insulin Injections: The GOLD 
Randomized Clinical Trial. 
Title Population: not children (adults/foetuses) 
 351. Continuous subcutaneous 
insulin infusion ("Insulin 
Pump") in pediatric patients 
with type 1 diabetes: 
Experience in a Chilean state 
hospital 
Abstract Outcome: not related to insulin treatment 
adherence 
 352. Continuous subcutaneous 
insulin infusion (CSII) 
Full Text Wrong study type (review, conference abstract 
etc.) 
 353. Continuous subcutaneous 
insulin infusion (insulin pump) 
therapy can be safely used in 
the hospital in select patients. 
Full Text Population: not children (adults/foetuses) 
 354. Continuous subcutaneous 
insulin infusion in Italy: third 
national survey. 
Abstract Outcome: not related to insulin treatment 
adherence 
 355. Control of type 2 diabetes 
mellitus among general 
practitioners in private practice 
in nine countries of Latin 
America 
Title Population: do not have T1DM 





 357. Correlates of insulin 
injection omission. 
Abstract Population: not children (adults/foetuses) 
 358. Correlates of medication 
adherence in the TODAY cohort 
of youth with type 2 diabetes 
Title Population: do not have T1DM 
 359. Costs associated with 
long-acting insulin analogues 
in patients with diabetes. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 360. Could clinical parameters 
at initiation of continuous 
glucose monitoring (CGM) 
predict efficacy on HbA1c in 
type 1 diabetes (T1D) pediatric 
patients at 3 months? 
Preliminary results in a 
prospective study of 141 
patients (Start-In!) 
Title Outcome: not related to insulin treatment 
adherence 
 361. CoYoT1 Clinic: Home 
Telemedicine Increases Young 
Adult Engagement in Diabetes 
Care. 
Title Population: not children (adults/foetuses) 
 362. Crisis intervention 




 363. Cross-cultural adaption 
and psychometric properties of 
the Chinese version of the 
Diabetes Behavior Rating 
Scale: a pilot study 
Abstract Outcome: not related to insulin treatment 
adherence 
 364. Current Diagnosis and 
Treatment, and Clinical 
Challenges in the Management 
of Lipodystrophy Syndromes in 
Children and Youth 
Abstract Population: do not have T1DM 
 365. Cyclical cushing's disease 
in an adolescent with type I 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 366. Cytoadherence of 
lymphocytes from type I 
diabetic subjects to insulin-
secreting cells. Marker of anti-
beta-cell cellular immunity. 
Title Outcome: not related to insulin treatment 
adherence 
 367. D-buddy peer support for 
better health outcomes in 
adolescents with diabetes 
mellitus 
Abstract Outcome: not related to insulin treatment 
adherence 
 368. Daily insulin requirement 
of children and adolescents 
with type 1 diabetes: Effect of 
age, gender, body mass index 
and mode of therapy 
Title Outcome: not related to insulin treatment 
adherence 
 370. Das diabetische kind auf 
der notfallstationThe diabetic 
child and adolescent in the 
emergency room 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 371. Day-to-day consistency in 
amount and source of 
carbohydrate intake 
associated with improved 
blood glucose control in type 1 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 373. Decision-making in 
diabetes mellitus type 1. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 374. Defective erythrocyte C3b 
receptor function associated 
with low serum complement 
(C3, C4) concentrations in 
insulin-dependent diabetes 
mellitus. 
Title Outcome: not related to insulin treatment 
adherence 
 375. Depression among adults 
with diabetes in Jordan: risk 
factors and relationship to 
blood sugar control. 
Title Population: not children (adults/foetuses) 
 376. Depression and suicidal 
ideation in adolescents with 
type 1 diabetes mellitus 
Abstract Outcome: not related to insulin treatment 
adherence 
 377. Depression-related 
hyperglycemia in type 1 
diabetes: a mediational 
approach. 
Full Text Population: not children (adults/foetuses) 
 378. Depressive symptoms and 
glycemic control in adolescents 
with type 1 diabetes: 
mediational role of blood 
glucose monitoring. 
Abstract Outcome: not related to insulin treatment 
adherence 
 379. Depressive symptoms in 
type 1 diabetic children with 
poor and excellent metabolic 
control 
Abstract Outcome: not related to insulin treatment 
adherence 
 380. Depressive symptoms, 
daily stress, and adherence in 




 381. Depressive symptoms, 
depression-related cognitions, 
and diabetes care in 
adolescence 
Abstract Wrong study type (review, conference abstract 
etc.) 
 382. Design, construction, and 
implementation of an online 
platform for patients with type 
1 diabetes: EncoDiab. 
Abstract Population: not children (adults/foetuses) 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 383. Detecting intentional 
insulin omission for weight loss 




 384. Determinacion continua 
de glucosa sistema glucoday. 
En ninos adolescentes con 
diabetes tipo 1[Continuous 
glucose monitoring using the 
Glucoday system, in children 
and adolescents who have type 
one diabetes] 
Abstract Outcome: not related to insulin treatment 
adherence 
 385. Determinants of Glycemic 
Control among Insulin Treated 
Diabetic Patients in Southwest 
Ethiopia: Hospital Based Cross 
Sectional Study 
Title Outcome: not related to insulin treatment 
adherence 
 386. Determinants of outcome 
of children with type 1 diabetes 
in Cameroon 
Title Outcome: not related to insulin treatment 
adherence 
 387. Determinants of self-
monitoring of blood glucose in 
patients with Type 1 diabetes: 
a multi-centre study in Brazil. 
Title Outcome: not related to insulin treatment 
adherence 
 388. Developing a theoretical 
maintenance model for 
disordered eating in Type 1 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 389. Development and 
evaluation by a cluster 
randomised trial of a 
psychosocial intervention in 
children and teenagers 




 391. Development and validity 
testing of the revised diabetes 




 392. Development of a New 
Measure for Assessing Insulin 
Delivery Device Satisfaction in 
Patients with Type 1 and Type 
2 Diabetes. 
Abstract Population: not children (adults/foetuses) 
 393. Development of an 
Insulin-Prescribing Chart for 
Paediatric Diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 394. Developmental effects of 
type 1 diabetes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 395. Developmental influences 
on adolescent health 
Title Population: do not have T1DM 
 396. Dextran-b-poly(lactide-
co-glycolide) polymersome for 
oral delivery of insulin: In vitro 
and in vivo evaluation. 
Title Outcome: not related to insulin treatment 
adherence 
 397. Diabeetikkonuoren 
hoitoon sitoutuminen ja 
perheen toimivuus nuoren 
itsensa arvioimanaCompliance 
of young diabetic patients with 
therapeutic regimens and 
participation by the family 
Full Text Outcome: not related to insulin treatment 
adherence 
 398. DIABEO App Software 
and Telemedicine Versus Usual 
Follow-Up in the Treatment of 
Diabetic Patients: Protocol for 
the TELESAGE Randomized 
Controlled Trial. 
Abstract Outcome: not related to insulin treatment 
adherence 
 399. Diabete di tipo 1 in eta 
pediatrica all'esordio: Casistica 
ospedaliera Italiana raccolta 
mediante networkChildhood 
type 1 diabetes at onset: 
Network for collection of case 
records in Italian hospitals 
Title Outcome: not related to insulin treatment 
adherence 
 400. Diabetes Control and 
Adherence in Adolescence. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 401. Diabetes Control and 
Complications Trial (DCCT): 
results of feasibility study. The 
DCCT Research Group. 
Title Outcome: not related to insulin treatment 
adherence 
 402. Diabetes control did not 
worsen after insulin pump 
discontinuation in non-
compliant adolescents with 
type 1 diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 403. Diabetes in childhood Abstract Wrong study type (review, conference abstract 
etc.) 
 404. Diabetes in Japan: a 
review of disease burden and 
approaches to treatment. 
Title Outcome: not related to insulin treatment 
adherence 
 405. Diabetes knowledge in 
preadolescents with type 1 
diabetes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 406. Diabetes melito do tipo 2 
na infancia e adolescencia: 
Revisao da literaturaType 2 
diabetes in children and 
adolescents: Literature review 
Title Population: do not have T1DM 
 407. Diabetes mellitus as a 
model of psychosomatic and 
somatopsychic 
interrelationships. 
Title Outcome: not related to insulin treatment 
adherence 
 408. Diabetes mellitus at a 
rural hospital in northwestern 
Tanzania 
Abstract Outcome: not related to insulin treatment 
adherence 
 409. Diabetes mellitus in the 
transition to adulthood: 
adjustment, self-care, and 
health status 
Abstract Population: not children (adults/foetuses) 
 410. Diabetes mellitus type 1 
in patient with medium-chain 
acyl-coenzyme a 
dehydrogenase deficiency 
Abstract Outcome: not related to insulin treatment 
adherence 
 411. Diabetes mellitus. Abstract Outcome: not related to insulin treatment 
adherence 
 412. Diabetes regimen 
behaviors. Predicting 
adherence 
Full Text Population: not children (adults/foetuses) 
 413. Diabetes resilience: 
Psychometric properties of a 
measure for preadolescents 
with type 1 diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 414. Diabetes technology and 
the human factor. 
Abstract Wrong study type (review, conference abstract 
etc.) 
 415. Diabetes technology in 
adolescents and young adults 
Abstract Wrong study type (review, conference abstract 
etc.) 
 416. Diabetes-specific risk 
taking-psychometric properties 
of a measure for adolescents 
with type 1 diabetes (T1D) 
Abstract Wrong study type (review, conference abstract 
etc.) 
 417. Diabetic care provision 
and glycemic control in a 
pediatrics diabetic clinic: An 
audit 
Abstract Outcome: not related to insulin treatment 
adherence 
 418. Diabetic control in 
adolescents 
Abstract Population: not children (adults/foetuses) 
 419. Diabetic ketoacidosis 
complicating pregnancy. 
Title Population: not children (adults/foetuses) 
 420. Diabetic ketoacidosis in a 
patient with islet cell 
transplant 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 421. Diabetic ketoacidosis in 
an adolescent and young adult 
population in the UK in 2014: 
National survey comparison of 
the management in adult and 
paediatric settings 
Title Outcome: not related to insulin treatment 
adherence 
 422. Diabetic ketoacidosis in 
the setting of HNF1A-maturity 
onset diabetes of the young. 
Title Outcome: not related to insulin treatment 
adherence 
 423. Diabetic ketoacidosis 
with acute renal failure and 
rhabdomyolsis: A case 
presentation and review of 
literate 
Title Outcome: not related to insulin treatment 
adherence 
 424. Diabetic ketoacidosis, 
determinants and mortality 
rate in Sudanese children with 
type 1 diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 425. Diabetic ketoacidosis--a 
study of 33 episodes 
Title Outcome: not related to insulin treatment 
adherence 
 426. Diabetic ketoacidosis: risk 
factors and management 
strategies. 
Title Outcome: not related to insulin treatment 
adherence 
 427. Diabetic mellitus type 1 in 
patient with beta major 
thalassemia (case report) 
Title Outcome: not related to insulin treatment 
adherence 
 428. Diabulimia: how eating 
disorders can affect 
adolescents with diabetes 
Full Text Wrong study type (review, conference abstract 
etc.) 
 430. Diagnosis and 
management of hyperglycemic 
emergencies. 
Title Outcome: not related to insulin treatment 
adherence 
 431. Diagnosis and 
management of type 2 
diabetes in youth in North 
Queensland and the Northern 
Territory: A health professional 
survey 
Title Population: do not have T1DM 
 432. Diazoxide in children with 
obesity after hypothalamic-
pituitary lesions: A 
randomized, placebo-
controlled trial 
Title Population: do not have T1DM 
 433. Diet and the diabetic 
patient. 
Title Outcome: not related to insulin treatment 
adherence 
 434. Diet therapy among 
young diabetics in the 
Philippines. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 435. Diet-related knowledge, 
skill, and adherence among 
children with insulin-
dependent diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 436. Dietary adherence and 
associated glycemic control in 
families of young children with 
type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 437. Dietary Adherence and 
Mealtime Behaviors in Young 
Children with Type 1 Diabetes 
on Intensive Insulin Therapy 
Title Outcome: not related to insulin treatment 
adherence 
 439. Dietary behaviors predict 
glycemic control in youth with 
type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 440. Dietary compliance 
among insulin-dependent 
diabetics. 
Title Outcome: not related to insulin treatment 
adherence 
 441. Dietary intake and risk of 
non-severe hypoglycemia in 
adolescents with type 1 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 442. Dietary survey of 
diabetics 
Title Outcome: not related to insulin treatment 
adherence 
 443. Differences between 
bulimia nervosa and binge-
eating disorder in females with 
type 1 diabetes: the important 
role of insulin omission. 
Full Text Population: not children (adults/foetuses) 
 444. Differences in family 
mealtime interactions between 
young children with type 1 
diabetes and controls: 
implications for behavioral 
intervention. 
Abstract Outcome: not related to insulin treatment 
adherence 
 445. Differences in long-term 
metabolic control and BMI in 
children with type 1 diabetes 
on insulin pumps stratified by 
age and sex 
Title Outcome: not related to insulin treatment 
adherence 
 446. Differences in the 
metabolism of postprandial 
lipoproteins after a high-
monounsaturated-fat versus a 
high-carbohydrate diet in 
patients with type 1 diabetes 
mellitus. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 447. Different health 
behaviours and clinical factors 
associated with bone mineral 
density and bone turnover in 
premenopausal women with 
and without type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 





dependiente (IDDM): su 
relacion con control 
metabolico, desesperanza, 
apoyo social y sintomatologia 
depresivaDifficulties and 
concerns identified by Puerto 
Rican youth with insulin-
dependent diabetes mellitus 
(IDDM): their relationship with 
metabolic control, 
hopelessness, social support, 
and depressive symptoms 
Included 
 
 449. Discontinuation of insulin 
pump treatment in children, 
adolescents, and young adults. 
A multicenter analysis based on 
the DPV database in Germany 
and Austria. 
Title Outcome: not related to insulin treatment 
adherence 
 450. Discordant diabetes 
family responsibility sharing is 
associated with increased 
diabetes family conflict in 
youth with type 1 diabetes 
(T1D) 
Abstract Wrong study type (review, conference abstract 
etc.) 
 451. Discriminacion de niveles 
de glucosa en sangre en 
diabeticos insulino-
dependientes mediante 
señales externas y perfiles 
glucemicos 
Abstract Outcome: not related to insulin treatment 
adherence 
 452. Discriminant analysis of 
treatment adherence in insulin-
dependent diabetes mellitus 
Full Text Population: not children (adults/foetuses) 
 453. Disease burden in young 
adults with Type 2 diabetes: A 
retrospective study 
Title Population: not children (adults/foetuses) 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 454. Disease management in 
the young diabetic patient: 
glucose monitoring, coping 
skills, and treatment 
strategies. 
Abstract Outcome: not related to insulin treatment 
adherence 
 455. Disease management 
programs for patients with 
type 2 diabetes mellitus in 
Germany: a longitudinal 
population-based descriptive 
study 
Title Population: do not have T1DM 
 456. Dismissing attachment 
and outcome in diabetes: The 
mediating role of coping 
Full Text Population: not children (adults/foetuses) 
 457. Disordered Eating 
Behaviors Are Not Increased by 
an Intervention to Improve Diet 
Quality but Are Associated 
With Poorer Glycemic Control 
Among Youth With Type 1 
Diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 458. Disposable insulin syringe 
reuse and aseptic practices in 
diabetic patients 
Title Outcome: not related to insulin treatment 
adherence 
 459. DKA management and 
outcomes 
Title Outcome: not related to insulin treatment 
adherence 
 460. Do European people with 
type 1 diabetes consume a high 
atherogenic diet? 7-year 
follow-up of the EURODIAB 
Prospective Complications 
Study. 
Title Outcome: not related to insulin treatment 
adherence 
 461. Do fat and protein need 
insulin? The complex food 
counting in meal-bolus 
calculation 
Title Outcome: not related to insulin treatment 
adherence 
 462. Do youth with type 1 
diabetes exercise safely? A 
focus on patient practices and 
glycemic outcomes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 463. Does high blood glucose 
mean more insulin? Type 1 
diabetes management in 
children and adolescents 
Title Outcome: not related to insulin treatment 
adherence 
 465. Does parental perception 
of their child's quality of life 
and diabetes knowledge 
matter in relation to improving 
glycaemic control? 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 466. Does patient behavior or 
access factors have the largest 
influence on screening in type 1 
diabetes? 
Title Outcome: not related to insulin treatment 
adherence 
 467. Does self-efficacy 
mediate the cross-sectional 
relationship between perceived 
quality of health care and self-
management of diabetes? 
Results from Diabetes MILES - 
Australia. 
Abstract Population: not children (adults/foetuses) 
 468. Durability of insulin pump 
use in pediatric patients with 
type 1 diabetes 
Full Text Outcome: not related to insulin treatment 
adherence 
 470. Dynamic regulation of 
plasma matrix 
metalloproteinases in human 
diabetic ketoacidosis 
Title Outcome: not related to insulin treatment 
adherence 
 472. Early age at menarche: a 
risk factor for overweight or 
obesity in patients with type 1 
diabetes living in urban areas? 
Title Outcome: not related to insulin treatment 
adherence 
 473. Early diabetic 
nephropathy in a pediatric 
renal transplant recipient 
leading to end stage renal 
disease 
Title Outcome: not related to insulin treatment 
adherence 
 474. Early feeding and risk of 
type 1 diabetes: Experiences 
from the Trial to Reduce 
Insulin-dependent diabetes 
mellitus in the Genetically at 
Risk (TRIGR) 
Title Outcome: not related to insulin treatment 
adherence 
 476. Early identification of 
monogenic diabetes: 
Implications on medical 
treatment and genetic 
counselling for an adolescent 
girl with MODY3 
Title Population: do not have T1DM 
 477. Early infant feeding and 
risk of developing type 1 
diabetes associated 
autoantibodies 
Title Outcome: not related to insulin treatment 
adherence 
 479. Early onset type 2 
diabetes mellitus in a Saudi 
child misdiagnosed as type 1 
diabetic: A case report. 
Title Population: do not have T1DM 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 480. Early pharmacokinetic 
and pharmacodynamic effects 
of mixing lispro with glargine 
insulin: Results of glucose 
clamp studies in youth with 
type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 482. Early presentation of type 
2 diabetes in Mexican-
American youth 
Title Population: do not have T1DM 
 484. Early risk factors for 
nonadherence in pediatric type 
1 diabetes: a review of the 
recent literature. 
Title Wrong study type (review, conference abstract 
etc.) 
 486. Early signs of 
atherosclerosis in diabetic 
children on intensive insulin 
treatment: A population-based 
study 
Title Outcome: not related to insulin treatment 
adherence 
 488. Eating disorders in 
adolescents with type 1 and 
type 2 diabetes mellitus: 
Prevelance and adherence to 
the regimen 
Abstract Wrong study type (review, conference abstract 
etc.) 
 489. Eating habits, body 
weight, and insulin misuse. A 
longitudinal study of teenagers 
and young adults with type 1 
diabetes. 
Abstract Population: not children (adults/foetuses) 
 490. Eating patterns in 
adolescents with type 1 
diabetes: Associations with 
metabolic control, insulin 




 491. Education and care in 
schooled diabetic children and 
adolescents 
Abstract Wrong study type (review, conference abstract 
etc.) 
 493. Educational program for 
patients with type-1 diabetes 
mellitus receiving free monthly 
supplies of insulin improves 
knowledge and attitude, but 
not adherence. 
Abstract Outcome: not related to insulin treatment 
adherence 
 494. Educational social games 
embedded in a telemonitoring 
tool for children with type 1 
diabetes: A preliminary paper 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 495. Educational strategies on 
insulin therapy for young 
people with diabetes mellitus: 
Systematic review 
Abstract Outcome: not related to insulin treatment 
adherence 
 496. Effect of dietary 
compliance on metabolic 
control in insulin-dependent 
diabetics 
Title Outcome: not related to insulin treatment 
adherence 
 497. Effect of fasting during 
Ramadan on different 
metabolic parameters and 
quality of life in type 1 diabetic 
patients 
Title Outcome: not related to insulin treatment 
adherence 
 498. Effect of gluten-free diet 
and adherence on growth and 
diabetic control in diabetics 
with coeliac disease 
Title Outcome: not related to insulin treatment 
adherence 
 500. Effect of health beliefs 
among physicians, families, 
and children with insulin-
dependent diabetes mellitus on 
treatment adherence and 
metabolic control 
Abstract Wrong study type (review, conference abstract 
etc.) 
 501. Effect of metformin on 
vascular function in children 
with type 1 diabetes: A 12-
month randomized controlled 
trial 
Title Outcome: not related to insulin treatment 
adherence 
 502. Effect of therapy with 
insulin glargine (lantus) on 
glycemic control in toddlers, 
children, and adolescents with 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 503. Effectiveness of a tailored 
medical support to overcome 
the barriers to education, 
treatment and good metabolic 
control in children with type-1 
diabetes from ethnic 
minorities. 
Abstract Outcome: not related to insulin treatment 
adherence 
 504. Effectiveness of 
lactobacillus reuteri oral 
administration on periodontal 
disease in children and 
adolescents with type 1 
diabetes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 505. Effectiveness of multiple 
daily injection or continuous 
infusion of insulin on children 
at different courses of T1DM 
Abstract Wrong study type (review, conference abstract 
etc.) 
 506. Effectiveness of sensor-
augmented pump therapy in 
children and adolescents with 
type 1 diabetes in the STAR 3 
study. 
Abstract Outcome: not related to insulin treatment 
adherence 
 507. Effectiveness of the 
sensor augmented pump in 
managing type i diabetes 
mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 508. Effects of a behavioral 
intervention on treatment 
adherence and stress 




 509. Effects of cognitive 
behavioural group training 
(CBGT) in adult patients with 
poorly controlled insulin-
dependent (type 1) diabetes: a 
pilot study. 
Title Population: not children (adults/foetuses) 
 510. Effects of diabetes em 
movimento community-based 
exercise program on body 
composition in patients with 
type 2 diabetes 
Title Population: do not have T1DM 
 511. Effects of enhanced 
conventional therapy on 
metabolic control in children 
with insulin-dependent 
diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 512. Effects of Lactobacillus 
rhamnosus GG and 
Bifidobacterium lactis Bb12 on 
beta-cell function in children 
with newly diagnosed type 1 
diabetes: A pilot study 
Title Outcome: not related to insulin treatment 
adherence 
 513. Efficacy and safety of 
insulin degludec in a flexible 
dosing regimen vs insulin 
glargine in patients with type 1 
diabetes (BEGIN: Flex T1): a 26-
week randomized, treat-to-
target trial with a 26-week 
extension. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 514. Efficacy and safety of the 
glucagon-like peptide-1 
receptor agonist liraglutide 
added to insulin therapy in 
poorly regulated patients with 
type 1 diabetes--a protocol for 
a randomised, double-blind, 
placebo-controlled study: the 
Lira-1 study. 
Title Outcome: not related to insulin treatment 
adherence 
 516. Efficacy of Humalog 
injections before an afternoon 
meal and their acceptance by 
children and adolescents with 
Type 1 diabetes 
Full Text Outcome: not related to insulin treatment 
adherence 
 518. Efficacy of Metformin 
Treatment with Respect to 
Weight Reduction in Children 
and Adults with Obesity: A 
Systematic Review 
Title Population: do not have T1DM 
 519. Efficacy of sensor-
augmented insulin pump with 
predictive low glucose 
suspension: A multicentre 
clinical experience in adults 
and children in Spain 
Abstract Outcome: not related to insulin treatment 
adherence 
 520. Efficacy of Thrice-daily 
versus Twice-daily Insulin 
Regimens on Glycohemoglobin 
(Hb A1c) in Type 1 Diabetes 
Mellitus: A Randomized 
Controlled Trial. 
Abstract Outcome: not related to insulin treatment 
adherence 
 521. Efficacy without barriers 
to insulin therapy: lessons from 
the BEGIN trial programme. 
Full Text Population: not children (adults/foetuses) 
 522. Efficacy, safety and 
acceptability of the new pen 
needle 33G?×?4?mm. AGO 01 
study. 
Title Outcome: not related to insulin treatment 
adherence 
 523. Efficacy, safety and 
acceptability of the new pen 
needle 34G?×?3.5?mm: a 
crossover randomized non-
inferiority trial; AGO 02 study. 
Title Outcome: not related to insulin treatment 
adherence 
 524. El cuidado de la diabetes 
mellitus insulino-dependiente: 
Efectos de un programa de 






Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 525. Elimination of dietary 
gluten does not reduce titers of 
type 1 diabetes-associated 
autoantibodies in high-risk 
subjects. 
Title Outcome: not related to insulin treatment 
adherence 
 526. Emotions and compliance 
in diabetic children 
Full Text Wrong study type (review, conference abstract 
etc.) 
 527. Empirical validation for a 
family-centered model of care 
Included 
 
 528. Endothelial cell-binding 
properties of lymphocytes 
infiltrated into human diabetic 
pancreas: Implications for 
pathogenesis of IDDM 
Title Outcome: not related to insulin treatment 
adherence 
 529. Endurance athletes and 
type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 530. Engagement with a Text-
Messaging Intervention 
Improves Adherence in 
Adolescents with Type 1 
Diabetes: Brief Report. 
Included 
 
 531. Engaging hispanic 
adolescents with type 2 
diabetes or obesity in 
personalized exercise 
Title Population: do not have T1DM 
 532. Entred-Ado study: Health, 
education and risk behaviours 
of adolescents with diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 533. Environmental factors 
affecting management of type 
1 diabetes in children below the 
age of 10. 
Included 
 
 534. Epidemiology and 
chelation therapy effects on 
glucose homeostasis in 
thalassaemic patients 
Title Population: do not have T1DM 
 535. Establishing a baseline for 
patients with type 1 diabetes 
who wear medical 
identification 
Title Outcome: not related to insulin treatment 
adherence 
 536. Estimation of secondary 
effect parameters in glycaemic 
dynamics using accumulating 
data from a virtual type 1 
diabetic patient. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 537. Evaluacion de un 
programa de atencion al 
diabetico. Estudio de 
continuidad a 40 
mesesEvaluation of a program 
for the care of the diabetic. A 
40-month continuity study 
Title Outcome: not related to insulin treatment 
adherence 
 538. Evaluating the 
carbohydrate counting method 
related to blood glucose 
monitoring habits in type 1 
diabetes mellitus patients 
Title Outcome: not related to insulin treatment 
adherence 
 539. Evaluating the impact of 
an insulin pump 
discontinuation action plan on 
patient or caregiver confidence 
and anxiety 
Abstract Outcome: not related to insulin treatment 
adherence 
 540. Evaluation of left 
ventricular diastolic function in 
insulin dependent diabetic 
children by M-mode and 
Doppler echocardiography 
Title Outcome: not related to insulin treatment 
adherence 
 542. Evaluation of the 
Adherence to Continuous 
Glucose Monitoring in the 
Management of Type 1 
Diabetes Patients on Sensor-
Augmented Pump Therapy: 
The SENLOCOR Study. 
Title Outcome: not related to insulin treatment 
adherence 
 544. Evaluation of the 
Carbohydrate, Insulin 
Collaborative Education 
(CHOICE) programme for 
young people with Type 1 
diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 545. Evaluation of the efficacy 
and tolerability of acarbose in 
patients with diabetes mellitus 
: a postmarketing surveillance 
study. 
Title Outcome: not related to insulin treatment 
adherence 
 546. Evaluation of the 
juniorSTAR half-unit insulin pen 
in young people with type 1 





Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 548. Evaluation of the 
knowledge and skills on self-
monitoring blood glucose in 
patients and caregivers of 
patients with diabetes mellitus 
type 1 
Title Outcome: not related to insulin treatment 
adherence 
 549. Evaluation of the 
treatment of diabetic 
ketoacidosis in the medical 
intensive care unit 
Title Outcome: not related to insulin treatment 
adherence 
 550. Evaluation of treatment 
adherence in type 1 diabetes: A 
novel approach 
Abstract Outcome: not related to insulin treatment 
adherence 
 552. Evidence for early stage 
atherosclerosis and low grade 
inflammation in diabetic 
children on intensive insulin 
treatment: A population based 
study 
Title Outcome: not related to insulin treatment 
adherence 
 553. Evolution of the diabetic 
diet: Fats and fallacies. 
Title Outcome: not related to insulin treatment 
adherence 
 554. Examining concurrent 
validity of the mealtime BOLUS 
score with common 
psychosocial correlates of 
adherence in youth 
Abstract Wrong study type (review, conference abstract 
etc.) 
 555. Executive functioning, 
parenting stress, and family 
factors as predictors of 
diabetes management in 
pediatric patients with type 1 




 556. Exercise capacity in 
healthy pubertal children in 
comparison with type 1 
diabetic pubertal children 
Title Outcome: not related to insulin treatment 
adherence 
 557. Exercise equipment and 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 558. Exercise therapy: 
prevention and treatment of 
disease 
Title Outcome: not related to insulin treatment 
adherence 
 559. Exercise to preserve beta 
cell function in recent-onset 
type 1 diabetes mellitus 
(EXTOD)--a study protocol for a 
pilot randomized controlled 
trial. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 560. Exercise to preserve ß-cell 
function in recent-onset Type 1 
diabetes mellitus (EXTOD) - a 
randomized controlled pilot 
trial. 
Title Outcome: not related to insulin treatment 
adherence 
 561. Exercise training and 
glycemic control in adolescents 
with poorly controlled type 1 
diabetes mellitus. 
Title Outcome: not related to insulin treatment 
adherence 
 562. Experience with the Enlite 
sensor in a multicenter 
pediatric study. 
Title Outcome: not related to insulin treatment 
adherence 
 563. Experiences and real life 
management of insulin pump 
therapy in adults with type 1 
diabetes. 
Title Population: not children (adults/foetuses) 
 564. Experiences in diabetes 
management: Interviews with 
children with type 2 diabetes 
and their caregivers 
Title Population: do not have T1DM 
 565. Experimental cannabidiol 
treatment reduces early 
pancreatic inflammation in 
type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 566. Expert Study: Utility of an 
Automated Bolus Advisor 
System in Patients with Type 1 
Diabetes Treated with Multiple 
Daily Injections of Insulin-A 
Crossover Study. 
Full Text Population: not children (adults/foetuses) 
 567. Explanatory style in 
parents and insulin-dependent 
diabetic children in relation to 
depressive symptoms, 
compliance and metabolic 
control 
Abstract Wrong study type (review, conference abstract 
etc.) 
 568. Exploring factors 
influencing HbA1c and 
psychosocial outcomes in 
people with type 1 diabetes 
after training in advanced 
carbohydrate counting. 
Full Text Population: not children (adults/foetuses) 
 569. Exploring the motivations 
behind misreporting self-
measured blood glucose in 
adolescents with type 1 
diabetes - a qualitative study 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 571. Expressed emotion and 
warmth: Extending the EE 
contrast to insulin-dependent 
diabetes mellitus 
Full Text Outcome: not related to insulin treatment 
adherence 
 572. Extremely elevated 
triglyceride blood 
concentration as a 
presentation of type 2 diabetes 
mellitus (T2DM) in childhood 
obesity 
Title Population: do not have T1DM 
 573. Exubera(®) (inhaled 
insulin): an evidence-based 
review of its effectiveness in 
the management of diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 574. Facteurs lies a l'evolution 
des connaissances du diabete 
de l'enfance a 
l'adolescenceFactors 
associated with change in 
diabetes knowledge from 
childhood to adolescence 
Abstract Outcome: not related to insulin treatment 
adherence 
 575. Factitious self-
manipulation of the external 
insulin pump in adolescents 
with Type 1 diabetes. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 576. Factores Psicológicos y 
Sociales Asociados a la 
Adherencia al Tratamiento en 
Adolescentes Diabéticos Tipo 1 
    
 577. Factors associated to 
adherence to blood glucose 
self-monitoring in patients with 
diabetes treated with insulin. 
The dapa study. 
Title Outcome: not related to insulin treatment 
adherence 
 578. Factors associated with 
adherence to continuous 
subcutaneous insulin infusion 
in pediatric diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 580. Factors associated with 
adherence to diabetes care 
recommendations among 
children and adolescents with 
type 1 diabetes: A facility-
based study in two urban 
diabetes clinics in Uganda 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 581. Factors associated with 
glycemic control in children and 
adolescents with type 1 
diabetes mellitus at a tertiary-
care center in Thailand: A 
retrospective observational 
study 
Title Outcome: not related to insulin treatment 
adherence 
 584. Factors associated with 
glycemic control: A cross-
sectional nationwide study in 
2,579 french children with type 
1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 585. Factors associated with 
having eye examinations in 
persons with diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 586. Factors associated with 
high levels of glycated 
haemoglobin in patients with 
type 1 diabetes: a multicentre 
study in Brazil. 
Title Outcome: not related to insulin treatment 
adherence 
 587. Factors associated with 
increased risk of insulin pump 
discontinuation in pediatric 
patients with type 1 diabetes. 
Full Text Outcome: not related to insulin treatment 
adherence 
 588. Factors associated with 
non-adherence to insulin in 
patients with type 1 diabetes. 
Full Text Population: not children (adults/foetuses) 
 590. Factors associated with 
shared decision-making in 
pediatric type 1 diabetes: The 
search for diabetes in youth 
study 
Title Outcome: not related to insulin treatment 
adherence 
 591. Factors influencing the 
quality of glycemic control in 
children and adolescents with 
type 1 diabetes, after five years 
of full and equal access of self-
monitoring supplies 
Title Outcome: not related to insulin treatment 
adherence 
 592. Factors related to CSII 
compliance 
Full Text Population: not children (adults/foetuses) 
 593. Failure to achieve target 
glycaemic control on 
continuous subcutaneous 
insulin infusion (CSII) - Is 
passive pumping to blame? 
Abstract Wrong study type (review, conference abstract 
etc.) 
 594. Familial idiopathic 
oedema in prepubertal 
children: A new syndrome 
Title Population: do not have T1DM 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 595. Family and disease 
management in young type 1 
diabetic patients. 
Abstract Outcome: not related to insulin treatment 
adherence 
 596. Family conflict, 
adherence, and glycaemic 
control in youth with short 
duration Type 1 diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 597. Family factors involved in 
insulin-dependent diabetes 
mellitus: Metabolic control and 
compliance 
Abstract Wrong study type (review, conference abstract 
etc.) 
 598. Family physicians' and 
general practitioners' 
approaches to drug 
management of diabetic 
hypertension in primary care 
Title Outcome: not related to insulin treatment 
adherence 
 599. Family-based behavior 
therapy for diabetic 
adolescents 
Abstract Wrong study type (review, conference abstract 
etc.) 
 600. Faster pharmacokinetics 
and increased patient 
acceptance of intradermal 
insulin delivery using a single 
hollow microneedle in children 




 602. Father-absent 
adolescents with insulin-
dependent diabetes mellitus: A 
population at risk? 
Included 
 
 603. Fatores associados a 
auto-aplicacao da insulina nos 
usuarios com diabetes mellitus 
acompanhados pela Estrategia 
Saude da FamiliaFactors 
associated with insulin self-
administration by diabetes 
mellitus patients in the Family 
Health Strategy 
Full Text Population: not children (adults/foetuses) 
 604. Fear of driving license 
withdrawal in patients with 
insulin-treated diabetes 
mellitus negatively influences 
their decision to report severe 
hypoglycemic events to 
physicians. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 605. Fear of hypoglycemia in 
adults with type 1 diabetes: 
impact of therapeutic advances 
and strategies for prevention - 
a review. 
Title Population: not children (adults/foetuses) 
 606. Fear of hypoglycemia in 
type 1 diabetes managed by 
continuous subcutaneous 
insulin infusion: is it associated 
with poor glycemic control? 
Full Text Population: not children (adults/foetuses) 
 607. Feasibility of a mobile 
phone-based data service for 
functional insulin treatment of 
type 1 diabetes mellitus 
patients. 
Abstract Population: not children (adults/foetuses) 
 608. Feasibility of an online 
intervention (STAK-D) to 
promote physical activity in 
children with type 1 diabetes: 
Protocol for a randomised 
controlled trial 
Title Outcome: not related to insulin treatment 
adherence 
 609. Feasibility of genetic and 
immunological prediction of 
Type I diabetes in a population-
based birth cohort 
Title Outcome: not related to insulin treatment 
adherence 
 610. First 20 months' 
experience with use of 
mefformin for type 2 diabetes 
in a large health maintenance 
organization 
Title Population: do not have T1DM 
 611. Flexible insulin dosing 
improves health-related 
quality-of-life (HRQoL): a time 
trade-off survey. 
Full Text Population: not children (adults/foetuses) 
 613. Frequency and motives of 
blood glucose self-monitoring 
in type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 614. Frequency and reasons 
for CSII discontinuation in 
children and young patients 
with T1DM 
Abstract Wrong study type (review, conference abstract 
etc.) 
 615. Frequency of blood 
glucose monitoring in relation 
to glycaemic control: 
observational study with 
diabetes database. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 616. Frequency of blood 
glucose testing in well 
educated patients with 
diabetes mellitus type 1: how 
often is enough? 
Title Outcome: not related to insulin treatment 
adherence 
 617. Frequency of diabetic 
keto-acidosis in children with 
cystic fibrosis related diabetes 
Title Population: do not have T1DM 
 618. Frequency of mealtime 
insulin bolus as a proxy 
measure of adherence for 
children and youths with type 1 
diabetes mellitus 
Abstract Outcome: not related to insulin treatment 
adherence 
 620. Frequency of mealtime 
insulin bolus predicts glycated 
hemoglobin in youths with type 
1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 622. Frequency of Missed 
Insulin Boluses in Type 1 
Diabetes and Its Impact on 
Diabetes Control. 
Title Outcome: not related to insulin treatment 
adherence 
 623. Function of the growth 
hormone-insulin-like growth 
factor I axis in the profoundly 
growth-retarded diabetic child: 
Evidence for defective target 
organ responsiveness in the 
mauriac syndrome 
Title Outcome: not related to insulin treatment 
adherence 
 624. Functional and 
psychosocial ramifications of 
type 1 diabetes mellitus in 
pediatric endocrinology 
Abstract Wrong study type (review, conference abstract 
etc.) 
 625. Fungal esophagitis in a 
child with insulin diabetes 
dependent mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 626. Further examination of a 
structured adherence interview 
of diabetes for children, 
adolescents, and parents 
Abstract Outcome: not related to insulin treatment 
adherence 
 627. Generic and disease-
specific quality of life in 
adolescents with type 1 
diabetes: comparison to age-
matched healthy peers. 
Abstract Outcome: not related to insulin treatment 
adherence 
 628. Gluten-free diet in 
children with recent-onset type 
1 diabetes without coeliac 
disease: A 12-month 
intervention trial 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 629. Gluten-free diet in newly 
diagnosed children with type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 630. Glycaemic control and 
associated factors in a 
population of children and 
adolescents living with type 1 
diabetes in Cameroon 
Title Outcome: not related to insulin treatment 
adherence 
 631. Glycaemic control in a 
type 1 diabetes clinic for 
younger adults. 
Title Population: not children (adults/foetuses) 
 632. Glycaemic control in type 
1 diabetes mellitus among 
children and adolescents in a 
resource limited setting in Dar 
es Salaam - Tanzania. 
Abstract Outcome: not related to insulin treatment 
adherence 
 634. Glycaemic control of 
insulin-dependent diabetes 




 635. Glycaemic control of Type 
1 diabetes in clinical practice 
early in the 21st century: an 
international comparison. 
Title Outcome: not related to insulin treatment 
adherence 
 636. Glycemic and lactate 
thresholds during incremental 
effort test in pubertal children 
with type 1 diabetes compared 
with healthy controls 
Title Outcome: not related to insulin treatment 
adherence 
 637. Glycemic control and 
associated factors among type 
2 diabetic patients at Shanan 
Gibe Hospital, Southwest 
Ethiopia 
Title Population: do not have T1DM 
 638. Glycemic control and 
correlates in a group of sub 
Saharan type 1 diabetes 
adolescents. 
Title Outcome: not related to insulin treatment 
adherence 
 639. Glycemic control and 
executive function in 
adolescents with type 1 
diabetes (T1d) 
Abstract Wrong study type (review, conference abstract 
etc.) 
 640. Glycemic control in adult 
type 1 diabetes patients from a 
brazilian country city: 
comparison between a 
multidisciplinary and a routine 
endocrinological approach. 
Title Population: not children (adults/foetuses) 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 641. Glycemic control with 
metformin or insulin therapy in 
adolescents with type 2 
diabetes mellitus 
Title Population: do not have T1DM 
 642. Glycemic management 
using simple continuous 
subcutaneous insulin infusion 
in patients with type 2 diabetes 
Title Population: do not have T1DM 
 643. Glycemic outcomes and 
system adherence between 
age groups in pediatric subjects 
using a hybrid closed-loop 
pump 
Abstract Wrong study type (review, conference abstract 
etc.) 
 644. Glycemic variability: A 
peril of modern insulin therapy 
among youths with type 1 
diabetes? 
Title Outcome: not related to insulin treatment 
adherence 
 645. Glycosylated hemoglobin 
feedback profile as one 
behavioral strategy for 
improving adherence to long-
term regimens: Insulin 
dependent diabetes mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 646. Good adherence to the 
Mediterranean diet reduces 
the risk for NASH and diabetes 
in pediatric patients with 
obesity: The results of an 
Italian Study 
Title Outcome: not related to insulin treatment 
adherence 
 647. Good cop, bad cop: 
quality of parental involvement 
in type 1 diabetes 
management in youth. 
Abstract Wrong study type (review, conference abstract 
etc.) 
 648. Growth and body 
composition in type 1 diabetes 
mellitus. 
Title Outcome: not related to insulin treatment 
adherence 
 650. Growth monitoring in 
management of T1DM children 
from low-sosioeconomic status 
Title Outcome: not related to insulin treatment 
adherence 
 651. Health status, regimen 
adherence, and psychosocial 
functioning of minority youth 
with type 2 diabetes 
Title Population: do not have T1DM 
 652. Health-related quality of 
life (HRQOL) and its associated 
factors in children with Type 1 
Diabetes Mellitus (T1DM) 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 653. Health-related quality of 
life and its associated factors in 
children with type 1 diabetes 
mellitus 
    
 654. Health-Related Stigma in 
Young Adults With Type 1 
Diabetes Mellitus. 
Title Population: not children (adults/foetuses) 
 655. Health-risk behaviors and 
type 1 diabetes outcomes in 
the transition from late 




 656. Healthcare costs and 
adherence associated with 
human regular U-500 versus 
high-dose U-100 insulin in 
patients with diabetes. 
Full Text Population: not children (adults/foetuses) 
 657. Helicobacter pylori 
infection and insulin 
requirement among children 
with type 1 diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 659. Help 'difficult' 
adolescents with type 1 
diabetes to improve metabolic 
control: The peter pan project 
Abstract Outcome: not related to insulin treatment 
adherence 
 660. Hepatic glycogenosis, a 
rare cause of hepatomegaly 
and abnormal liver enzymes in 
type 1 diabetes mellitus: A case 
report 
Title Outcome: not related to insulin treatment 
adherence 
 661. High intrapatient 
variability of calcineurin 
inhibitor levels is associated 
with post-transplant diabetes 
mellitus in pediatric kidney 
transplant 
Title Population: do not have T1DM 
 662. High-risk youth with 
diabetes need home-based 
behavioral interventions 
Abstract Wrong study type (review, conference abstract 
etc.) 
 663. Home-based behavioral 
health intervention: Use of a 
telehealth model to address 
poor adherence to type-1 
diabetes medical regimens 
Full Text Outcome: not related to insulin treatment 
adherence 
 665. Home-based 
management can achieve 
intensification cost-effectively 
in type 1 diabetes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 666. Hope and mealtime 
insulin boluses are associated 
with depressive symptoms and 
glycemic control in youth with 
type 1 diabetes mellitus 
Included 
 
 667. Hospitalization of 
diabetics 12-30 years of age in 
Kuwait: Patients' 
characteristics, and frequency 
and reasons for admission 
Title Outcome: not related to insulin treatment 
adherence 
 668. How diabetes specialists 
treat their own diabetes: 
findings from a study of the 
AADE and ADA membership. 
Title Population: not children (adults/foetuses) 
 669. How do we educate 
young people to balance 
carbohydrate intake with 
adjustments of insulin? 
Abstract Outcome: not related to insulin treatment 
adherence 
 670. How effective are trained 
dogs at alerting their owners to 
changes in blood glycaemic 
levels?: Variations in 
performance of glycaemia alert 
dogs. 
Title Outcome: not related to insulin treatment 
adherence 
 671. How much do forgotten 
insulin injections matter to 
hemoglobin a1c in people with 
diabetes? A simulation study. 
Abstract Outcome: not related to insulin treatment 
adherence 
 672. How poorer quality of life 
in adolescence predicts 
subsequent type 1 diabetes 
management and control. 
Abstract Outcome: not related to insulin treatment 
adherence 
 673. How useful are serum 
IGF-I measurements for 
managing GH replacement 
therapy in adults and children? 
Title Outcome: not related to insulin treatment 
adherence 
 674. Huge transient elevation 
of liver enzymes during diabetic 
ketoacidosis 
Title Outcome: not related to insulin treatment 
adherence 
 675. Human Factors and Data 
Logging Processes With the 
Use of Advanced Technology 
for Adults With Type 1 
Diabetes: Systematic 
Integrative Review. 
Title Population: not children (adults/foetuses) 
 676. Human factors associated 
with continuous glucose 
monitor use in patients with 
diabetes: A systematic review 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 677. Hydrolyzed infant 
formula and early beta-cell 
autoimmunity 
Title Outcome: not related to insulin treatment 
adherence 
 678. Hyperglycaemia and 
metabolic syndrome: Not 
always synonymous of T2D 
Title Outcome: not related to insulin treatment 
adherence 
 679. Hyperglycaemic 
emergencies are a common 
problem 
Title Outcome: not related to insulin treatment 
adherence 
 680. Hypoglycaemia and 
counterregulation during 
childhood. 
Title Outcome: not related to insulin treatment 
adherence 
 682. Hypoglycaemia and 
driving in people with insulin-
treated diabetes: adherence to 
recommendations for 
avoidance. 
Title Outcome: not related to insulin treatment 
adherence 
 683. Hypoglycaemia in type 1 
diabetes: technological 
treatments, their limitations 
and the place of psychology. 
Abstract Outcome: not related to insulin treatment 
adherence 
 684. Hypoglycemia and 
ketoacidosis with insulin pump 
therapy in children and 
adolescents 
Abstract Outcome: not related to insulin treatment 
adherence 
 685. Hypoglycemia 
unawareness is associated with 
reduced adherence to 
therapeutic decisions in 
patients with type 1 diabetes: 
evidence from a clinical audit. 
Full Text Population: not children (adults/foetuses) 
 686. Hypoglycemic episodes in 
an adolescent with diabetes 
type 1: A case report and a 
review of the literature 
Title Outcome: not related to insulin treatment 
adherence 
 687. Hypothalamic obesity: 
Pathogenesis and natural 
history 
Title Population: do not have T1DM 
 688. I get by with a little help 
from my family and friends: 




 689. I know, so i do! 
Relationship between literacy 
and metabolic control in 
patients with type i diabetes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 690. Identification of clinically 
relevant dysglycemia 
phenotypes based on 
continuous glucose monitoring 
data from youth with type 1 
diabetes and elevated 
hemoglobin A1c 
Title Outcome: not related to insulin treatment 
adherence 
 691. Identifying and 
preventing eating disorders in 
youth with diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 692. Identity and treatment 
adherence in predominantly 
ethnic minority teens and 
young adults with type 1 
diabetes 
Full Text Outcome: not related to insulin treatment 
adherence 
 693. Illness perceptions and 
self efficacy beliefs in 
adolescents and young adults 




 694. Illness representations 
and glycemic control in 
adolescents with type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 695. Illness representations 
predict adherence in 
adolescents and young adults 
with type 1 diabetes 
Included 
 
 697. Illness specific self-
esteem in adolescents with 
type 1 diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 698. Illness-Specific Risk-
Taking in Adolescence: A 
Missing Piece of the 
Nonadherence Puzzle for Youth 
With Type 1 Diabetes? 
Full Text Wrong study type (review, conference abstract 
etc.) 
 699. Immediate management 
of diabetic ketoacidosis (DKA) 
in the emergency department 
(ED): What needs 
improvement? 
Title Outcome: not related to insulin treatment 
adherence 
 700. Immune responses to an 
encapsulated allogeneic islet 
beta-cell line in diabetic NOD 
mice. 
Title Outcome: not related to insulin treatment 
adherence 
 701. Immunotherapy-based 
strategies for the treatment of 
autoimmune diabetes: 
searching for the cure. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 702. Impact of a high-
monounsaturated-fat diet on 
lipid profile in subjects with 
type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 703. Impact of a serious 
videogame designed for 
flexible insulin therapy on the 
knowledge and behaviors of 
children with type 1 diabetes: 
The LUDIDIAB pilot study 
Full Text Outcome: not related to insulin treatment 
adherence 
 705. Impact of ambulatory, 
family-focused teamwork 
intervention on glycemic 
control in youth with type 1 
diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 706. Impact of combination 
therapy with dulaglutide and 
SGLT2i on vascular age, an 
indicator of cardiovascular risk, 
in Indian adults with type 2 
diabetes: A real-world study 
Title Population: not children (adults/foetuses) 
 707. Impact of disease-
management programs on 
metabolic control in patients 
with type 1 diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 708. Impact of elective 
hospital admissions on 
glycaemic control in 
adolescents with poorly 
controlled type 1 diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 709. Impact of family 
environment and support on 
adherence, metabolic control, 
and quality of life in 
adolescents with diabetes. 
Included 
 
 710. Impact of family factors 
on metabolic control and on 
regimen adherence in type 1 
diabetes among Hispanic and 
African-American adolescents 
Abstract Wrong study type (review, conference abstract 
etc.) 
 711. Impact of long-term use 
of eHealth systems in 
adolescents with type 1 
diabetes treated with sensor-
augmented pump therapy 
Full Text Outcome: not related to insulin treatment 
adherence 
 713. Impact of nutrition on 
type 1 diabetes management 
and outcomes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 714. Impact of patient 
education on diabetic distress 
& clinical outcomes in type II 
diabetes mellitus patients 
Title Population: do not have T1DM 
 715. Impact of psychology 
services in an integrated 
pediatric endocrinology clinic 
Abstract Wrong study type (review, conference abstract 
etc.) 
 716. Impact of SMBG on 
control of diabetes as 
measured by HbA1. 3-yr Survey 
of a juvenile IDDM clinic 
Title Outcome: not related to insulin treatment 
adherence 
 717. Impact of telemedicine in 
managing type 1 diabetes 
among school-age children and 
adolescents: an integrative 
review. 
Abstract Outcome: not related to insulin treatment 
adherence 
 718. Impact of type 1 diabetes 
mellitus and celiac disease on 
nutrition and quality of life. 
Title Outcome: not related to insulin treatment 
adherence 
 719. Impacto psicosocial de la 
diabetes mellitus tipo 1 en 
ninos, adolescentes y sus 
familias. Revision de la 
literaturaPsychosocial impact 
of type 1 diabetes mellitus in 
children, adolescents and their 
families. Literature review 
Title Wrong study type (review, conference abstract 
etc.) 
 720. Impaired absorption and 
omission of insulin: a novel 
method of detection using the 
diabetes advisory system 
computer model. 
Abstract Population: not children (adults/foetuses) 
 721. Impaired awareness of 
hypoglycemia in children and 
adolescents with type 1 
diabetes mellitus in north of 
Jordan 
Title Outcome: not related to insulin treatment 
adherence 
 722. Impaired left-ventricular 
function in insulin-dependent 
diabetic patients with 
increased urinary albumin 
excretion. 
Title Outcome: not related to insulin treatment 
adherence 
 723. Implementation of a 
multicomponent process to 
obtain informed consent in the 
Diabetes Control and 
Complications Trial. The DCCT 
Research Group. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 724. Implementation of 
treatment protocols in the 
diabetes control and 
complications trial 
Title Outcome: not related to insulin treatment 
adherence 
 725. Implementing a pathway 
for the investigation of Cystic 
Fibrosis-Related Diabetes in a 
paediatric cystic fibrosis clinic 
Title Population: do not have T1DM 
 726. Importancia de los 
sistemas de informacion en 
programas de salud publica: 
bases de datos de pacientes 
diabeticos[Importance of the 
information systems in public 
health programs: diabetic 
patients databases] 
Title Outcome: not related to insulin treatment 
adherence 
 727. Important determinants 
of diabetes control in insulin 
pump therapy in patients with 
type 1 diabetes mellitus 
Abstract Outcome: not related to insulin treatment 
adherence 
 729. Improper Insulin 
Compliance May Lead to 
Hepatomegaly and Elevated 
Hepatic Enzymes in Type 1 
Diabetic Patients [7] 
Full Text Outcome: not related to insulin treatment 
adherence 
 730. Improper insulin 
compliance may lead to 
hepatomegaly and elevated 
hepatic enzymes in type 1 
diabetic patients: Response to 
Yu and Howard [8] 
Abstract Wrong study type (review, conference abstract 
etc.) 
 731. Improved BMI in long-
term tube-fed pediatric 
patients with use of a clinic 
survey 
Title Population: do not have T1DM 
 732. Improved glycemic 
control and acute 
complications among children 
with type 1 diabetes mellitus in 
Moshi, Tanzania. 
Title Outcome: not related to insulin treatment 
adherence 
 733. Improvement of diabetic 
control and acceptability of a 
three-injection insulin regimen 
in diabetic adolescents: A 
multicenter controlled study 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 734. Improvement of the 
compliance with blood glucose 
monitoring in young insulin-
dependent diabetes mellitus 
patients by the Sensorlink(TM) 
system 
Title Outcome: not related to insulin treatment 
adherence 
 735. Improving adherence to 
blood glucose testing in insulin-
dependent diabetic children 
Title Outcome: not related to insulin treatment 
adherence 
 736. Improving care for 
pediatric diabetic ketoacidosis 
Title Outcome: not related to insulin treatment 
adherence 
 737. Improving children's 
compliance with diabetes 
management 
Full Text Wrong study type (review, conference abstract 
etc.) 
 738. Improving compliance 
with exercise in adolescents 
with insulin-dependent 
diabetes mellitus: results of a 
self-motivated home exercise 
program. 
Title Outcome: not related to insulin treatment 
adherence 
 739. In adult patients with 
type 1 diabetes healthy lifestyle 
associates with a better 
cardiometabolic profile. 
Title Population: not children (adults/foetuses) 
 740. In pursuit of excellence in 
diabetes care: trends in insulin 
delivery. 
Full Text Outcome: not related to insulin treatment 
adherence 
 741. In situ simulation-based 
study to determine adherence 
to pediatric diabetic 
ketoacidosis management 
guidelines 
Title Outcome: not related to insulin treatment 
adherence 
 742. In vitro-generation of 
surrogate islets from adult 
stem cells. 
Title Outcome: not related to insulin treatment 
adherence 
 744. In vivo microscopy of 
murine islets of Langerhans: 
increased adhesion of 
transferred lymphocytes to 
islets depends on macrophage-
derived cytokines in a model of 
organ-specific insulitis. 
Title Outcome: not related to insulin treatment 
adherence 
 745. In-home nighttime 
predictive low glucose suspend 
experience in children and 
adults with type 1 diabetes. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 746. Incidence and prevalence 
of insulin-dependent diabetes 
mellitus in the zero- to 19-
years' age-group in Sydney 
Title Outcome: not related to insulin treatment 
adherence 
 747. Incidence of symptomatic 
mild hypoglycaemic events: A 
prospective study in adult 
patients with insulin-treated 
diabetes mellitus using a 
portable microcomputer-based 
data-logger 
Title Population: not children (adults/foetuses) 
 748. Incorporating Long-
Acting Insulin Glargine into the 
UVA/ Padova Type 1 Diabetes 
Simulator for In Silico Testing of 
MDI Therapies. 
Title Outcome: not related to insulin treatment 
adherence 
 749. Increasing the adherence 
of diabetic adolescents. 
Full Text Population: not children (adults/foetuses) 
 750. Individualized growth 
hormone therapy in children: 
Advances beyond weight-
based dosing 
Title Population: do not have T1DM 
 751. Influence of food 
consumption in glycemic 
control and the 
cardiometabolic risk of children 
and adolescents with diabetes 
mellitus type 1 
Title Outcome: not related to insulin treatment 
adherence 
 752. Influence of imaginative 
teaching of diet on compliance 
and metabolic control in insulin 
dependent diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 753. Influence of intensive 
education coupled with 
counseling on glycosylated 
hemoglobin levels and other 
parameters of diabetes control 
in pediatric patients with type 1 
diabetes mellitus in India 
Abstract Outcome: not related to insulin treatment 
adherence 
 754. Inhaled human insulin. Title Outcome: not related to insulin treatment 
adherence 
 755. Inhaled insulin in diabetes 
mellitus. 
Title Outcome: not related to insulin treatment 
adherence 
 757. Inhaled insulin: overview 
of a novel route of insulin 
administration. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 758. Inhaled therapy: A 
commercial success but a 
therapeutic embarrassment. 
Are we seeing the first signs of 
change? << plus ca change, 
plus c'est la meme chose >> 
Title Outcome: not related to insulin treatment 
adherence 
 759. Injection distress, quality 
of life and treatment 
adherence in a sample of youth 
with type 1 diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 760. Insights into the 
percutaneous penetration of 
antidiabetic agents. 
Abstract Outcome: not related to insulin treatment 
adherence 
 761. Institution of basal-bolus 
therapy at diagnosis for 
children with type 1 diabetes 
mellitus. 
Abstract Outcome: not related to insulin treatment 
adherence 
 762. Insulin adherence 
behaviours and barriers in the 
multinational Global Attitudes 
of Patients and Physicians in 
Insulin Therapy study. 
Full Text Population: not children (adults/foetuses) 
 763. Insulin adherence in 
patients with diabetes: Risk 
factors for injection omission 
Full Text Population: not children (adults/foetuses) 
 764. Insulin administration 
and the impacts of forgetting a 
dose. 
Abstract Population: not children (adults/foetuses) 
 766. Insulin allergy can be 
successfully managed by a 
systematic approach 
Title Outcome: not related to insulin treatment 
adherence 
 767. Insulin bolus dose 
calculator: A web app to create 
an insulin dose spreadsheet 
Abstract Wrong study type (review, conference abstract 
etc.) 
 768. Insulin bolusing software: 
The potential to optimize 




 770. Insulin delivery by 
injection in children and 
adolescents with diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 772. Insulin delivery using 
hollow microneedles in children 
with type 1 diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 773. Insulin dependent 
diabetes mellitus: Regimen 





Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 774. Insulin detemir in a twice 
daily insulin regimen versus a 
three times daily insulin 
regimen in the treatment of 
type 1 diabetes in children: A 
pilot randomized controlled 
trial 
Full Text Outcome: not related to insulin treatment 
adherence 
 776. Insulin for children, 
education for the life 
Abstract Wrong study type (review, conference abstract 
etc.) 
 777. Insulin glargine 300 U/mL 
in the management of 
diabetes: clinical utility and 
patient perspectives. 
Abstract Outcome: not related to insulin treatment 
adherence 
 778. Insulin Injection 
Technique Questionnaire: 
results of an international 
study comparing Brazil, Latin 
America and World data. 
Full Text Population: not children (adults/foetuses) 
 779. Insulin manipulation as 
an indicator of psychiatric 
comorbidity in children and 
adolescents with type 1 
diabetes mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 780. Insulin omission in 
women with IDDM 
Full Text Population: not children (adults/foetuses) 
 781. Insulin pen use and 
diabetes treatment goals: A 
study from Iran STEPS 2016 
survey 
Abstract Population: not children (adults/foetuses) 
 782. Insulin Pump Adherence 
Behaviors Do Not Correlate 
With Glycemic Variability 
Among Youth With Type 1 
Diabetes (T1D). 
Full Text Outcome: not related to insulin treatment 
adherence 
 783. Insulin pump at the onset 
of type 1 diabetes: An 
expensive toy or a wise choice? 
Abstract Outcome: not related to insulin treatment 
adherence 
 784. Insulin Pump Combined 
with Flash Glucose Monitoring: 
A Therapeutic Option to 
Improve Glycemic Control in 
Severely Nonadherent Patients 
with Type 1 Diabetes. 
Full Text Population: not children (adults/foetuses) 
 785. Insulin pump therapy - 
Practical aspects 
Abstract Outcome: not related to insulin treatment 
adherence 
 786. Insulin Pump Therapy for 
Type 1 Diabetes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 787. Insulin pump therapy in 
Type 1 pediatric patients: Now 
and into the year 2000 
Abstract Wrong study type (review, conference abstract 
etc.) 
 788. Insulin pump use in young 
adolescents with type 1 
diabetes: A descriptive study 
Abstract Outcome: not related to insulin treatment 
adherence 
 790. Insulin Pumps in Type 1 
Diabetes with Mental 
Disorders: Real-Life Clinical 
Data Indicate Discrepancies to 
Recommendations. 
Abstract Outcome: not related to insulin treatment 
adherence 
 791. Insulin resistance: Policy 
plan to address burning issue 
by NGO from rural India 
Title Outcome: not related to insulin treatment 
adherence 
 792. Insulin therapy during 
diabetic ketoacidosis in 
children 
Title Outcome: not related to insulin treatment 
adherence 
 793. Insulin therapy in Europe. Abstract Outcome: not related to insulin treatment 
adherence 
 794. Insulin therapy in type 2 
diabetes for physicians and 
practitioners. 
Title Population: do not have T1DM 
 795. Insulin therapy regimens 
in paediatric age 
Abstract Outcome: not related to insulin treatment 
adherence 
 796. Insulin withholding for 
weight control in women with 
diabetes 
Full Text Population: not children (adults/foetuses) 
 797. Insulin-coated gold 
nanoparticles as a new concept 
for personalized and adjustable 
glucose regulation. 
Title Outcome: not related to insulin treatment 
adherence 
 798. Insulin-dependent 
diabetes mellitus in childhood 
Abstract Wrong study type (review, conference abstract 
etc.) 
 799. Insulin-induced oedema 
in a patient with diabetes 
mellitus complicated by 
ketoacidosis 
Title Outcome: not related to insulin treatment 
adherence 
 801. Insulin-treated diabetes 
patients with fear of self-
injecting or fear of self-testing: 
psychological comorbidity and 
general well-being. 
Abstract Population: not children (adults/foetuses) 
 802. Integrated insulin pump 
therapy with continuous 
glucose monitoring for 
improved adherence: 
technology update. 
Abstract Population: not children (adults/foetuses) 
319 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 803. Intensive diabetes 
education program and 
multidisciplinary team 
approach in management of 
newly diagnosed type 1 
diabetes mellitus: a greater 
patient benefit, experience at 
Siriraj Hospital. 
Abstract Outcome: not related to insulin treatment 
adherence 
 804. INTENSIVIERTE INSULIN-
THERAPIE BEI ADOLESZENTEN 
MIT DIABETES MELLITUS TYP I: 




insulin therapy in adolescents 
with type I diabetes mellitus: 
First experience with insulin 
pen 
Full Text Population: not children (adults/foetuses) 




GRUNDE FUR DAS VERSAGEN 
DIESES 
THERAPIEKONZEPTESIntensifie
d conventional insulin 
treatment: Long-term results 
and reasons for failure of this 
treatment concept 
Abstract Outcome: not related to insulin treatment 
adherence 
 806. Interaction of pubertal 
development and metabolic 
control in 1303 adolescents 
with diabetes mellitus type 1 
Title Outcome: not related to insulin treatment 
adherence 
 807. Interdisciplinary 
education group in type 1 
diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 808. Interim report on the 
effective intraperitoneal 
therapy of insulin-dependent 
diabetes mellitus in pet dogs 
using "Neo-Islets," aggregates 
of adipose stem and pancreatic 
islet cells (INAD 012-776). 
Title Population: not humans 
 809. Intermittent hypoxia 
maintains glycemia in 
streptozotocin-induced 
diabetic rats. 
Title Population: not humans 
320 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 810. Interplay between Type 1 
Diabetes Mellitus and Celiac 
Disease: Implications in 
Treatment. 
Abstract Outcome: not related to insulin treatment 
adherence 
 811. INTERPRET, an 
international report on routine 
practice of sensor-augmented 
pump therapy: Results from the 
6 months interim analysis of 
the pediatric population 
Abstract Outcome: not related to insulin treatment 
adherence 
 812. INTERPRET, an 
international report on routine 
practice of sensorenabled 
pump therapy: Result from the 
6 months interim analysis 
Abstract Outcome: not related to insulin treatment 
adherence 
 813. Intervention needed to 
optimize insulin pump use 
Abstract Wrong study type (review, conference abstract 
etc.) 
 814. Interventions with 
adherence-promoting 
components in pediatric type 1 
diabetes: meta-analysis of 
their impact on glycemic 
control. 
Abstract Outcome: not related to insulin treatment 
adherence 
 815. Intrinsic motivation in 
minority youths with type 1 
diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 816. Is compliance with 
diabetes retinopathy (DR) 
screening associated with 
achievement of therapeutic 
goals in youth with type 1 
diabetes (T1DM)? 
Title Outcome: not related to insulin treatment 
adherence 
 817. Is continuous glucose 
monitoring (CGM) for 
everyone? To whom should 
CGM be prescribed and how? 
Abstract Outcome: not related to insulin treatment 
adherence 
 818. Is everything new 
necessarily better? The pros 
and cons of new technology 
Title Outcome: not related to insulin treatment 
adherence 
 819. Is insulin pump therapy 
effective in Type 1 diabetes? 
Abstract Outcome: not related to insulin treatment 
adherence 
 820. Is it useful to propose 
insulin pump at the onset of 
type 1 diabetes mellitus 
(T1DM)? 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 821. Is living a dolce vita with 
diabetes possible?-metabolic 
control and quality of life in 
patients treated with 640G 
system 
Abstract Wrong study type (review, conference abstract 
etc.) 
 822. Is the frequency of self-
monitoring of blood glucose 
related to long-term metabolic 
control? Multicenter analysis 
including 24,500 patients from 
191 centers in Germany and 
Austria. 
Title Outcome: not related to insulin treatment 
adherence 
 823. ISPAD and its role in the 
management of diabetes in the 
young in the Indian 
subcontinent and the Far East 
Title Outcome: not related to insulin treatment 
adherence 
 824. Italian multicentre study 
of intensive therapy with 
insulin lispro in 1184 patients 
with Type 1 diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 825. Juvenile diabetes Abstract Wrong study type (review, conference abstract 
etc.) 
 826. Juvenile insulin 
dependent diabetes control, a 
reflection on patient 
satisfaction and their 
awareness in a peripheral 
hospital 
Abstract Wrong study type (review, conference abstract 
etc.) 
 827. Key considerations when 
repositioning a known drug for 
inhalation therapy 
Title Outcome: not related to insulin treatment 
adherence 
 828. La retinopathie 
diabetique du sujet jeune: 
l'Enfant et l'adolescentDiabetic 
retinopathy in children and 
adolescents 
Title Outcome: not related to insulin treatment 
adherence 
 829. Labour productivity 
effects of prescribed medicines 
for chronically ill workers 
Abstract Population: not children (adults/foetuses) 
 830. Lactobacillus reuteri oral 
administration improves 
periodontal disease in children 
and adolescents with type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 831. Learned helplessness in 
diabetic youths 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 832. Left ventricular mass and 
arterial compliance: relation to 
coronary heart disease and its 
risk factors in South Indian 
adults. 
Title Population: not children (adults/foetuses) 
 833. Lessons learned from a 
pilot RCT of simultaneous 
versus delayed initiation of 
continuous glucose monitoring 
in children and adolescents 
with type 1 diabetes starting 
insulin pump therapy 
Abstract Outcome: not related to insulin treatment 
adherence 
 835. Lifestyle and 
cardiometabolic risk in adults 
with type 1 diabetes: a review. 
Title Population: not children (adults/foetuses) 
 836. Lipoatrophy in a girl after 
switching insulin analog 
injection to a pump 
Abstract Outcome: not related to insulin treatment 
adherence 
 837. Lived experience of 
diabetes among older, rural 
people 
Title Population: not children (adults/foetuses) 
 838. Locus of control beliefs 
predicting oral and diabetes 
health behavior and health 
status 
Abstract Outcome: not related to insulin treatment 
adherence 
 839. Long term experiences 
with a computerized diabetes 
management and glucose 
monitoring system in insulin-
dependent diabetic patients 
Abstract Outcome: not related to insulin treatment 
adherence 
 840. Long-Term Adherence to 
Automated Bolus Calculators. 
Full Text Population: not children (adults/foetuses) 
 841. Long-term benefits of 
continuous subcutaneous 
insulin infusion in children with 
Type 1 diabetes: A 4-year 
follow-up 
Abstract Outcome: not related to insulin treatment 
adherence 
 843. Long-Term Efficacy and 
Safety of Sensor Augmented 
Insulin Pump Therapy with 
Low-Glucose Suspend Feature 
in Patients with Type 1 
Diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 844. Long-term glycaemic 
control achieved in young 
insulin-dependent diabetics 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 845. Long-term metformin 
treatment in adolescents with 
obesity and insulin resistance, 
results of an open label 
extension study 
Title Population: do not have T1DM 
 846. Long-term outcomes of 
continuous glucose monitoring 
in young children with type 1 
diabetes undergoing insulin 
pump therapy: A retrospective 
evaluation 
Abstract Outcome: not related to insulin treatment 
adherence 
 847. Longitudinal associations 
of maternal depressive 
symptoms, maternal 





 848. Low Carbohydrate and 
Low-Fat Diets: What We Don't 
Know and Why we Should 
Know It. 
Title Outcome: not related to insulin treatment 
adherence 
 849. Low carbohydrate diet in 
type 1 diabetes, long-term 
improvement and adherence: A 
clinical audit. 
Title Outcome: not related to insulin treatment 
adherence 
 850. Low discomfort and pain 
associated with intensified 
insulin therapy in children and 
adolescents. 
Full Text Outcome: not related to insulin treatment 
adherence 
 851. Lower executive 
functioning associated with 
greater diabetes-specific risk-
taking in adolescents with type 
1 diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 852. Lower plasma insulin 
levels during overnight closed-
loop in school children with 
type 1 diabetes: Potential 
advantage? A randomized 
cross-over trial. 
Title Outcome: not related to insulin treatment 
adherence 
 853. Making Insulin 
Accessible: Does Inhaled Insulin 
Fill an Unmet Need? 
Abstract Wrong study type (review, conference abstract 
etc.) 
 854. Management and 
outcomes in paediatric 
ketoacidosis-West Midlands 
experience 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 855. Management of children 
with type 1 diabetes during 
illness: a national survey. 
Abstract Outcome: not related to insulin treatment 
adherence 
 856. Management of cystic 
fibrosis related diabetes: A 
survey of UK cystic fibrosis 
centers 
Title Population: do not have T1DM 
 857. Management of diabetes 
in Morocco: results of the 
International Diabetes 
Management Practices Study 
(IDMPS) - wave 5. 
Abstract Outcome: not related to insulin treatment 
adherence 
 858. Management of diabetic 
ketoacidosis in children and 
adolescents. 
Title Outcome: not related to insulin treatment 
adherence 
 860. Management of diabetic 
ketoacidosis in limited resource 
setting 
Title Outcome: not related to insulin treatment 
adherence 
 861. Management of juvenile 
diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 862. Management of ketosis-
prone type 2 diabetes mellitus. 
Title Population: do not have T1DM 
 863. Management of third-
trimester diabetic pregnancies 
with the use of continuous 
subcutaneous insulin infusion 
therapy: a pilot study. 
Abstract Population: not children (adults/foetuses) 
 864. Managing diabetic 
ketoacidosis: Keeping with the 
programme 
Title Outcome: not related to insulin treatment 
adherence 
 865. Managing insulin-
dependent diabetes mellitus in 
adolescence: A developmental 
perspective 
Abstract Wrong study type (review, conference abstract 
etc.) 
 866. Managing psychosocial 
issues in a family with diabetes 
Full Text Wrong study type (review, conference abstract 
etc.) 
 867. Managing special 
occasions and fasts 
Abstract Wrong study type (review, conference abstract 
etc.) 
 868. Maternal depressive 
symptoms and disease care 
behaviors in youths with type 1 
diabetes: A mediational model 
Abstract Wrong study type (review, conference abstract 
etc.) 
 869. Mauriac syndrome: A 
case report 
Title Outcome: not related to insulin treatment 
adherence 
 870. Mauriac syndrome: A rare 
differential diagnosis of 
abnormal liver tests in diabetic 
patients 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 871. Mauriac Syndrome: A 
Rare Hepatic Glycogenosis in 
Poorly Controlled Type 1 
Diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 872. Mauriac syndrome: Still 
exists and haunts us from time 
to time. A case series 
Title Outcome: not related to insulin treatment 
adherence 
 873. Mauriac's syndrome: An 
uncommon and old 
complication of type 1 diabetes 
mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 874. May gender influence the 
quality of life in children and 
adolescents with type 1 
diabetes? 
Abstract Outcome: not related to insulin treatment 
adherence 
 875. Mealtime insulin bolus 
adherence and glycemic 
control in adolescents on 
insulin pump therapy 
Abstract Outcome: not related to insulin treatment 
adherence 
 876. Measures of Adherence 
and Challenges in Using 
Glucometer Data in Youth with 
Type 1 Diabetes: Rethinking the 
Value of Self-Report. 
Abstract Outcome: not related to insulin treatment 
adherence 
 877. Measuring illness 
management behaviors on 
intensive insulin regimens: A 
revision of the twenty-four 
hour recall interview 
Abstract Outcome: not related to insulin treatment 
adherence 
 878. Medication adherence 
and economic problem among 
patients with type 1 diabetes in 
Central Java Province , 
Indonesia 
Abstract Wrong study type (review, conference abstract 
etc.) 
 879. Metabolic control and 
compliance with self-
monitoring of blood glucose in 
adolescents and young adults 
with type 1 diabetes: Results of 
the I-NewTrend randomized 
clinical trial 
Title Outcome: not related to insulin treatment 
adherence 
 880. Metabolic control and 
diet in Finnish diabetic 
adolescents 
Title Outcome: not related to insulin treatment 
adherence 
 881. Metabolic control and 
treatment patterns in patients 
with type 1 diabetes in Castilla-
La Mancha: the DIAbetes tipo 1 
in Castilla La Mancha study. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 882. Metabolic control in 
adolescents with diabetes: An 
examination of systemic 
variables 
Title Outcome: not related to insulin treatment 
adherence 
 883. Metabolic control in 
children and adolescents with 
insulin-dependent diabetes 
mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 884. Metabolic control in 
emerging adults with type 1 
diabetes 
Title Population: not children (adults/foetuses) 
 885. Metabolic outcomes in 
overweight adults according to 
birth weight and overweight 
onset 
Title Population: not children (adults/foetuses) 
 886. Metabolische 
hepatopathie bei einem 16-
jahrigen jungen mit diabetes 
mellitus: Eine diagnostische 
und therapeutische 
herausforderungMetabolic 
hepatopathy in a 16 year old 
boy with diabetes. A diagnostic 
and therapeutic challenge 
Title Outcome: not related to insulin treatment 
adherence 
 887. Metformin as additional 
therapy in adolescents with 
poorly controlled type 1 
diabetes: randomised placebo-
controlled trial with aspects on 
insulin sensitivity. 
Title Outcome: not related to insulin treatment 
adherence 
 888. Metformin improves 
vascular function in children 
and adolescents with type 1 
diabetes: The adelaide 
metformin RCT trial 
Title Outcome: not related to insulin treatment 
adherence 
 889. Metformin in adults with 
type 1 diabetes: Design and 
methods of REducing with 
MetfOrmin Vascular Adverse 
Lesions (REMOVAL): An 
international multicentre trial. 
Title Population: not children (adults/foetuses) 
 890. Metformin levels and 
adherence in children and 
adolescents with type 1 
diabetes enrolled in a 12 month 
randomised controlled trial 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 891. Methods for insulin 
delivery and glucose 
monitoring in diabetes: 
summary of a comparative 
effectiveness review 
Abstract Outcome: not related to insulin treatment 
adherence 
 892. Methods for Insulin 
Delivery and Glucose 
Monitoring: Comparative 
Effectiveness 
Abstract Outcome: not related to insulin treatment 
adherence 
 893. Microalbuminuria in 
diabetes mellitus - Efficacy of a 
new screening method in 
comparison with timed 
overnight urine collection 
Title Outcome: not related to insulin treatment 
adherence 
 894. MicroRNAs and histone 
deacetylase inhibition-
mediated protection against 
inflammatory ß-cell damage. 
Title Outcome: not related to insulin treatment 
adherence 
 895. Mindfulness-based Group 
Intervention for an Adolescent 
Girl at Risk for Type 2 Diabetes: 
A Case Report 
Title Population: do not have T1DM 
 896. Missed insulin boluses for 
snacks in youth with type 1 
diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 897. Missed Medical 
Appointments and Disease 
Control in Children With Type 1 
Diabetes. 
Full Text Outcome: not related to insulin treatment 
adherence 
 898. Mixing rapid-acting 
insulin analogues with insulin 
glargine in children with type 1 
diabetes mellitus. 
Abstract Outcome: not related to insulin treatment 
adherence 
 899. Mobile Momentary 
Assessment and Biobehavioral 
Feedback for Adolescents with 
Type 1 Diabetes: Feasibility and 
Engagement Patterns. 
Abstract Outcome: not related to insulin treatment 
adherence 
 900. Mobile phone support is 
associated with reduced 
ketoacidosis in young adults. 
Title Population: not children (adults/foetuses) 
 901. Model of associations 
between psychosocial 
variables and health-outcome 






Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 902. Modern clinical 
management helps reducing 
the impact of type 1 diabetes in 
children 
Abstract Outcome: not related to insulin treatment 
adherence 
 904. MODERNE ASPEKTE DER 
THERAPIE DES 
INSULINABHANGIGEN 
DIABETES MELLITUS BEI 
KINDERN UND 
JUGENDLICHENModern 
aspects of therapy in insulin-
dependent diabetes mellitus in 
children and adolescents 
Abstract Wrong study type (review, conference abstract 
etc.) 
 905. MODY2 and type 1 
diabetes in a pediatric patient 
who developed DKA 
Title Outcome: not related to insulin treatment 
adherence 
 906. Momentary Predictors of 
Insulin Restriction Among 
Adults With Type 1 Diabetes 
and Eating Disorder 
Symptomatology. 
Title Population: not children (adults/foetuses) 
 907. Momentary sampling 
using personal digital 
assistants (PDAs) to assess 
adherence in teens with type 1 
diabetes (T1D): Feasibility, 
burden and acceptability 
Abstract Outcome: not related to insulin treatment 
adherence 
 908. Morbidity and mortality 
of diabetic ketoacidosis with 
and without insulin pump care. 
Abstract Outcome: not related to insulin treatment 
adherence 
 910. Motor vehicle accidents 
during episodes of 
hypoglycaemia--case reports 
and lessons to be learnt. 
Title Outcome: not related to insulin treatment 
adherence 
 911. Moving Into Action: 
Informing Policy and 
Strengthening Healthcare 
Systems in Asia Pacific 
Title Outcome: not related to insulin treatment 
adherence 
 912. Multicenter closed-
loop/hybrid meal bolus insulin 
delivery with type 1 diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 913. Multicentre study on 
prevalence of endocrine 
complications in thalassaemia 
major 
Title Population: do not have T1DM 
329 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 914. Multicentre study on 
prevalence of endocrine 
complications in thalassaemia 
major. Italian Working Group 
on Endocrine Complications in 
Non-endocrine Diseases. 
Title Population: do not have T1DM 
 915. Multidisciplinary care on 
type 1 diabetics: "ADINF doce 
vida Nova Friburgo" project 
Abstract Wrong study type (review, conference abstract 
etc.) 
 916. Multidisciplinary 
treatment of pediatric obesity 
Title Population: do not have T1DM 
 917. Multifamily group 
problem-solving intervention 
for adherence challenges in 
pediatric insulin-dependent 
diabetes 
Full Text Outcome: not related to insulin treatment 
adherence 
 918. Multivariate assessment 
of adherence and glycemic 
control in youth with type 1 
diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 919. Neurog3 misexpression 
unravels mouse pancreatic 
ductal cell plasticity. 
Title Population: not humans 
 920. New concepts in diabetes: 
how multihormonal regulation 
can improve glycemic control. 
Title Outcome: not related to insulin treatment 
adherence 
 921. New insights in CF-related 
diabetes 
Title Population: do not have T1DM 
 922. New insulins and quality 
of life. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 923. New onset type 1 
diabetes in the pediatric 
population of a second level 
hospital: 12 years' review and 
evaluation of recent treatment 
and connection between 
hospitals 
Title Outcome: not related to insulin treatment 
adherence 
 924. New paradigms for 
growth hormone therapy in 
children 
Title Population: do not have T1DM 
 925. New technologies for 
promoting hypoglycaemia self-
management in type 1 diabetic 
children 
Title Outcome: not related to insulin treatment 
adherence 
 926. Nicotinamide protected 
first-phase insulin response 
(FPIR) and prevented clinical 
disease in first-degree relatives 
of type-1 diabetics 
Title Population: do not have T1DM 
330 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 928. No effect of insulin pen 
with memory function on 
glycemic control in a patient 
cohort with poorly controlled 
type 1 diabetes: A randomized 
open-label study 
Full Text Population: not children (adults/foetuses) 
 930. No effect of the FitFor2 
exercise programme on blood 
glucose, insulin senesitivity, 
and birthweight in pregnant 
women who were overweight 
and at risk for gestational 
diabetes : results of a 
randomised controlled trial. 
Title Population: do not have T1DM 
 931. Non-compliance of insulin 
pump users; questionnaire and 
case reports 
Abstract Outcome: not related to insulin treatment 
adherence 
 932. Non-insulin-dependent 
diabetes mellitus in Indian 
children in Manitoba 
Title Population: do not have T1DM 
 933. Nonadherence to insulin 
therapy in low-income, type 2 
diabetic patients. 
Title Population: do not have T1DM 
 934. Noncommunicable 
disease management in 
resource-poor settings: a 
primary care model from rural 
South Africa. 
Title Outcome: not related to insulin treatment 
adherence 
 935. Normalizing blood 
glucose levels in children with 
type I diabetes: Mystery 
motivators used within the 
context of behavioral 
consultation models 
Abstract Wrong study type (review, conference abstract 
etc.) 
 936. NOUVELLES TECHNIQUES 
D'ADMINISTRATION DE 
L'INSULINE LES MULTI-
INJECTIONS A L'AIDE DE 
STYLOS INJECTEURSNew 
techniques of insulin 
administration: Multiple 
injections by means of injection 
pens 
Full Text Outcome: not related to insulin treatment 
adherence 
 937. Novel therapies in the 
management of type I diabetes 
mellitus. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 938. NovoPen EchoTM for the 
delivery of insulin in paediatric 
patients: A comparison of 
usability, functionality and 
preference among patients, 
their parents and healthcare 
professionals 
Abstract Wrong study type (review, conference abstract 
etc.) 
 939. Numerical and clinical 
precision of continuous glucose 
monitoring in Colombian 
patients treated with insulin 
infusion pump with automated 
suspension in hypoglycemia. 
Abstract Outcome: not related to insulin treatment 
adherence 
 940. Nutritional management 
of children and adolescents 
with insulin-dependent 
diabetes mellitus: A review by 
the Diabetes Care and 
Education dietetic practice 
group 
Title Outcome: not related to insulin treatment 
adherence 
 941. Objectively Measured 
Adherence in Adolescents With 
Type 1 Diabetes on Multiple 
Daily Injections and Insulin 
Pump Therapy 
Full Text Outcome: not related to insulin treatment 
adherence 
 942. Observational study of 
diabetes management in type 
1 diabetic school-age children 
during holiday versus school 
days 
Full Text Outcome: not related to insulin treatment 
adherence 
 944. OcobeHHocT HcyHoTepa 
p caxapHoM dabeTe 1 Ta y 
deTe odpocTkoB, oyayux 
yukokopTkodblCharacteristics 
of insulin therapy of diabetes 
mellitus type 1 in children and 
adolescents receiving 
glucocorticoids 
Abstract Outcome: not related to insulin treatment 
adherence 
 945. Optimal pump settings 
differ according to age and 
insulin dose 
Title Outcome: not related to insulin treatment 
adherence 
 946. Optimal Use of Diabetes 
Devices: Clinician Perspectives 
on Barriers and Adherence to 
Device Use. 
Full Text Population: not children (adults/foetuses) 
 947. Optimization of insulin 
treatment in children 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 948. Optimizing insulin pump 
therapy: a quality 
improvement project. 
Abstract Outcome: not related to insulin treatment 
adherence 
 949. Optimum bolus wizard 
settings in insulin pumps in 
children with Type 1 diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 950. Oral glucose tolerance 
testing: A quality improvement 
initiative to increase adherence 
Title Population: do not have T1DM 
 951. Oral hypoglycemic 
glibenclamide: Can it be a 
substitute to insulin in the 
management of gestational 
diabetes mellitus? a 
comparative study 
Title Population: do not have T1DM 
 952. Oral insulin: an update. Title Outcome: not related to insulin treatment 
adherence 
 953. Our initial experience 
with insulin pump treatment 
Abstract Outcome: not related to insulin treatment 
adherence 
 954. Outcomes of a rural 
model of extended adolescent 
diabetes care to mid 20s 
without transition to adult 
services 
Title Population: not children (adults/foetuses) 
 955. Outcomes of admissions 
with diabetic ketoacidosis 
(DKA) compared to the 
national British Society of 
Paediatric Endocrinology and 
Diabetes (BSPED) guidelines 
Title Outcome: not related to insulin treatment 
adherence 
 956. Outpatient-to-inpatient 
transition of insulin pump 
therapy: successes and 
continuing challenges. 
Abstract Population: not children (adults/foetuses) 
 957. Outside-hospital 
assistance for children and 
adolescents with type 1 
diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 959. Overcoming the 
challenges in the nutritional 
management of toddlers with 
diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 960. Paediatric diabetes in 
Tanzania: Problems and 
perspectives 
Abstract Wrong study type (review, conference abstract 
etc.) 
 961. Paediatric diabetes: 
achieving practical, effective 
insulin therapy in type 1 and 
type 2 diabetes. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 962. Paediatric non-ketotic 
hyperglycaemic hemichorea-
hemiballismus. 
Title Population: do not have T1DM 
 963. Pancreatic islet 
transplantation. 
Title Outcome: not related to insulin treatment 
adherence 
 964. Pancreatic stem cells: a 
therapeutic agent that may 
offer the best approach for 
curing type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 965. Parent and child 
perceptions of the 




 966. Parent-child relationships 





 967. Parental expectations 
about their involvement in 
diabetes management: 
Reliability and validity of the 
outcome expectations of 
parental involvement (OEPI) 
scale 
Abstract Outcome: not related to insulin treatment 
adherence 
 968. Parental involvement and 
adolescents' diabetes 
management: the mediating 
role of self-efficacy and 




 969. Parental involvement 
buffers associations between 
pump duration and metabolic 
control among adolescents 
with type 1 diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 970. Parental involvement in 
diabetes management tasks: 
Relationships to blood glucose 
monitoring adherence and 
metabolic control in young 
adolescents with insulin-
dependent diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 971. Parental involvement in 
regimen responsibilities: 
Implications for the adherence 
behaviors and psychosocial 
adjustment of adolescents with 
insulin-dependent diabetes 
mellitus 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 972. Parental stress response 
within a family context: 
Association with diabetic 
control in adolescents with 
IDDM 
Full Text Outcome: not related to insulin treatment 
adherence 
 973. Parent–child 
relationships and insulin-
dependent diabetes mellitus: 
Observational ratings of 
clinically relevant dimensions 
Full Text Outcome: not related to insulin treatment 
adherence 
 974. Participant and parent 
experiences in the oral insulin 
study of the Diabetes 
Prevention Trial for Type 1 
Diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 976. Participant and parent 
experiences in the parenteral 
insulin arm of the diabetes 
prevention trial for type 1 
diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 978. Participant 
characteristics and study 
features associated with high 
retention rates in a longitudinal 
investigation of type 1 diabetes 
mellitus. 
Title Outcome: not related to insulin treatment 
adherence 
 979. Pathways from emotional 
adjustment to glycemic control 




 980. Patient education and 
compliance in non-insulin 
dependent diabetes mellitus 
Title Population: do not have T1DM 
 981. Patient Perspectives on 
Nurse-led Consultations Within 
a Pilot Structured Transition 
Program for Young Adults 
Moving From an Academic 
Tertiary Setting to Community-
based Type 1 Diabetes Care 
Abstract Outcome: not related to insulin treatment 
adherence 
 982. Patient perspectives on 
peer support for adults with 
type 1 diabetes: a need for 
diabetes-specific social capital. 
Title Population: not children (adults/foetuses) 
 983. Patient perspectives on 
personalized glucose advisory 
systems for type 1 diabetes 
management. 
Abstract Population: not children (adults/foetuses) 
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Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 984. Patient recruitment in 
paediatric clinical trials 
Title Population: do not have T1DM 
 985. Patient safety and 
minimizing risk with insulin 
administration - role of insulin 
degludec. 
Title Outcome: not related to insulin treatment 
adherence 
 986. Patient with MSUD 
presenting with diabetic 
ketoacidosis 
Title Outcome: not related to insulin treatment 
adherence 
 987. Patients with poorly 
controlled diabetes in primary 
care: healthcare clinicians' 
beliefs and attitudes 
Title Outcome: not related to insulin treatment 
adherence 
 988. Patients' empowerment, 
physicians' perceptions, and 
achievement of therapeutic 
goals in patients with type 1 
and type 2 diabetes mellitus in 
Mexico. 
Abstract Outcome: not related to insulin treatment 
adherence 
 989. Patterns of adherence to 
diabetes vision care guidelines: 
baseline findings from the 
Diabetic Retinopathy 
Awareness Program. 
Title Outcome: not related to insulin treatment 
adherence 
 990. Pediatric diabetes 
management in Appalachian 
Kentucky: adherence of 
primary care physicians to ADA 
guidelines 
Title Outcome: not related to insulin treatment 
adherence 
 992. Peptic ulcer disease in 
youths with insulin-dependent 
diabetes mellitus: a 
prospective study. 
Title Outcome: not related to insulin treatment 
adherence 
 993. Perceived peer support 
and diabetes management 
from adolescence into early 
emerging adulthood. 
Full Text Outcome: not related to insulin treatment 
adherence 
 994. Perceptions and 
experiences of using 
automated bolus advisors 
amongst people with type 1 
diabetes: a longitudinal 
qualitative investigation. 
Abstract Outcome: not related to insulin treatment 
adherence 
 995. Percutaneous 
transhepatic pancreatic islet 
cell transplantation in type 1 
diabetes mellitus: radiologic 
aspects. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 996. Perfil clinico de ninos con 
cetoacidosis diabetica en una 
unidad de paciente 
criticoClinical profile of children 
with diabetic ketoacidosis in a 
critical care unit 
Title Outcome: not related to insulin treatment 
adherence 
 997. Persistent effects of a 
pedagogical device targeted at 
prevention of severe 
hypoglycaemia: a randomized, 
controlled study. 
Abstract Outcome: not related to insulin treatment 
adherence 
 998. Personal continuous 
glucose monitoring (CGM) in 
diabetes management: review 
of the literature and 
implementation for practical 
use. 
Title Outcome: not related to insulin treatment 
adherence 
 1000. Personality traits as 
predictors of adherence in 




1001. Personalized medicine 
switching from insulin to 
sulfonylurea in permanent 
neonatal diabetes mellitus 
dictated by a novel activating 
ABCC8 mutation 
Title Outcome: not related to insulin treatment 
adherence 
 1002. Perspectives of patients 
with type 1 or insulin-treated 
type 2 diabetes on self-
monitoring of blood glucose: a 
qualitative study. 
Title Outcome: not related to insulin treatment 
adherence 
 1003. Pharmaceutical care of 
an adolescent with type 1 
diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1004. Pharmacokinetic 
Properties of Liraglutide as 
Adjunct to Insulin in Subjects 
with Type 1 Diabetes Mellitus. 
Title Outcome: not related to insulin treatment 
adherence 
 1005. Pharmazeutische 
Betreuung von Jugendlichen 
mit Diabetes mellitus Typ 1 Zeit 
fur "Diabetes 
Stewardship"?Diabetes 
Stewardship - Pharmaceutical 
care of adolescents with type 1 
diabetes mellitus provided by 
community pharmacists 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1006. Physical activity and 
sedentary behavior levels in 
children and adolescents with 
type 1 diabetes using insulin 
pump or injection therapy - The 
importance of parental activity 
profile. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1007. Physical activity 
intensity and type 2 diabetes 
risk in overweight youth: A 
randomized trial 
Title Population: do not have T1DM 
 1008. Physical activity 
intensity and type 2 diabetes 
risk in overweight youth: The 
power trial, a randomized, 
controlled trial 
Title Population: do not have T1DM 
 1009. Pilot study of self-
measurement of blood glucose 
using the Dextrostix-Eyetone 
system for juvenile-onset 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 1010. Polymer-Based 
Nanoparticle Strategies for 
Insulin Delivery. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1011. Poor adherence in 
adolescents with type 1 
diabetes associated with 
distress, fear of hypoglycemia, 
and executive functioning 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1012. Poor adherence to 
integral daily tasks limits the 
efficacy of CSII in youth 
Included 
 
 1014. Poor home compliance 
in brittle diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1015. Post-Graduate 
education program for 
dieticians - Medical nutrition 
therapy in diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1016. Post-transplant diabetes 
mellitus (PTDM) in pediatric 
renal transplant recipient 
Title Population: do not have T1DM 
 1017. Postpartum physiology, 
psychology and paediatric 
study-P4 study 
Title Population: do not have T1DM 
 1018. Potential beneficial 
effects of a gluten-free diet in 
newly diagnosed children with 
type 1 diabetes: a pilot study. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1019. Potential reno-
protective effects of a gluten-
free diet in type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 1020. Precipitating factors of 
diabetic ketoacidosis at a 
public hospital in a middle-
income country. 
Title Outcome: not related to insulin treatment 
adherence 
 1022. Predicting adolescent 
adjustment to diabetes 
mellitus from locus of control 
and optimism 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1023. Predictors and 
treatment outcome of 
hyperglycemic emergencies at 
Jimma University Specialized 
Hospital, southwest Ethiopia 
Title Outcome: not related to insulin treatment 
adherence 
 1025. Predictors of 
deteriorations in diabetes 
management and control in 
adolescents with type 1 
diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 1026. Predictors of glucose 
control in children and 
adolescents with type 1 
diabetes: results of a cross-
sectional study in Cameroon 
Title Outcome: not related to insulin treatment 
adherence 
 1027. Predictors of glycemic 
control and diabetes-related 
costs among type 2 diabetes 
patients initiating therapy with 
liraglutide in the United States. 
Title Population: do not have T1DM 
 1028. Predictors of good 





 1029. Predictors of metabolic 
control at one year in a 
population of pediatric 
patients with type 2 diabetes 
mellitus: A retrospective study 
Title Population: do not have T1DM 
 1030. Predictors of parental 
monitoring of diabetes care in 
a high-risk sample 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1031. Predictors of response to 
insulin therapy in youth with 
poorly-controlled type 2 
diabetes in the TODAY trial 
Title Population: do not have T1DM 
339 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1032. Predictors of study 
completion and withdrawal in 
a randomized clinical trial of a 
pediatric diabetes adherence 
intervention. 
Title Outcome: not related to insulin treatment 
adherence 
 1033. Preprandial versus 
postprandial blood glucose 
monitoring in type 1 diabetic 
pregnancy: a randomized 
controlled clinical trial. 
Title Outcome: not related to insulin treatment 
adherence 
 1034. Presente e futuro della 
terapia insulinica nel bambino 
e adolescente con diabete 
mellito di tipo 1Insulin therapy 
in children and adolescents 
with T1DM - What's here and 
what's to come 
Full Text Wrong study type (review, conference abstract 
etc.) 
 1035. Prevalence and 
management of patients with 
type 1 diabetes and autism 
spectrum disorder 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1036. Prevalence of diabetic 
eye disease in an inner city 
population: The Liverpool 
Diabetic Eye Study 
Title Outcome: not related to insulin treatment 
adherence 
 1037. Prevalence of endocrine 
complications and short 
stature in patients with 
thalassaemia major: A 
multicenter study by the 
Thalassaemia International 
Federation (TIF) 
Title Population: do not have T1DM 
 1038. Prevalence of injection-
meal interval usage and its 
association with variables of 
metabolic control in patients 
with Type 1 and Type 2 
diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1039. Prevalence of 
intentional under- and 
overdosing of insulin in children 




 1041. Prevalence of 
intentional under- and 
overdosing of insulin in diabetic 
children and adolescents 
    
340 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1042. Primary dietary 
intervention study to reduce 
the risk of islet autoimmunity in 
children at increased risk for 
type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1043. Primary dietary 
intervention study to reduce 
the risk of islet autoimmunity in 
children at increased risk for 
type 1 diabetes: the BABYDIET 
study. 
Title Outcome: not related to insulin treatment 
adherence 
 1044. Problem solving and 
diabetes regimen adherence by 
children and adolescents with 
IDDM in social pressure 
situations: A reflection of 
normal development 
Full Text Outcome: not related to insulin treatment 
adherence 
 1045. Profile of internection of 
pediatric patients with 
diabetes mellitus type 1 in a 
reference service in Rio de 
Janeiro 
Title Outcome: not related to insulin treatment 
adherence 
 1046. Prolonged use of 
continuous glucose monitors in 
children with type 1 diabetes 
on continuous subcutaneous 
insulin infusion or intensive 
multiple-daily injection 
therapy. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1047. Proposed clinical 
application for tuning fuzzy 
logic controller of artificial 
pancreas utilizing a 
personalization factor 
Abstract Outcome: not related to insulin treatment 
adherence 
 1048. Prospects for smoking 
cessation among people with 
insulin-dependent diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 1049. Protocol for Meal-time 
Administration of Exenatide for 
Glycaemic Control in Type 1 
Diabetes Cases (The MAG1C 
trial): a randomised, double-
blinded, placebo-controlled 
trial. 
Title Outcome: not related to insulin treatment 
adherence 
 1050. Psychiatric illness and 
family support in children and 
adolescents hospitalized with 
diabetic ketoacidosis 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1051. Psychiatric illness and 
family support in children and 
adolescents with diabetic 
ketoacidosis: A controlled 
study 
Abstract Outcome: not related to insulin treatment 
adherence 
 1052. Psycho-social aspects of 
children and adolescents with 
diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1053. Psychoanalytic 
formulation and treatment: 
Chronic metabolic disturbance 
in insulin-dependent diabetes 
mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1054. Psychologic predictors 
of compliance in children with 




 1055. Psychological and 
demographic correlates of 
glycaemic control in adult 
patients with type 1 diabetes. 
Title Population: not children (adults/foetuses) 
 1057. Psychological aspects of 
childhood diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1058. Psychological aspects of 
continuous glucose monitoring 
in pediatric type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 1059. Psychological barriers to 
optimal insulin therapy: more 
concerns in adolescent females 
than males. 
Full Text Outcome: not related to insulin treatment 
adherence 
 1060. Psychological factors 
associated with diabetes self-
management among 
adolescents with Type 1 
diabetes: A systematic review 
Title Wrong study type (review, conference abstract 
etc.) 
 1061. Psychological 
functioning among mothers of 
children with insulin-
dependent diabetes mellitus: A 
longitudinal study 
Full Text Outcome: not related to insulin treatment 
adherence 
 1062. Psychological impact of 
continuous subcutaneous 
insulin infusion pump therapy 
in non-selected newly 
diagnosed insulin dependent 
(type 1) diabetic children: 






Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1064. Psychological responses 
to the needle-free injection of 
insulin with the disposable 
front-end Medi-Jector (MJ-6) 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1065. Psychometric analysis of 
the Spanish and Catalan 
versions of the Diabetes Self-
Care inventory-revised version 
questionnaire. 
Abstract Population: not children (adults/foetuses) 
 1066. Psychometric evaluation 




 1068. Psychometric properties 
of a diabetes resilience 
measure for adolescents 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1069. Psychometric properties 
of the preschool diabetes 
behavior checklist 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1070. Psychopathology and 
continuous subcutaneous 
insulin infusion in type 1 
diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1071. Psychosocial adaptation 
following the diagnosis of 
insulin-dependent diabetes 
mellitus: An intervention 
Abstract Outcome: not related to insulin treatment 
adherence 
 1072. Psychosocial and 
psychopathologic influences on 
management and control of 
insulin-dependent diabetes 
Full Text Population: not children (adults/foetuses) 
 1073. Psychosocial aspects of 
xenotransplantation: survey in 
adolescent recipients of 
porcine islet cells. 
Title Outcome: not related to insulin treatment 
adherence 
 1074. Psychosocial correlates 
of glycemic control: the 
Pittsburgh Epidemiology of 
Diabetes Complications (EDC) 
Study. 
Title Outcome: not related to insulin treatment 
adherence 
 1075. Psychosocial 
determinants of regimen 
adherence behaviors in 
adolescents with type I insulin-
dependent diabetes mellitus: 
Individual cognitive factors, 
social factors, and perceived 
barriers to adherence 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1076. Psychosocial factors 
associated with use of 
continuous glucose 
monitoring. 
Title Outcome: not related to insulin treatment 
adherence 
 1077. Psychosocial predictors 
of adherence and metabolic 
control in adolescents with 
insulin-dependent diabetes 
mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1078. Psychosocial problems 
in adolescents with type 1 
diabetes mellitus. 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1080. Psychosocial profile, 
glycemic control and well being 
in poverty associated type 1 
diabetes mellitus [T1DM] 
adolescents in India 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1081. Psyllium 
supplementation improves 
parameters of the metabolic 
syndrome: A randomized, 
participant-blinded, placebo 
controlled, crossover trial 
Title Population: do not have T1DM 
 1082. Puberty in CF Title Population: do not have T1DM 
 1083. Pulmonary function in 
insulin-dependent diabetes 
mellitus with limited joint 
mobility. 
Title Outcome: not related to insulin treatment 
adherence 
 1084. Pump settings in 
different age groups 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1085. Pumpers, skypers, 
surfers and texters: Technology 
to improve the management of 
diabetes in teenagers 
Abstract Outcome: not related to insulin treatment 
adherence 
 1086. Quality of life and 
diabetes knowledge of young 
persons with type 1 diabetes: 
Influence of treatment 
modalities and demographics 
Full Text Outcome: not related to insulin treatment 
adherence 
 1088. Quality of life and 
glycemic control in adolescents 
with type 1 diabetes and the 




 1090. Quality of life and new 
devices in the management of 
type 1 diabetes in children and 
adolescents. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1091. Quality of life in children 
with diabetes and celiac 
disease: minimal impact of the 
'double diagnosis'. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1092. Quality of life in insulin 
users measured by ITR-QOL 
Full Text Population: not children (adults/foetuses) 
 1093. Quality of Life in Type 1 
Diabetes and Celiac Disease: 
Role of the Gluten-Free Diet 
Title Outcome: not related to insulin treatment 
adherence 
 1094. Quality of life of children 
and adolescents with type 1 
diabetes in Kuwait. 
Included 
 
 1095. Quality of life related to 
health in adolescents with type 
1 diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1096. Quality of life, perceived 
difficulties in adherence to a 
diabetes regimen, and blood 
glucose control. 
Full Text Population: not children (adults/foetuses) 
 1097. Quality of the parent-
child interaction in young 
children with type 1 diabetes 
mellitus: study protocol. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1098. Race and sex differences 
in metabolic control of 
adolescents with IDDM: A 
function of psychosocial 
variables? 
Abstract Outcome: not related to insulin treatment 
adherence 
 1099. Randomised placebo-
controlled trial of human 
recombinant insulin-like 
growth factor I plus intensive 
insulin therapy in adolescents 
with insulin-dependent 
diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 1100. Randomized, controlled 
trial of behavior therapy for 
families of adolescents with 
insulin-dependent diabetes 
mellitus 
Abstract Outcome: not related to insulin treatment 
adherence 
 1101. Rare, acute 
complications in children with 
diabetes mellitus type 1 
Title Outcome: not related to insulin treatment 
adherence 
 1102. Real world management 
of pregestational diabetes not 
achieving glycemic control for 
many patients in the UK 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1103. Real-time continuous 
glucose monitoring in children 
and adolescents 
Title Outcome: not related to insulin treatment 
adherence 
 1105. Reasons for the 
discontinuation of therapy of 
personal insulin pump in 
children with type 1 diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1106. Recent challenges in 
insulin delivery systems: a 
review. 
Title Wrong study type (review, conference abstract 
etc.) 
 1107. Recent Updates on 
Novel Approaches in Insulin 
Drug Delivery: A Review of 
Challenges and Pharmaceutical 
Implications. 
Title Wrong study type (review, conference abstract 
etc.) 
 1108. Recommendations for 
the use of sensor-augmented 
pumps with predictive low-
glucose suspend features in 
children: The importance of 
education. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1109. Recurrent diabetic 
ketoacidosis-like symptoms 
and factitious hyperglycemia 
as a Munchausen syndrome in 
diabetes mellitus type 1: A case 
report 
Title Outcome: not related to insulin treatment 
adherence 
 1110. Recurrent 
Hypertriglyceridemic 
Pancreatitis (HTGP); and the 
Use of Insulin Drip as 
Treatment. 
Title Population: do not have T1DM 
 1111. Redesigning an intensive 
insulin service for patients with 
type 1 diabetes: a patient 
consultation exercise. 
Abstract Population: not children (adults/foetuses) 
 1112. Reduction in severe 
hypoglycaemia in paediatric 
type 1 diabetes during the first 
year of continuous glucose 
monitoring: Real-world data 
from the DPV registry 
Title Outcome: not related to insulin treatment 
adherence 
 1113. Reduction of protein 
intake decreases glomerular 
filtration rate in young type 1 
(insulin-dependent) diabetic 
patients mainly in 
hyperfiltering patients. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1114. Reemergence of a rare 
syndrome: Mauriac syndrome 
Title Outcome: not related to insulin treatment 
adherence 
 1115. Relation of different 
measures of psychological 
characteristics to oral health 
habits, diabetes adherence and 
related clinical variables 
among diabetic patients 
Full Text Population: not children (adults/foetuses) 
 1116. Relation of serum leptin 
and insulin-like growth factor-1 
levels to intima-media 
thickness and functions of 
common carotid artery in 
children and adolescents with 
type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1118. Relationship between 
age at menarche and 
cardiovascular risk factors in 
women with type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1119. Relationship between 
blood glucose levels and manic 
episodes in a patient with 
bipolar-I disorder: Presentation 
of a case 
Title Population: do not have T1DM 
 1120. Relationship between 
disinhibition and metabolic 
control in adolescents with 
type 1 diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1121. Relationship between 
food consumption and 
glycemic control of adolescents 
with type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1122. Relationship between 
glycemic control, ethnicity and 
socioeconomic status in 
Hispanic and white non-
Hispanic youths with type 1 
diabetes mellitus. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1123. Relationship between 
health locus of control, health 
value, and social support and 
compliance of persons with 
diabetes mellitus. 
Full Text Population: not children (adults/foetuses) 
 1124. Relationship of self-
efficacy and binging to 






Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1125. Relationship of the 
patient age and intensity of 
type 2 diabetes treatment 
Title Population: do not have T1DM 
 1126. Relationships between 
goals and health outcomes in 
children and adolescents with 
insulin-dependent diabetes 
mellitus 
Abstract Outcome: not related to insulin treatment 
adherence 
 1127. Relationships between 
quality of life, family factors, 
adherence, and glycemic 
control in pediatric patients 
with Type 1 diabetes mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1128. Reliability of reporting of 
self-monitoring of blood 
glucose in pregnant women. 
Title Population: do not have T1DM 
 1129. Research on social 
support in adolescents with 
IDDM: a critical review 
Title Wrong study type (review, conference abstract 
etc.) 
 1130. Response to comment 
on Gomes et al. Adherence to 
insulin therapeutic regimens in 
patients with type 1 diabetes. A 
nationwide survey in Brazil. 
Diabetes Res Clin Pract. 
2016;120:47-55. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 1131. Responsibility for the 
type 1 diabetes regimen and 
fear of hypoglycemia in 
adolescents who use insulin 
pumps and their parents 
Abstract Outcome: not related to insulin treatment 
adherence 
 1132. Reversal of type 2 
diabetes in youth who adhere 
to a very-low-energy diet: a 
pilot study 
Title Population: do not have T1DM 
 1133. Reversible 
steatohepatosis in a young boy 
with brittle type 1 diabetes 
mellitus: Mauriac syndrome 
Title Outcome: not related to insulin treatment 
adherence 
 1135. Review and update of 
insulin dependent diabetes 
mellitus. 
Title Wrong study type (review, conference abstract 
etc.) 
 1136. Review of genetic 
diabetes in an irish paediatric 
diabetes centre 
Title Population: do not have T1DM 
 1137. Revisit of a rare 
complication of type 1 diabetes 
mellitus: Mauriac syndrome 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1138. Rhino-orbital-cerebral 
mucormycosis: a lethal 
complication of body 
dysmorphic disorder. 
Title Population: do not have T1DM 
 1139. Rising incidence and 
challenges of childhood 
diabetes. A mini review. 
Title Wrong study type (review, conference abstract 
etc.) 
 1141. Risk factors and 
predictors of uncontrolled 
hyperglycemia and diabetic 
ketoacidosis in children and 
adolescents with type 1 
diabetes mellitus in Jeddah, 
western Saudi Arabia 
Abstract Outcome: not related to insulin treatment 
adherence 
 1143. Risk factors for poor 
glycemic control in diabetic 
children in France. 
Included 
 
 1144. Risk factors for poor 
glycemic control in diabetic 
children in France: Immigrant 
versus nonimmigrant mothers 
    
 1145. Risk factors for recurrent 
admissions with diabetic 
ketoacidosis: a case-control 
observational study. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1146. Risk Factors for 
Recurrent Diabetic 
Ketoacidosis in Adults With 
Type 1 Diabetes. 
Title Population: not children (adults/foetuses) 
 1147. Risk factors of eating 
disorders in adolescents with 
type 1 diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1148. Risk factors of recurrent 
diabetic ketoacidosis among 
type 1 diabetes mellitus 
children in Dr. Hasan Sadikin 
General Hospital 
Abstract Outcome: not related to insulin treatment 
adherence 
 1149. Role of Social Factors in 
Glycemic Control Among 
African American Children and 
Adolescents with Type 1 
Diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1150. Root cause analysis of 
diabetic ketoacidosis and its 
complications: A developing 
country experience 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1151. Salient characteristics of 
youth with type 1 diabetes 
initiating continuous glucose 
monitoring 
Title Outcome: not related to insulin treatment 
adherence 
 1153. Satisfaction and quality 
of life with premeal inhaled 
versus injected insulin in 
adolescents and adults with 
type 1 diabetes 
Included 
 
 1155. School adherence with 
guidelines for children with 
diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1156. Screening for diabetes 
mellitus in patients with a 
history of gestational diabetes 
mellitus: A comparison of 
practice patterns and 
adherence to the 
recommended guidelines in 
community teaching hospitals 
Title Population: do not have T1DM 
 1157. Self-administered 
diabetes self-management 
profile-short form (DSMP-SF): A 
user-friendly adherence 
screener for youth with T1D 
Abstract Outcome: not related to insulin treatment 
adherence 
 1158. Self-care behaviors and 
glycemic control in type I 
diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1159. Self-care behaviors in 
insulin-dependent diabetes: 
Evaluative tools and their 
associations with glycemic 
control 
Abstract Outcome: not related to insulin treatment 
adherence 
 1160. Self-care behaviour, 
treatment satisfaction and 
quality of life in people on 
intensive insulin treatment. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1161. Self-disclosure and peer 
support in adolescents with 
insulin-dependent diabetes 
mellitus 
Abstract Outcome: not related to insulin treatment 
adherence 
 1162. Self-efficacy as a 
common variable in oral health 
behavior and diabetes 
adherence 
Full Text Population: not children (adults/foetuses) 
350 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1163. Self-efficacy as a 
mediator variable for 
adolescents' adherence to 
treatment for insulin-
dependent diabetes mellitus 
Included 
 
 1164. Self-efficacy scale for 
Brazilians with type 1 diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1165. Self-esteem as a 
characteristic of adherence to 
diabetes and dental self-care 
regimens 
Full Text Population: not children (adults/foetuses) 
 1166. Self-Management 
Behaviors in Adults on Insulin 
Pump Therapy. 
Title Population: not children (adults/foetuses) 
 1167. Self-monitored blood 
glucose: a common pitfall. 
Title Outcome: not related to insulin treatment 
adherence 
 1168. Self-monitoring 
adherence to physical activity 
in children and adolescents 
with type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 1170. Self-monitoring of blood 
glucose (SMBG) in youth with 
poorly controlled type 2 
diabetes (T2D) in the today 
study 
Title Population: do not have T1DM 
 1171. Self-monitoring of blood 
glucose among patients with 
diabetes in Jordan: Perception, 
adherence, and influential 
factors 
Title Outcome: not related to insulin treatment 
adherence 
 1172. Self-monitoring of blood 
glucose and insulin dose 
alteration in type 1 diabetes 
mellitus 
Full Text Population: not children (adults/foetuses) 
 1174. Self-monitoring of blood 
glucose in youth-onset type 2 
diabetes: Results from the 
ToDay study 
Title Population: do not have T1DM 
 1175. Self-monitoring of blood 
glucose levels and glycemic 
control: the Northern California 
Kaiser Permanente Diabetes 
registry. 
Title Outcome: not related to insulin treatment 
adherence 
 1176. Self-reported 
compliance with diabetes self-
management during 
pregnancy. 
Abstract Population: not children (adults/foetuses) 
351 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1177. Sensor augmented 
pump therapy from onset of 
type 1 diabetes: Late follow-up 
results of the Pediatric ONSET 
Study 
Abstract Outcome: not related to insulin treatment 
adherence 
 1178. Sensor-augmented 
insulin pump therapy: results of 
the first randomized treat-to-
target study. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1179. Sensor-augmented 
pump and multiple daily 
injection therapy in the United 
States and Canada: post-hoc 
analysis of a randomized 
controlled trial. 
Abstract Population: not children (adults/foetuses) 
 1180. Sertraline induced acute 
pancreatitis in a diabetic 
adolescent? 
Title Outcome: not related to insulin treatment 
adherence 
 1181. Serum C-peptide assay 
of patients with hyperglycemic 
emergencies at the Lagos State 
University Teaching Hospital 
(LASUTH), Ikeja 
Title Outcome: not related to insulin treatment 
adherence 
 1182. Severe diabetic 
papillopathy mimicking non-
arteritic anterior ischemic optic 
neuropathy (NAION) in a young 
patient. 
Title Outcome: not related to insulin treatment 
adherence 
 1183. Severe Growth Failure 
and Poorly Controlled Type 1 
Diabetes Mellitus in a 7-Year-
Old Girl: Mauriac Syndrome. 
Title Outcome: not related to insulin treatment 
adherence 
 1184. Severe 
hypertriglyceridemia in 3 
adolescents with type 2 
diabetes mellitus and all 
treated with l-asparaginase 
Title Population: do not have T1DM 
 1185. Severe hypoglycemia in 
IDDM children 
Abstract Outcome: not related to insulin treatment 
adherence 
 1186. Shared decision making 
between adolescents with type 
1 diabetes and physicians 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1187. Short-term effects of a 
low carbohydrate diet on 
glycaemic variables and 
cardiovascular risk markers in 
patients with type 1 diabetes: A 
randomized open-label 
crossover trial. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1188. Should we mix lispro 
with glargine? removing the 
guesswork by euglycemic 
clamp studies 
Title Outcome: not related to insulin treatment 
adherence 
 1189. Simulation of diabetic 
eye disease to compare 
screening policies. 
Title Outcome: not related to insulin treatment 
adherence 
 1190. Simultaneous vs delayed 
initiation of Real-Time 
Continuous Glucose 
Monitoring (RT-CGM) in 
children and adolescents with 
established type 1 diabetes 
starting insulin pump therapy: 
A pilot study 
Abstract Outcome: not related to insulin treatment 
adherence 
 1191. Situational obstacles to 
adherence for adolescents with 
diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1192. Six months of gluten-
free diet do not influence 
autoantibody titers, but 
improve insulin secretion in 
subjects at high risk for type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1194. Six months of gluten-
free diet lowers insulin 
requirement but does not 
influence residual betacell 
capacity in children with recent 
T1D onset 
Title Outcome: not related to insulin treatment 
adherence 
 1195. Sleep duration and its 
impact on adherence in 




 1197. Sleep in children with 
type 1 diabetes and their 
parents in the T1D Exchange 
Abstract Outcome: not related to insulin treatment 
adherence 
 1198. Sleepovers and diabetic 
ketoacidosis: A cross sectional 
chart review of DKA admissions 
in established patients with 
type 1 diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1199. Social competence and 
parental support as mediators 
of the link between stress and 
metabolic control in 
adolescents with insulin-





Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1200. Social learning 
intervention to promote 
metabolic control in type I 
diabetes mellitus: pilot 
experiment results. 
Full Text Outcome: not related to insulin treatment 
adherence 
 1201. Socio-economic, 
demographic, and clinical 
correlates of poor glycaemic 
control within insulin regimens 
among children with Type 1 
diabetes: the SEARCH for 
Diabetes in Youth Study 
Abstract Outcome: not related to insulin treatment 
adherence 
 1202. Sociodemographic and 
psychosocial factors associated 
with continuous subcutaneous 
insulin infusion in adolescents 
with type 1 diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1203. Sponsorship for 
adolescents with diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1204. Spontaneous complete 
remission of type 1 diabetes 
mellitus in an adult - review 
and case report. 
Title Population: not children (adults/foetuses) 
 1205. Stabilization of glycemic 
control and improved quality of 
life using a shared medical 
appointment model in 
adolescents with type 1 
diabetes in suboptimal control. 
Included 
 
 1206. Strategies to improve 
insulin adherence in 
adolescents with type 1 
diabetes 
Full Text Outcome: not related to insulin treatment 
adherence 
 1208. Strengths, risk factors, 
and resilient outcomes in 
adolescents with type 1 
diabetes (T1D): Results from 
diabetes MILES Youth-Australia 
Abstract Outcome: not related to insulin treatment 
adherence 
 1209. Stressful Life Events in 
Young Adults With Type 1 
Diabetes in the U.S. T1D 
Exchange Clinic Registry 
Title Population: not children (adults/foetuses) 
 1210. Study medication 
adherence and outcomes in the 
TODAY cohort of youth with 
type 2 diabetes (T2D) 
Title Population: do not have T1DM 
354 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1211. Study on pregnancy 
outcomes in patients with 
prepubertal onset of type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1212. Subcutaneous rapid-
acting insulin analogues for 
diabetic ketoacidosis 
Title Outcome: not related to insulin treatment 
adherence 
 1214. Successful switching of 
multiple dose insulin to oral 
agents after mixedmeal 
tolerance test in patient with 
childhood-onset diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1215. Sulfonylurea treatment 
in a celiac girl with neonatal 
diabetes (KCNJ11 R201H): 
Impact of low compliance to 
the gluten free diet 
Title Outcome: not related to insulin treatment 
adherence 
 1216. Support as a crucial 
predictor of good compliance 
of adolescents with a chronic 
disease 
Full Text Outcome: not related to insulin treatment 
adherence 
 1217. Supported 
telemonitoring and glycemic 
control in people with type 2 
diabetes : the Telescot diabetes 
pragmatic multicenter 
randomized controlled trial. 
Title Population: do not have T1DM 
 1218. Supportive and 
nonsupportive family 
behaviors: relationships to 
adherence and metabolic 
control in persons with type I 
diabetes. 
Full Text Outcome: not related to insulin treatment 
adherence 
 1219. Surreptitious insulin 
overdosing in adolescents with 
type 1 diabetes. 
Included 
 
 1220. Survey of antiobesity 
drug prescribing for obese 
children and young people in 
UK primary care 
Title Population: do not have T1DM 
 1221. Survey of insulin site 




 1222. Sustained CGM use in 
low income youth following 
insurance coverage 
Title Outcome: not related to insulin treatment 
adherence 
 1223. SWEET: Developing 
centers of excellence (CoR) 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1224. Systematic 
desensitization in the 
treatment of needle phobias 
for children with diabetes 
Full Text Wrong study type (review, conference abstract 
etc.) 
 1225. Systematic Review of 
the Cost Effectiveness of Insulin 
Analogues in Type 1 and Type 2 
Diabetes Mellitus. 
Title Outcome: not related to insulin treatment 
adherence 
 1226. Tamoxifen suppresses 
pancreatic ß-cell proliferation 
in mice. 
Title Population: not humans 
 1227. Targeting optimal 
metabolic parameters in type 1 
diabetes mellitus and coeliac 
disease: An extra challenge 
Title Outcome: not related to insulin treatment 
adherence 
 1228. Teaching children with 
diabetes about adequate 
dietary choices 
Title Outcome: not related to insulin treatment 
adherence 
 1230. Technical determinants 
of diabetes control in insulin 
pump therapy in children and 
adolescents 
Abstract Outcome: not related to insulin treatment 
adherence 
 1231. Teen power: Group 
intervention for poorly 
adherent teens with insulin-
treated diabetes mellitus and 
their families 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1232. Teenagers with 
diabetes--management 
challenges 
Abstract Outcome: not related to insulin treatment 
adherence 
 1234. Telemedicine and type 1 
diabetes: is technology per se 
sufficient to improve glycaemic 
control? 
Abstract Outcome: not related to insulin treatment 
adherence 
 1235. Ten years' evaluation of 
diet, anthropometry, and 
physical exercise adherence 
after islet allotransplantation. 
Title Outcome: not related to insulin treatment 
adherence 
 1236. Tender hepatomegaly 
and abnormal pattern of 
hepatic steatosis in non-
compliant adolescents with 
poorly controlled type 1 
diabetes mellitus 
Abstract Outcome: not related to insulin treatment 
adherence 
 1237. The 600-step program 
for type 1 diabetes self-
management in youth: the 
magnitude of the self-
management task. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1239. The advantages of bolus 
advisor for automatic 
calculation of preprandial 
insulin requirements in patients 
with type 1 diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1240. The Audit of Diabetes-
Dependent Quality of Life 19 
(ADDQoL): feasibility, reliability 
and validity in a population-
based sample of Australian 
adults 
Title Population: not children (adults/foetuses) 
 1241. The barriers against 
initiating insulin therapy 
among patients with diabetes 
living in Yazd, Iran 
Title Outcome: not related to insulin treatment 
adherence 
 1242. The basal to total insulin 
ratio in outpatients with 
diabetes on basal-bolus 
regimen. 
Title Outcome: not related to insulin treatment 
adherence 
 1243. The burden of severe 
hypoglycemia in type 1 
diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1244. The challenging years: 
Surviving adolescence 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1245. The Choice Should Be 
Yours: Diabetes-Related 
Distress by Insulin Delivery 
Method for People with Type 1 
Diabetes. 
Abstract Population: not children (adults/foetuses) 
 1246. The contribution of art 
therapy in poorly controlled 
youth with type 1 diabetes 
mellitus 
Abstract Outcome: not related to insulin treatment 
adherence 
 1248. The contribution of hope 
and affectivity to diabetes-
related disability: An 
exploratory study 
Title Outcome: not related to insulin treatment 
adherence 
 1249. The course of glucose 
intolerance in children with 
cystic fibrosis: a retrospective 
study - preliminary report 
Title Population: do not have T1DM 
 1250. The current status of 
treatment-related severe 
hypoglycemia in Japanese 
patients with diabetes mellitus: 
a report from the committee on 
a survey of severe 
hypoglycemia in the Japan 
Diabetes Society. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1251. The daily (Daily 
Automated Intensive Log for 
Youth) trial: A wireless, 
portable system to improve 
adherence and glycemic 
control in youth with diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 




support from family members 
Included 
 
 1254. The diabetic 
ketoacidosis 
Title Outcome: not related to insulin treatment 
adherence 
 1255. The diet in children with 
diabetes mellitus (DM) 
Title Outcome: not related to insulin treatment 
adherence 
 1256. The Effect of Family-
centered Care on Management 
of Blood Glucose Levels in 
Adolescents with Diabetes. 
Included 
 
 1257. The effect of limited and 
strategic blood glucose 
monitoring on metabolic 
control in an indian type 1 
diabetes clinic 
Title Outcome: not related to insulin treatment 
adherence 
 1258. The effect of metformin 
in overweight patients with 
type 1 diabetes and poor 
metabolic control. 
Title Outcome: not related to insulin treatment 
adherence 
 1259. The effect of nutritional 
status on the endocrine 
system: Endocrinologist's role 
in approaching malnutrition in 
young adults with cystic 
fibrosis 
Title Population: do not have T1DM 
 1260. The effect of peer 
support in adults with insulin 
pump-treated type 1 diabetes: 
a pilot study of a flexible and 
participatory intervention. 
Title Population: not children (adults/foetuses) 
 1261. The effect of the Talking 
Diabetes consulting skills 
intervention on glycaemic 
control and quality of life in 
children with type 1 diabetes: 
Cluster randomised controlled 
trial (DEPICTED study) 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1263. The effect of whole body 
vibration training on insulin 
sensitivity in overweight 
adolescents: A randomized 
controlled trial 
Title Population: do not have T1DM 
 1264. The effectiveness of a 
daily practice clinical weight 
management program on 
cardiometabolic risk in obese 
children 
Title Population: do not have T1DM 
 1265. The effectiveness of 
Internet-based blood glucose 
monitoring system on 
improving diabetes control in 
adolescents with type 1 
diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1266. The Effects of Mental 
Stress on Non-insulin-
dependent Diabetes: 
Determining the Relationship 
Between Catecholamine and 
Adrenergic Signals from Stress, 
Anxiety, and Depression on the 
Physiological Changes in the 
Pancreatic Hormone Secretion. 
Title Population: do not have T1DM 
 1267. The effects of parent 
education on adherence and 
metabolic control of children 
with insulin-dependent 
diabetes mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1268. The effects of 
psychosocial factors on control 
and compliance with diabetes 
treatment regimens in a 
sample of children with insulin-
dependent diabetes mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1269. The effects of targeting 
improvements in urine glucose 
on metabolic control in children 
with insulin dependent 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1270. The effects of weight 
status on treatment outcomes 
in a randomized clinical trial of 
multisystemic therapy for 
adolescents with type 1 
diabetes and chronically poor 
metabolic control 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1272. The efficacy and safety 
of growth hormone (GH) 
treatment used for children 
born small for gestational age 
(SGA) between 1991-2011: The 
experience of a regional centre 
Title Population: do not have T1DM 
 1273. The efficacy of intensive 
individual play therapy for 
children diagnosed with 
insulin-dependent diabetes 
mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1274. The efficacy of intensive 
individual play therapy for 
chronically ill children 
Included 
 
 1275. The efficiency of 
telemedicine to optimize 
metabolic control in patients 
with type 1 diabetes mellitus: 
Telemed study. 
Abstract Population: not children (adults/foetuses) 
 1276. The egg or the chicken? 
Further data on whether good 
compliance to multi-injection 
insulin therapy should be a 
criterion for insulin pump 
therapy, or does insulin pump 
therapy improve compliance? 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1277. The egg or the chicken? 
Should good compliance to 
multi-injection insulin therapy 
be a criterion for insulin pump 
therapy, or does insulin pump 
therapy improve compliance? 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1278. The establishment of a 
new national network leads to 
quality improvement in 
childhood diabetes: 
Implementation of the ISPAD 
Guidelines 
Title Outcome: not related to insulin treatment 
adherence 
 1280. The feasibility of peer 
mentoring to improve 
adherence in adolescents and 
young adults with type 1 
diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1281. The focus is on the 
families: Racial differences in 
parents' perception of diabetes 
care 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1282. The health and lifestyles 
of adolescents with type 1 
diabetes in Portugal 
Abstract Outcome: not related to insulin treatment 
adherence 
 1283. The health belief model 
and adolescents with insulin-
dependent diabetes mellitus 
Included 
 
 1284. The impact of adherence 
to the nutritional education on 
glycemic control and quality of 
life in children and adolescents 
with type 1 diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 1285. The impact of ethnicity, 
educational and economic 
status on the prescription of 
insulin therapeutic regimens 
and on glycemic control in 
patients with type 1 diabetes. A 
nationwide study in Brazil. 
Title Outcome: not related to insulin treatment 
adherence 
 1286. The impact of family 
functioning on treatment 
adherence and metabolic 
control for adolescents with 
poorly controlled type 1 
diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1287. The impact of insulin 
glargine on clinical and 
humanistic outcomes in 
patients uncontrolled on other 
insulin and oral agents: an 
office-based naturalistic study. 
Title Outcome: not related to insulin treatment 
adherence 
 1288. The impact of mothers' 
sense of empowerment on the 
metabolic control of their 
children with juvenile diabetes 
Included 
 
 1289. The Impact of Patient-
Centered Medical Homes on 
Quality of Care and Medication 
Adherence in Patients with 
Diabetes Mellitus 
Abstract Outcome: not related to insulin treatment 
adherence 
 1290. The impact of 
physiological, therapeutic and 
psychosocial variables on 
glycemic control in youth with 
type 1 diabetes mellitus 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1292. The Impact of Self-
Monitoring Blood Glucose 
Adherence On Glycemic Goal 
Attainment in an Indigent 
Population, With Pharmacy 
Assistance. 
Title Outcome: not related to insulin treatment 
adherence 
 1293. The impact of sensor-
augmented insulin pump (SAP) 
therapy on quality of life (QOL) 
in children and adolescents 
with type 1 diabetes (T1D) and 
their parents 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1294. The impact of sleep on 
adherence behaviors in 
adolescents with type 1 
diabetes mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1295. The Impact of 
Technology on Current 
Diabetes Management. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1297. The influence of patient 
variables on insulin total daily 
dose in paediatric inpatients 
with new onset type 1 diabetes 
mellitus. 
Title Outcome: not related to insulin treatment 
adherence 
 1298. The influence of process, 
structure and policy on HbA1c 
levels in treatment of children 
and adolescents with type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1301. The Interactive Effect of 
Diabetes Family Conflict and 
Depression on Insulin Bolusing 
Behaviors for Youth 
Included 
 
 1302. The International 
Diabetes Closed-Loop Study: 
Testing Artificial Pancreas 
Component Interoperability 
Title Outcome: not related to insulin treatment 
adherence 
 1303. The International 
Xenotransplantation 
Association consensus 
statement on conditions for 
undertaking clinical trials of 
porcine islet products in type 1 
diabetes--chapter 3: Pig islet 
product manufacturing and 
release testing. 
Title Population: not humans 
362 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1304. The JDRF CCTN CGM 
TIME Trial: Timing of Initiation 
of continuous glucose 
Monitoring in Established 
pediatric type 1 diabetes: Study 
protocol, recruitment and 
baseline characteristics 
Title Outcome: not related to insulin treatment 
adherence 
 1306. The lived experiences of 
young people (13-16 years) 
with Type 1 diabetes mellitus 
and their parents--a qualitative 
phenomenological study. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1307. The multinational 
second Diabetes, Attitudes, 
Wishes and Needs study: 
results of the French survey. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1308. The natural history of 
brittle diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1309. The onset of a chronic 
disease as a traumatic psychic 
experience: A psychodynamic 
survey on type 1 diabetes in 
young patients 
Full Text Outcome: not related to insulin treatment 
adherence 
 1310. The patient-doctor 
relationship and metabolic 
control in patients with type 1 
(insulin-dependent) diabetes 
mellitus. 
Abstract Population: not children (adults/foetuses) 
 1311. The psychology of the 
adolescent with chronic 
disease: What to learn from the 
diabete 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1312. The relationship among 
independence, diet adherence, 
and ego identity in adolescents 
with insulin-dependent 
diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 1313. The relationship 
between adherence behaviors 
and metabolic control in 
childhood diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1314. The relationship 
between carbohydrate and the 
mealtime insulin dose in type 1 
diabetes. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1315. The relationship 
between diabetes self-
management and metabolic 
control in youth with type 1 
diabetes: an integrative 
review. 
Title Wrong study type (review, conference abstract 
etc.) 
 1316. The relationship 
between maternal fear of 
hypoglycaemia and adherence 
in children with type-1 
diabetes. 
Full Text Outcome: not related to insulin treatment 
adherence 
 1317. The relationship 
between negative 
communication and body 
image dissatisfaction in 




 1319. The relationship 
between primary care 
physicians' adherence to 
guidelines for the treatment of 
diabetes and patient 
satisfaction : findings from a 
pilot study. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1320. The relationship 
between psychological stress 
and insulin-dependent diabetic 
blood glucose control: 
preliminary investigations 
Abstract Population: not children (adults/foetuses) 
 1321. The Relationship 
between Self-Management 
and Glycemic Control in a 
Cohort of Children with Type 1 
and Type 2 Diabetes. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1322. The relationship of 
stress and coping to regimen 
adherence and glycemic 
control of diabetes 
Abstract Population: not children (adults/foetuses) 
 1323. The rise of technology in 
diabetes care. Not all that is 
new is necessarily better. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1324. The role of coping with 
disease in adherence to 
treatment regimen and disease 
control in type 1 and insulin 
treated type 2 diabetes 
mellitus. 
Abstract Population: not children (adults/foetuses) 
364 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1325. The role of diet 
behaviors in achieving 
improved glycemic control in 
intensively treated patients in 
the diabetes control and 
complications trial 
Title Outcome: not related to insulin treatment 
adherence 
 1326. The role of family 
environment and treatment 
adherence in the metabolic 
control of children with type 1 
diabetes: A meta-analysis 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1327. The role of health beliefs 
in the regimen adherence and 
metabolic control of 




 1328. The role of marital 
distress, parental and child 
depression, family functioning 
and health care behaviors in 
treatment adherence and 
metabolic control among 
adolescents with diabetes 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1329. The Role of Peers for 
Diabetes Management in 
Adolescents and Emerging 
Adults With Type 1 Diabetes: A 
Longitudinal Study. 
Full Text Population: not children (adults/foetuses) 
 1330. The role of self-
monitoring of blood glucose in 
the routine management of 
children with insulin-
dependent diabetes mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 1331. The screening and 
diagnosis of cystic fibrosis-
related diabetes in the United 
Kingdom 
Title Population: do not have T1DM 
 1332. The self-regulation of 
health behavior in children with 
insulin-dependent diabetes 
mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1333. The short-term results of 
intensive insulin therapy in 
preadolescent children with 
type-1 diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1334. The state of young 
adults with juvenile onset 
diabetes. 
Title Population: not children (adults/foetuses) 
365 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1335. The structure of parental 
involvement and relations to 
disease management for youth 
with type 1 diabetes. 
Included 
 
 1336. The theory of reasoned 
action in describing tooth 
brushing, dental caries and 
diabetes adherence among 
diabetic patients 
Full Text Population: not children (adults/foetuses) 
 1337. The Type 1 Diabetes-
Resistance Locus Idd22 
Controls Trafficking of 
Autoreactive CTLs into the 
Pancreatic Islets of NOD Mice. 
Title Population: not humans 
 1338. The unusual 
presentation and challenges in 
managing thyroid storm with 
concominant diabetic 
ketoacidosis 
Title Outcome: not related to insulin treatment 
adherence 
 1339. The ups and downs of 
low-carbohydrate diets in the 
management of Type 1 
diabetes: a review of clinical 
outcomes. 
Title Outcome: not related to insulin treatment 
adherence 
 1340. The use of a CoolSense 
device to lower pain sensation 
during finger pricking while 
measuring blood glucose in 
diabetes patients--a 
randomized placebo. 
Abstract Population: not children (adults/foetuses) 
 1341. The use of computers in 
the control of diabetes in 
children and adolescents. 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1342. The use of insulin pump 
therapy in adolescents 
Full Text Outcome: not related to insulin treatment 
adherence 
 1343. The use of premixed 
30/70 insulin in high risk youth 
with type 1 diabetes: A quality 
audit 
Title Outcome: not related to insulin treatment 
adherence 
 1344. The utility of natriuretic 
peptides as novel 
cardiovascular biomarkers in 
girls with Turner syndrome: 
Comparison of findings to 
obese children and adolescents 
Title Population: do not have T1DM 
 1345. There is a bright future 
in the management of diabetes 
in children in resource limited 
countries 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1346. Thyroiditis as a silent 
cause of hyperglycaemia in 
type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1347. Tiempo de exposicion al 
gluten y marcadores de riesgo 
de diabetes mellitus insulino 
dependiente en pacientes 
celiacosRisk markers for 
insulin-dependent diabetes 
mellitus and duration of 
exposure to gluten in celiac 
patients 
Title Outcome: not related to insulin treatment 
adherence 
 1348. Time of Day When Type 
1 Diabetes Patients With 
Eating Disorder Symptoms 
Most Commonly Restrict 
Insulin. 
Abstract Population: not children (adults/foetuses) 
 1349. Time to failure of oral 
therapy in children with type 2 
diabetes: A single center 
retrospective chart review 
Title Population: do not have T1DM 
 1350. Timing of initiation of 
continuous glucose monitoring 
(CGM) in established pediatric 
diabetes (The CGM TIME trial) 
Title Outcome: not related to insulin treatment 
adherence 
 1351. Timing of Meal Insulin 
and Its Relation to Adherence 
to Therapy in Type 1 Diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1352. Tip 1 diyabetli 
cocuklarda glisemik kontrolu 
etkileyen faktorlerFactors 
influencing glycemic control in 
children with type 1 diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1353. To evaluate various 
precipitating factors for 
diabetic ketoacidosis 
Abstract Outcome: not related to insulin treatment 
adherence 
 1354. To study the clinical 
profile of children admitted 
with diabetic ketoacidosis in a 
Tertiary Hospital in India 
Abstract Outcome: not related to insulin treatment 
adherence 
 1355. To study the efficacy of 
intervention strategies on 
features of metabolic 
syndrome in asian urban 
adolescent girls with pcos 
Title Population: do not have T1DM 
367 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1356. To whatsapp or not to 
whatsapp? what could be done 
with new social media to 
manage type 1 diabetes in 
adolescents 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1357. Too sweet for too long? Abstract Population: do not have T1DM 
 1358. Total body irradiation 
(TBI) increases cardio-
metabolic risk and induces 
carotid vascular stiffness in 
survivors after hematopoietic 
cell transplant (HCT) for 
childhood hematologic 
malignancies 
Title Population: do not have T1DM 
 1359. Transition instead of 
transfer for drug treatment in 
adolescent diabetes type 1 
Title Outcome: not related to insulin treatment 
adherence 
 1360. Translation and 
validation of the diabetes self-
management profile (DSMP) in 
Brazilian Portuguese language: 
First instrument to access type 
1 diabetes self-management in 
a Brazilian pediatric population 
Abstract Outcome: not related to insulin treatment 
adherence 
 1361. Treatment of osteopenia 
in children with insulin-
dependent diabetes mellitus: 
The effect of 1alpha-
hydroxyvitamin D3 
Title Outcome: not related to insulin treatment 
adherence 
 1362. Treatment of type 1 
diabetes with insulin lispro 
during Ramadan. 
Full Text Population: not children (adults/foetuses) 
 1364. Treatment of type 2 
diabetes in a Hispanic 
population of South Florida - 
Economic analysis 
Title Population: do not have T1DM 
 1365. Treatment of type 2 
diabetes mellitus in children 
and adolescents 
Title Population: do not have T1DM 
 1366. Trends in cannabis use 
among patients with diabetes-
the national survey on drug use 
and health, 2005-2017 
Abstract Outcome: not related to insulin treatment 
adherence 
 1367. Trends in cardiovascular 
risk factor management in type 
1 diabetes by sex. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1368. Trends in health-related 
quality of life among 
adolescents with type 1 
diabetes mellitus in Saudi 
Arabia 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1369. Twin studies in diabetes 
mellitus. 
Title Outcome: not related to insulin treatment 
adherence 
 1370. Two cases of diabetic 
ketoacidosis in HNF1A-MODY 
linked to severe dehydration: Is 
it time to change the diagnostic 
criteria for MODY? 
Title Population: do not have T1DM 
 1371. Type 1 diabetes among 
adolescents: Reduced diabetes 
self-care caused by social fear 
and fear of hypoglycemia 
Included 
 
 1373. Type 1 diabetes and 
prolonged fasting 
Abstract Outcome: not related to insulin treatment 
adherence 
 1375. Type 1 diabetes mellitus Abstract Wrong study type (review, conference abstract 
etc.) 
 1376. Type 1 diabetes mellitus 
and pregnancy. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1377. Type 1 diabetes mellitus 
and sickle cell disease: A case 
series of pediatric patients at 
rainbow babies & children's 
hospital 
Abstract Outcome: not related to insulin treatment 
adherence 
 1378. Type 1 diabetes mellitus: 
Metabolic control before and 
after puberty 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1379. Type 1 diabetes 
structured education: What are 
the core self-management 
behaviours? 
Abstract Outcome: not related to insulin treatment 
adherence 
 1380. Type 1 diabetes, sickle 
thalassemia in a toddler, case 
report in Saudi Arabia 
Title Outcome: not related to insulin treatment 
adherence 
 1381. Type 2 diabetes mellitus 
in children and adolescents. 
Title Population: do not have T1DM 
 1382. Type 2 diabetes mellitus 
is becoming the most common 
type of diabetes in school 
children 
Title Population: do not have T1DM 
 1383. Type I diabetes mellitus 
in toddlers 
Abstract Outcome: not related to insulin treatment 
adherence 
 1384. UCD School of Medicine 
and Medical Science, SMMS, 
Summer Student Research 
Awards 2013, SSRA 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1385. UK service level audit of 
insulin pump therapy in 
paediatrics. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1386. Uncontrolled 
hypertension in type 1 
diabetes: assessment of 
patients' desires about 
treatment and improvement of 
blood pressure control by a 
structured treatment and 
teaching programme. 
Title Outcome: not related to insulin treatment 
adherence 
 1388. Uncovering undetected 
hypoglycemic events. 
Title Outcome: not related to insulin treatment 
adherence 
 1389. Underestimated impact 
of non-severe nocturnal 
hypoglycaemic events (NHEs) 
on patients' functioning and 
well being 
Title Outcome: not related to insulin treatment 
adherence 
 1390. Understanding your 
diabetic patient. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1391. Undiagnosed coeliac 
disease and risk of 
autoimmune disorders in 
subjects with type I diabetes 
mellitus 
Title Outcome: not related to insulin treatment 
adherence 
 1392. Unstable type 1 diabetes 
in adolescence 
Abstract Outcome: not related to insulin treatment 
adherence 
 1393. Updated and revised 
diabetes family conflict scale 
Full Text Outcome: not related to insulin treatment 
adherence 
 1395. Uptake of a novel tool to 
adjust insulin boluses, based on 
CGM trend arrows and insulin 
sensitivity (trend arrow 
adjustment tool); In children 
with type 1 diabetes, who are 
using insulin pump therapy and 
continuous glucose monitoring 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1396. Urine alpha-Glutathione 
S-Transferase, systemic 
inflammation and arterial 
function in juvenile type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1398. Use and discontinuation 
of continuous subcutaneous 
insulin infusion and continuous 
glucose monitoring in 
paediatric patients with type 1 
diabetes: Rates and causes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1399. Use of a glucose-
controlled insulin infusion 
system in children and 
adolescents with insulin-
dependent diabetes. 
Full Text Outcome: not related to insulin treatment 
adherence 
 1400. Use of an automated 
bolus calculator reduces fear of 
hypoglycemia and improves 
confidence in dosage accuracy 
in patients with type 1 diabetes 
mellitus treated with multiple 
daily insulin injections 
Full Text Outcome: not related to insulin treatment 
adherence 
 1402. Use of an insulin pen 
with memory is not enough to 
give better glycaemic control 
Abstract Outcome: not related to insulin treatment 
adherence 
 1403. Use of an integrated 
strip-free blood glucose 
monitoring system increases 
frequency of self-monitoring 
and improves glycemic control: 
Results from the ExAct study. 
Title Outcome: not related to insulin treatment 
adherence 
 1404. Use of Commonly 
Available Technologies for 
Diabetes Information and Self-
Management Among 
Adolescents With Type 1 
Diabetes and Their Parents: A 
Web-Based Survey Study. 
Included 
 




automated data processing in 
a pediatric trial of tight 
glycemic control 
Abstract Outcome: not related to insulin treatment 
adherence 
 1406. Use of continuous 
subcutaneous insulin infusion 
(insulin pump) therapy in the 
hospital: a review of one 
institution's experience. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1407. Use of FGM as a clinical 
tool in type 1 diabetes young 
adults 
Title Outcome: not related to insulin treatment 
adherence 
 1408. Use of insulin pump 
therapy at nighttime only for 
children 7-10 years of age with 
type 1 diabetes 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1410. Use of multisystemic 
therapy to improve regimen 
adherence among adolescents 
with type 1 diabetes in chronic 
poor metabolic control: a 
randomized controlled trial. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1411. Use of nutrition therapy 
in the management of diabetes 
mellitus. 
Title Outcome: not related to insulin treatment 
adherence 
 1412. Use of the real-time 
continuous glucose monitor at 
initiation of insulin pump 
therapy in children and 
adolescents 
Abstract Outcome: not related to insulin treatment 
adherence 
 1413. Using a primary nurse 
manager to implement DCCT 
recommendations in a large 
pediatric program. 
Title Outcome: not related to insulin treatment 
adherence 
 1414. Using an injection port 
helps improve metabolic 
control and compliance to a 
strict basal-bolus regimen in 
children and adolescents with 
type 1 diabetes. 
Full Text Wrong study type (review, conference abstract 
etc.) 
 1415. Using behavioral 
interventions to assist children 
with type 1 diabetes manage 
blood glucose levels 
Full Text Outcome: not related to insulin treatment 
adherence 
 1416. Using gamification to 
encourage blood glucose 
testing in children with Type 1 
diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1417. Using insulin pump with 
a remote control system in 
patients with diabetes 
improves glyemic control and 
enhances patient satisfaction 
Abstract Outcome: not related to insulin treatment 
adherence 
 1418. Using mobile phones to 
measure adolescent diabetes 
adherence 
Abstract Outcome: not related to insulin treatment 
adherence 
 1420. Using spatio-temporal 
surveillance data to test the 
infectious environment of 
children before type 1 diabetes 
diagnosis. 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1421. Using the Internet-
based upload blood glucose 
monitoring and therapy 
management system in 
patients with type 1 diabetes. 
Title Outcome: not related to insulin treatment 
adherence 
 1422. USO DI INSULINE 
PREMISCELATE NEL 
TRATTAMENTO DEL BAMBINO 
DIABETICOUse of premixed 
insulins in the management of 
children with type 1 diabetes 
Title Outcome: not related to insulin treatment 
adherence 
 1423. Vaccination adherence 
to influenza, pneumococcal 
and hepatitis B virus in adult 
type 1 diabetes mellitus 
patients. 
Title Population: not children (adults/foetuses) 
 1424. Validation of a 
contemporary adherence 
measure for children with Type 
1 diabetes: The Diabetes 
Management Questionnaire 
Abstract Outcome: not related to insulin treatment 
adherence 
 1426. Validation of a diabetes 
self-care measure for parents 
of children with type 1 diabetes 
Abstract Outcome: not related to insulin treatment 
adherence 
 1427. Validation of a diabetes-
specific quality-of-life scale for 
patients with type 1 diabetes. 
Full Text Population: not children (adults/foetuses) 
 1428. Validation of an 
abbreviated adherence 
measure in youth with type 1 
diabetes (T1D) 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1429. Validation of the 
diabetes self management 
profile-self report form: 
Measure of adolescent 
adherence 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1430. Value of serum 1,5-
anhydroglucitol measurements 
in childhood obesity in the 
continuum of diabetes 
Title Population: do not have T1DM 
 1431. Variations in the quality 
and sustainability of long-term 
glycaemic control with 
continuous subcutaneous 
insulin infusion. 
Title Outcome: not related to insulin treatment 
adherence 
 1432. Vessel wall properties of 
large arteries in uncomplicated 
IDDM 




Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1433. Victimization of youth 
with type-1 diabetes by 
teachers: relations with 




 1435. Virtual reality and 
interactive gaming technology 
for obese and diabetic children: 
is military medical technology 
applicable? 
Abstract Outcome: not related to insulin treatment 
adherence 
 1436. Visceral fat, 
independent of total-body 
adiposity, is associated with 
cardiovascular risk factors, 
insulin resistance, and vascular 
dysfunction among children 
and adolescents 
Title Population: do not have T1DM 
 1437. Web-based diabetes 
education and coping skills 
training 
Abstract Outcome: not related to insulin treatment 
adherence 
 1438. Weight gain associated 
with intensive therapy in the 
diabetes control and 
complications trial. The DCCT 
Research Group. 
Full Text Outcome: not related to insulin treatment 
adherence 
 1439. What do professionals 
recommend regarding the 
frequency of self-monitoring of 
blood glucose? 
Title Outcome: not related to insulin treatment 
adherence 
 1440. What's new in the 
psychosomatics of insulin-
dependent diabetes mellitus 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1441. When to treat a diabetic 
patient using an external 
insulin pump. Expert 
consensus. Société 
francophone du diabète (ex 
ALFEDIAM) 2009. 
Title Outcome: not related to insulin treatment 
adherence 
 1442. White Coat Adherence in 
Pediatric Patients with Type 1 




 1444. White Coat Adherence 
Occurs in Adolescents with 
Type 1 Diabetes Receiving 
Intervention to Improve Insulin 
Pump Adherence Behaviors 
    
374 
 
Result Number and Title Excluded 
by/included 
First Exclusion Criteria Met 
 1445. Who participates in 
research on adherence to 
treatment in insulin-dependent 
diabetes mellitus? Implications 
and recommendations for 
research. 
Abstract Outcome: not related to insulin treatment 
adherence 
 1446. Wilson disease and 
metabolic syndrome: Is there a 
link? 
Title Population: do not have T1DM 
 1447. WITHDRAWN: Inhaled 
insulin in diabetes mellitus. 
Abstract Wrong study type (review, conference abstract 
etc.) 
 1448. Wolfram (DIDMOAD) 
syndrome: A multidisciplinary 
clinical study in nine Turkish 
patients and review of the 
literature 
Title Outcome: not related to insulin treatment 
adherence 
 1449. Wystepowanie celiakii 
oraz chorob 
autoimmunologicznych 
tarczycy u dzieci i mlodziey z 
cukrzyca typu 1 z regionu 
Dolnego SlaskaThe incidence 
celiac disease and autoimmune 
thyroid diseases in children and 
adolescents with diabetes type 
1 from Lower Silesia 
Title Outcome: not related to insulin treatment 
adherence 
 1450. Yineleyen diyabetik 
ketoasidoz benzeri belirtiler ve 
yapay hiperglisemi, diyabet tip 




and factitious hyperglycemia 
as a munchausen syndrome in 
diabetes mellitus type 1: A case 
report 
Title Outcome: not related to insulin treatment 
adherence 
 1451. Young children's 
subjective reports about their 
diabetes mellitus: a validation 
of the Diabetes Pictorial Scale 
Title Outcome: not related to insulin treatment 
adherence 
 1452. Young patients with 
type 1 diabetes poorly 
controlled and poorly 
compliant with self-monitoring 
of blood glucose: can 
technology help? Results of the 
i-NewTrend randomized 
clinical trial 




Appendix 9 All studies found from database searching and if they were included or reasons for exclusion. Studies that have 
been left blank were either duplicates seen elsewhere in the table (often alternative language versions) or had been 




Search Number Database Search Term Number of Results 
1 EMBASE exp "INSULIN 
DEPENDENT DIABETES 




2 EMBASE ("type 1 
diabetes").ti,ab 
59 601 
3 EMBASE (1 OR 2) 916 691 
4 EMBASE (insulin).ti,ab 458 125 
5 EMBASE (3 AND 4) 201 771 
6 EMBASE (adherence).ti,ab 169 529 
7 EMBASE (compliance).ti,ab 175 573 
8 EMBASE (6 OR 7) 331 482 
9 EMBASE (5 AND 8) 4 406 
10 EMBASE 9 [Human age groups 
Infant to one year OR 
Child unspecified age 
OR Preschool Child 1 
to 6 years OR School 
Child 7 to 12 years OR 
Adolescent 13 to 17 
years] 
727 
11 HMIC exp "INSULIN 
DEPENDENT DIABETES 




12 HMIC ("type 1 
diabetes").ti,ab 
168 
13 HMIC (11 OR 12) 2 907 
14 HMIC (insulin).ti,ab 645 
15 HMIC (13 AND 14) 371 
16 HMIC (adherence).ti,ab 1 474 
377 
 
17 HMIC (compliance).ti,ab 2 256 
18 HMIC (16 OR 17) 3 603 
19 HMIC (15 AND 18) 21 
21 Medline exp "DIABETES 
MELLITUS, TYPE 1"/ 
73 975 
22 Medline ("type 1 
diabetes").ti,ab 
37 576 
23 Medline (21 OR 22) 85 036 
24 Medline (insulin).ti,ab 345 339 
25 Medline (23 AND 24) 34 757 
26 Medline (adherence).ti,ab 110 853 
27 Medline (compliance).ti,ab 109 996 
28 Medline (26 OR 27) 214 135 
29 Medline (25 AND 28) 711 
50 Medline 29 [Human age groups 
Infant OR 
Child,preschool OR 
Child OR Adolescent] 
342 
31 PsycINFO exp "DIABETES 
MELLITUS"/ 
8 102 
32 PsycINFO ("type 1 
diabetes").ti,ab 
1 868 
33 PsycINFO (31 OR 32) 9 281 
34 PsycINFO (insulin).ti,ab 10 647 
35 PsycINFO (33 AND 34) 2 050 
36 PsycINFO (adherence).ti,ab 27 143 
37 PsycINFO (compliance).ti,ab 22 868 
38 PsycINFO (36 OR 37) 48 566 
39 PsycINFO (35 AND 38) 234 
51 PsycINFO 39 [Human age groups 
Childhood birth-12 Yrs 
OR Neonatal birth-1 
Mo OR Infancy 2-23 




2-5 Yrs OR School Age 
6-12 Yrs OR 
Adolescence 13-17 
Yrs] 
41 PubMed ("type 1 diabetes" OR 
"insulin dependent 
diabetes" OR "juvenile 
onset diabetes").ti,ab 
38 798 
42 PubMed ("type 1 
diabetes").ti,ab 
38 519 
43 PubMed (41 OR 42) 39 798 
44 PubMed (insulin).ti,ab 404 899 
45 PubMed (43 AND 44) 17 502 
46 PubMed (adherence).ti,ab 152 775 
47 PubMed (compliance).ti,ab 178 118 
48 PubMed (46 OR 47) 288 448 
49 PubMed (45 AND 48) 599 
Appendix 10: Full search strategy used during systematic review. Legend; EMBASE: Excerpta Medica Database, HMIC: 
Healthcare Management Information Consortium, exp: explode – used within search engine to include the term as well as 






















 Appendix 15 Submitted ethical amendment 2. 
